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Structural self-healing of Fiber Reinforced Polymer Composites (FRPC) using 
microencapsulated 5E2N/Grubbs catalyst system is investigated in this work for low 
temperature applications. Microcapsule containing liquid 5E2N monomer in poly 
melamine urea formaldehyde (PMUF) shells have been synthesized following the in-situ 
polymerization technique. The effects of stirring speed and concentration of surfactant on 
the quality of microcapsules in terms of their average sizes, size distribution, surface 
morphology and shell thickness are investigated. An optimum combination of stirring 
speed-SLS concentration is established through numerous synthesis trials of 
microcapsules. The feasibility of self-healing with the current materials system is first 
demonstrated by visually observing the healing of crack network that is created on 
unreinforced epoxy samples impacted with high velocity projectiles. Different strength-
based approaches like impact-heal-flexure, flexure-heal-flexure are examined to evaluate 
the self-healing performance of FRPC in the preliminary investigations. A fracture based 
approach based on the mode II delamination of FRPC which deals with determining 
material properties independent of geometry of samples is found to be a better choice for 
the evaluation of healing performance of FRPC. In the new proposed protocol, healing 
performance is evaluated by measuring and comparing the mode II fracture toughness of 
regular neat (not incorporated with healing agents) and modified (incorporated with 
healing agents) FRPC samples during the Non pre-cracked (NPC) and Pre-cracked (PC) 
test post healing without any manual intervention for achieving healing. Healing 
performance index, instead of healing efficiency, is defined by comparing the fracture 
toughness of regular and modified samples taking into account the possible toughening or 
weakening effect of incorporating healing agents into the composites. Healing 
performance index is shown to be a better and realistic indicator of actual healing 
performance than conventional healing efficiency definition. Effects of average size and 
 iv 
concentration of microcapsules on the self-healing performance of FRP composites are 
investigated at room temperature using the proposed protocol. Finally, the effect of low 













































 I like to express my sincere gratitude to my supervisor, Dr. Suong Van Hoa, for 
his support in guiding me towards achieving my dream Ph.D. degree in mechanical 
engineering at Concordia University. His passion for excellence enlightened and 
energized me to love my work and overcome the difficulties of research works through 
tireless efforts. His suggestions, valuable discussions and continuous guidance stimulated 
critical thinking and showed me the right directions in fulfilling the objectives of my 
Ph.D. research works. 
 I would like to remember and be grateful to late Dr. Ming Xie who helped me feel 
at home as a member of CONCOM (Concordia Centre for Composite Materials) research 
group. He and subsequently, Dr. Daniel Rosca, helped me a lot in providing technical 
supports to carry out my research works. I would also like to acknowledge the supports of 
the technical and administrative support staff of the department and all my colleagues for 
their support and cooperation.  
 I appreciate the support of my wife, Hasna Hena Zamal, and our child, Warsi 
Azam Khan, who sacrificed a lot and made this challenging journey enjoyable for me. I 
also like to thank all my family members who were always a source of inspiration for me. 
I would like to dedicate my work to my late father, Golam Mohiuddin Khan, who 
transferred his passion for knowledge to me. 
Finally, the financial support from NSERC (Natural Sciences and Engineering 
Research Council of Canada) and CSA (Canadian Space Agency) in carrying out this 
study is gratefully acknowledged.  
 vi 
Table of Contents 
 
 
List of figures ....…………………………………………………………………………ix 
List of tables …..……………………………………………………………………….xvii 
CHAPTER 1 ...................................................................................................................... 1 
Framework and Scope of the Work ................................................................................ 1 
1.1 Introduction .......................................................................................................... 1 
1.2 Motivation ............................................................................................................ 5 
1.3 Objectives of the work ......................................................................................... 6 
1.4 Scope of the Current Work................................................................................... 7 
1.5 Construction of the thesis ..................................................................................... 8 
CHAPTER 2 ...................................................................................................................... 9 
Literature Review............................................................................................................ 9 
2.1 Introduction .......................................................................................................... 9 
2.2 Category of healing concepts ............................................................................. 10 
2.2.1 Hollow fiber approach .................................................................................... 13 
2.2.2 Hollow channel/microvascular network approach ......................................... 20 
2.2.3 Microencapsulation approach ......................................................................... 29 
2.3 5-Ethylidene-2-norbornene (5E2N) as a candidate for microencapsulated 
healing agent ................................................................................................................. 42 
CHAPTER 3 .................................................................................................................... 45 
Synthesis of Microcapsules and Investigation of the Effect of Processing Parameters 
on their Quality Characteristics .................................................................................... 45 
3.1   Introduction ....................................................................................................... 45 
3.2 Synthesis of microcapsules and the key roles of different ingredients used in the 
encapsulation process.................................................................................................... 45 
3.2.1 Materials, processes and preliminary synthesis runs ...................................... 46 
3.2.2 Understanding the mechanism and the role of different ingredients used in the 
encapsulation process.................................................................................................... 51 
3.3 Investigating the effect of processing parameters on the quality of microcapsules
 55 
3.3.1 Effect of agitation speed ................................................................................. 56 
3.3.2 Effect of SLS concentration ........................................................................... 64 
3.3.3 Optimum combinations of agitation speed and SLS concentration ..................... 69 
3.4 Thermal stability and core monomer content of microcapsules ........................ 78 
3. 5 Concluding remarks ............................................................................................... 80 
 vii 
CHAPTER 4 .................................................................................................................... 81 
Preliminary Experiments .............................................................................................. 81 
4.1   Introduction ....................................................................................................... 81 
4.2  Demonstration of self-healing of resin sample (without reinforcement) ........... 82 
4.2.1 Fabrication of modified resin sample and impact condition ................................ 82 
4.2.2 Observation and analysis of self-healing ............................................................. 83 
4.3  Investigation of self-healing of FRP composites ............................................... 90 
4.3.1 Flexure After Impact (FAI) .................................................................................. 90 
4.3.2 Flexure after Flexure (FAF) ............................................................................... 101 
4.4 Concluding remarks .............................................................................................. 109 
CHAPTER 5 .................................................................................................................. 110 
Protocol for Evaluating Self-Healing Performance of FRPC and Scenario Analysis 110 
5.1   Introduction ..................................................................................................... 110 
5.2 Assessment of the mode I fracture test protocol and definition of a new protocol
 110 
5.2.1 Elaboration of healing performance index and definition of conventional 
healing efficiency ........................................................................................................ 116 
5.3 Qualitative comparisons of healing performance index and conventional healing 
efficiency..................................................................................................................... 118 
5.3.1 Scenario analysis .......................................................................................... 120 
5.4 Summary of the distinguishing features of the new protocol versus existing 
protocol for evaluating healing performance .............................................................. 131 
CHAPTER 6 .................................................................................................................. 134 
Investigation of Self-healing of FRP Composites at Room Temperature .................. 134 
6.1   Introduction ..................................................................................................... 134 
6.2  Fabrication of composite samples .................................................................... 134 
6.2.1 Formulation of epoxy matrix ............................................................................. 135 
6.2.2 Fabrication of FRP composite samples.............................................................. 136 
6.3 Fracture test procedure and measurement of mode II fracture toughness of 
composites................................................................................................................... 139 
6.4   Results and Discussions .................................................................................. 153 
6.4.1 Elaboration of representative load-displacement curves and measured values of 
fracture toughness of regular (Type I) composite sample as example ........................ 153 
6.4.2. Effect of inclusion of microcapsules on the NPC fracture toughness of composite 
samples ........................................................................................................................ 156 
6.4.3 Effect of self-healing on PC fracture toughness of composite samples............. 168 
6.5 Comparison of fracture toughness and evaluation of healing performance of the 
composites................................................................................................................... 179 
6.6 Conclusions ........................................................................................................... 187 
 viii 
CHAPTER 7 .................................................................................................................. 189 
Investigation of Self-healing of FRP Composites at Low Temperature ..................... 189 
7.1   Introduction ..................................................................................................... 189 
7.2   Limitations of healing agents at low temperature and choice of suitable catalyst
 190 
7.2.1 Understanding the mechanism of self-healing reaction between 5E2N and Grubbs 
catalyst ........................................................................................................................ 190 
7.3   Fabrication of composite samples ................................................................... 195 
7.3.1 Fabrication of epoxy (without reinforcement) samples ..................................... 195 
7.4 Testing................................................................................................................... 196 
7.4.1 Thermal shock testing of unreinforced epoxy sample ....................................... 197 
7.4.2 Fracture test of fiber reinforced composites at low temperature (-40oC) .......... 197 
7.4.3 Set up for low temperature test .......................................................................... 198 
7.4.4 Types of tests performed on different types of FRP samples at  -40oC ............. 200 
..................................................................................................................................... 201 
7.5 Results and Discussions ........................................................................................ 201 
7.5.1 Result of the thermal shock experiment of unreinforced epoxy samples .......... 201 
7.5.2 Effect of inclusion of microcapsules on the low temperature NPC fracture 
toughness of FRP composite samples ......................................................................... 204 
7.5.3 Effect of self-healing on the low temperature PC fracture toughness of composite 
samples ........................................................................................................................ 208 
7.5.4 Comparison of fracture toughness and evaluation of healing performance of the 
composites tested at low temperature ......................................................................... 212 
7.5.5 Effect of low temperature on the self-healing performance of the composites . 217 
7.6 Conclusions ........................................................................................................... 223 
CHAPTER 8 .................................................................................................................. 224 
Conclusions, Contributions and Recommendations for Future Work ........................ 224 
8.1   Conclusions ..................................................................................................... 224 
8.2   Contributions ................................................................................................... 226 















List of figures 
Figure 1.1 Damage modes in polymer composites. Indentation, impact, corrosive environments, 
ballistic punctures, surface scratching, and fatigue can lead to various damage modes in polymer 
composites, as shown here: The type of composite system, the nature of the polymer matrix, and 
the extent and rate of loading all influence the type and extent of damage modes [2] 2 
Figure 1.2 The autonomic healing concept. A microencapsulated healing agent is embedded in a 
structural composite matrix containing a) catalyst capable of polymerizing the healing agent. i) 
Cracks form in the matrix wherever damage occurs; ii) the crack ruptures the microcapsules, 
releasing the healing agent into the crack plane through capillary action; iii) the healing agent 
contacts the catalyst, triggering polymerization that bonds the crack faces closed. [3] 4 
Figure 2.1 Common existing and conceptual repair methods for advanced FRPC structures 12 
Figure 2.2 Fiber breaks due to loading; chemical is released at break [19] 13 
Figure 2.3 Self-healing system proposed and investigated by Nishiwaki et al. [24] 15 
Figure 2.4 Variations of healing strategy using the hollow fiber approach [29] 17 
Figure 2.5 Schematic diagram of the vacuum assisted capillary action filling technique [29] 18 
Figure 2.6 Schematic diagram of the self-healing structure composed of a microvascular 
substrate and a brittle epoxy coating containing embedded catalyst in a four-point bending 
configuration monitored with an acoustic-emission sensor [35] 20 
Figure 2.7 Healing efficiency for specimens with 2 wt%, 5 wt% and 10 wt% catalyst in the 
coating that exhibited healing. The white numbers at the bottom of each column denote the 
number of successfully healed specimens in the average and the error bars are one standard 
deviation [35] 22 
Figure 2.8 Schematic view of epoxy coating/substrate architecture with embedded 
interpenetrating microvascular networks. Two of these networks house epoxy resin (blue) and 
hardener (red), while the third network provides thermal control (green) to accelerate healing 
kinetics after damage occurs [39] 24 
Figure 2.9 Transverse vascule fabricated via a) route A and b) route B [41] 26 
Figure 2.10 Image of the fracture sample and schematic detailing microchannel position and 
content [44] 27 
Figure 2.11 Schematic images of sacrificial fibers embedded in a matrix and subsequential fiber 
removal resulting in microvascular networks in the matrix [47] 28 
Figure 2.12 Micro CT image of glass/epoxy composite embedded with Ga-In filled 3D 
microvascular network [45] 29 
Figure 2.13 TDCB geometry; samples were prepared with three SMA wires perpendicular to the 
crack plane, spaced uniformly. The distance units are mm [54] 31 
Figure 2.14 Load-displacement curve of the epoxy TDCB fracture specimen containing DCPD 
microcapsules, Grubbs catalyst and SMA wires [54]. Virgin sample actually refers to the 
modified resin sample (with healing agents) during the first loading of the fracture test method 32 
Figure 2.15 a) DCB specimen during testing [56] and b) schematic of WTDCB specimen [57] 32 
Figure 2.16 a) Reference specimen where catalyzed healing agent is manually injected into the 
delamination after first loading; b) Self-activated specimen where catalyst is already embedded 
 x 
in the matrix and only monomer is manually injected into the delamination and c) Self-healing 
specimen where both encapsulated monomer and catalyst are embedded into the matrix [57] 33 
Figure 2.17 Residual compressive strength (RCS) for non-healing control panels (C-III, micro-
encapsulated DCPD and wax microsphere, no catalyst) and self-healing panels (SH, 
microencapsulated DCPD and catalyst) versus nominal incident impact energy. Error bars are 
±one standard deviation. Also plotted is a fit to RCS [58] 35 
Figure 2.18 Skin/stiffener flange debond specimen configuration [59] 35 
Figure 2.19 Self-healing (modified) prepreg [59] 36 
Figure 2.20 Typical load-displacement curves recorded during TDCB tests. The fracture loads of 
both unfilled epoxy and manually healed unfilled epoxy specimens are shown in the form of 
horizontal lines as references. Healing of the fractured specimens was conducted at 25 C for 72 
h. [64] 38 
Figure 2.21 Evolution of shear storage modulus (G’) of various healing agents using a modified 
rheokinetic technique (ENB = Ethylidene Norbornene, NBE-MeBr = 5-Norbornene-2-
methylbromide,  NBE-MeCl = 5-Norbornene-2-methylchloride, DCPD = Dicyclopentadiene) [8]
 43 
Figure 3.1 Procedure to synthesize the MUF microcapsules containing Ethylidene-norbornene 
(ENB). [88] 46 
Figure 3.2 Set-up for the synthesis of microcapsules by in-situ polymerization method [sonication 
is introduced optionally]. 47 
Figure 3.3 Accumulation of microcapsules on the top of the mixture 48 
Figure 3.4 a) Filtering of microcapsules after washing and b) freely flowing particles indicating 
successful synthesis of microcapsules 49 
Figure 3.5 a) Microcapsule synthesized according to flowchart in figure 1 and with 500 rpm 
agitation speed and b) their distribution of sizes (diameters) 50 
Figure 3.6 5-ethylidene-2-norbornene (5E2N) [94] 52 
Figure 3.7 Urea [95] 52 
Figure 3.8 Melamine [95] 52 
Figure 3.9 Formaldehyde [95] 53 
Figure 3.10 Reaction scheme of PMUF   [95] 53 
Figure 3.11 Sodium Lauryl Sulphate (SLS) [96] 54 
Figure 3.12 Polyvinyl alcohol (PVA)   [94] 55 
Figure 3.13 Microcapsules produced with 600 rpm agitation speed keeping the SLS 
concentration fixed at 0.5 wt% and b) their size distribution 61 
Figure 3.14 Microcapsules obtained with 800 rpm agitation speed keeping the SLS concentration 
fixed at 0.5 wt% showing lot of dross produced during the in situ polymerization of the shell 
materials which sticks to the surface of the microcapsules 63 
Figure 3.15 Microcapsules produced with SLS concentration of 1 wt% keeping the agitation 
speed fixed at 600 rpm and b) their size distribution 65 
Figure 3.16 Comparison of surface morphology of microcapsules produced with 600 rpm 
agitation speed with a) 0.5 wt% SLS and b) 1 wt% SLS 66 
 xi 
Figure 3.17 Comparison of shell thickness of microcapsules produced with 600 rpm agitation 
speed with a) 0.5 wt% SLS and b) 1 wt% SLS 67 
Figure 3.18 Unsuccessful microencapsulation with 1.5 wt% SLS at 600 rpm 68 
Figure 3.19 a) Individually separated small microcapsules (average diameter 40 µm) produced 
with 850 rpm agitation speed and 1 wt% SLS and b) their size distribution 70 
Figure 3.20 a). Successful synthesis of small microcapsules (average diameter 30 µm) produced 
with 950 rpm agitation speed and 1.5 wt% SLS and b) their distribution of sizes 72 
Figure 3.21 a). Successful synthesis of small microcapsules (average diameter 12 µm) produced 
with 1200 rpm agitation speed and 2 wt% SLS and b) their distribution of sizes 74 
Figure 3.22 Comparison of surface morphology of microcapsules obtained with optimum 
agitation speed-SLS concentration a) 600 rpm-0.5 wt%, b) 850 rpm-1 wt% and c) 1200 rpm-
2wt% 75 
Figure 3.23 Comparison of shell thickness of microcapsules obtained with optimum agitation 
speed-SLS concentration a) 600 rpm-0.5 wt%, b) 850 rpm-1 wt% and c) 1200 rpm-2wt% 76 
Figure 3.24 Optimum combination of agitation speed-SLS concentration for successful 
production of free-flowing individually separated microcapsules with desired quality 
characteristics 77 
Figure 3.25 Typical TGA curve showing the thermal stability and core content of microcapsules
 79 
Figure 4.1 Single stage gas launcher [105] 82 
Figure 4.2 Photograph of the modified resin sample after impact a) side of the impact and b) 
opposite side of the impact 83 
Figure 4.3 Optical micrographs of the crack networks on the impacted modified resin sample 
showing examples of a) encounter of microcapsules with a propagated crack and b-f) cracks 
healed by monomer which oozed out from broken microcapsules and subsequent polymerization
 84 
Figure 4.4 Reconstructed image of the damaged region under 6.3X magnification 85 
Figure 4.5 Reconstructed image (downsized to accommodate to the paper) of the damaged region 
at the opposite side of the impacted modified resin sample. Each crack branched out from the 
centre is indicated by letters (B-H) and the crack in the outer circumference is indicated by letter 
A. 86 
Figure 4.6 [02/902]S Laminate construction with artificial flaws. Projectiles travel from bottom to 
top. Layers are also counted in the same direction; bottom (1), top (8). 91 
Figure 4.7 3-point bending samples prepared from regular and modified carbon/epoxy composite 
panels 92 
Figure 4.8 Shooting set up for the composite samples 92 
Figure 4.9 Calibration curves for the velocity of projectiles in high pressure gas gun [105] 93 
Figure 4.10 Typical delamination pattern of regular [02/902]S  composite sample with artificial 
mid-layer flaw under high velocity impact. Projectiles travel from bottom to top. Layers are also 
counted in the same direction; bottom (1), top (8). 94 
 xii 
Figure 4.11 Typical delamination pattern of modified [02/902]S composite sample with artificial 
mid-layer flaw under high velocity impact. Projectiles travel from bottom to top. Layers are also 
counted in the same direction; bottom (1), top (8). 95 
Figure 4.12 A composite sample undergoing flexural test on MTS machine equipped with three-
point bending fixture 96 
Figure 4.13 Load-displacement curves for regular composite samples after being shot with 
different impact energy with high velocity projectiles. 96 
Figure 4.14 Load-displacement curves for modified composite samples after being shot with 
different impact energies with high velocity projectiles. 97 
Figure 4.15 Residual stiffness retained by the composite samples after subjected to damage by 
impact and subsequent healing (modified composites) compared with regular samples (no 
healing ability) 99 
Figure 4.16 Peak loads per unit thickness (p/h) retained by the composite samples after subjected 
to damages by impact and subsequent healing (modified composites) compared with regular 
samples 100 
Figure 4.17 Test scheme 1 under FAF protocol for evaluation of self-healing performance 102 
Figure 4.18 Typical load-displacement curve with the proposed test scheme 1 under FAF 
protocol for evaluation of self-healing performance 103 
Figure 4.19 Test scheme 2 under FAF protocol for evaluation of self-healing performance 104 
Figure 4.20 Typical load-displacement curves for a) regular samples and b) modified samples 
with the proposed test scheme 2 105 
Figure 4.21 Comparison of stiffness of the regular and modified composite samples during the 
first loading and second loading under the test scheme 2. M refers to modified and R refers to 
regular composite samples. Error bars represent one standard deviation. 106 
Figure 4.22 Peak loads per unit thickness (p/h) retained by the regular and modified composite 
samples during the first and second loading under the test scheme 2. M refers to modified and R 
refers to regular composite samples. Error bars represent one standard deviation. 108 
Figure 5.1 Mode I fracture testing of a) resin (without reinforcement) sample [51] and b) FRPC 
sample [56] 111 
Figure 5.2 Schematic of the composite sample showing the relative positions of the tip of the 
crack a) before the NPC fracture loading b) After the NPC fracture loading and c) before the PC 
fracture loading [108]. 114 
Figure 5.3 Terms used in the healing performance indicators 118 
Figure 5.4 Comparison of conventional healing efficiency, ηh, c Vs healing performance index 
PI, for fixed values of m equals to a) 0.3, b) 0.4 and c) 0.5 according to equations (2b) and (5b). 
m is the % decrease of NPC fracture toughness of regular sample when a real precrack is 
present. 124 
Figure 5.5 Comparison of conventional healing efficiency, ηh, c Vs healing performance index 
PI, for fixed values of m according to equations (2d) and (5d). m is the % decrease of NPC 
fracture toughness of regular sample when a real precrack is present. 128 
Figure 5.6 Comparison of conventional healing efficiency, ηh, cVs healing performance index 
PI, for fixed values of m according to equations (2e) and (5e). m is the % decrease of NPC 
fracture toughness of regular sample when a real precrack is present. 130 
 xiii 
Figure 6.1 Vacuum bagging assembly 137 
Figure 6.2 Typical DSC curve for composite samples showing a complete curing of the samples
 138 
Figure 6.3 Composite sample, fixture and dimensions for NPC test [108] 140 
Figure 6.4 Typical plot of displacement Vs load data obtained in a NPC test of a composite 
sample to determine the compliances at different crack lengths. The sample configuration for the 
NPC test is shown in the inset of the graph. The peak load achieved during the compliance and 
fracture loadings are highlighted with star symbols. The calculated compliance value for each 
crack length is also shown encircled inside the graph. 142 
Figure 6.5 Plot of compliance Vs crack length cubed (a3) to determine the compliance 
parameters. The compliance values (y-axis values) indicated in the graph are taken from the 
previous graph in figure 6.4. The compliance parameters are calculated from the slope (m) and 
the y-axis intercept (A) of the line shown in the graph. 143 
Figure 6.6 Schematic of the composite sample showing the relative position of the tip of the a) 
artificial crack (pre-implanted insert) before the NPC fracture loading and b) natural crack after 
the NPC fracture loading. Dotted line represents the natural crack created due to the NPC 
fracture loading [108] 147 
Figure 6.7 Unloading compliance (Cu) determined from the displacement-load data obtained 
during the unloading after the NPC fracture loading. The unloading compliance value for the 
current example is encircled inside the graph. 149 
Figure 6.8 Schematic of the composite sample showing the relative position of the tip of the 
natural precrack for the PC fracture loading. Dotted line represents the natural crack created 
during the NPC fracture loading [108] 151 
Figure 6.9 Representative load-displacement curves for the NPC and PC fracture loading of 
regular (Type I) composite samples 153 
Figure 6.10 NPC and PC fracture toughness of regular (Type I) composite samples designated as 
NPC (0%) and PC (0%), respectively. Error bars represent one standard deviation of measured 
values. The scale and spacing of the graph are chosen for later comparisons. 155 
Figure 6.11 NPC fracture toughness of composite samples as a function of concentration of 
microcapsules of average size of 100 µm.  Error bars represent one standard deviation of 
measured values. 157 
Figure 6.12 Matrix-microcapsule debonding during crack propagation leaving deep impression 
of microcapsules on the fracture surface. 159 
Figure 6.13 NPC fracture toughness of composite samples as a function of concentration of 
microcapsules of average size of 45 µm.  Error bars represent one standard deviation of 
measured values. 160 
Figure 6.14 a) and b). SEM micrographs showing good bonding of smaller microcapsules 
(average size 45 µm) with the matrix on the fracture surface. 161 
Figure 6.15 SEM micrograph (2700X) showing broken shells of smaller microcapsules (average 
size 45 µm) still attached to the fracture surface. 162 
Figure 6.16 SEM micrographs showing features of fracture surface near NPC crack front of 
modified composite samples containing a) 2wt% (Type V) b) 5wt% (Type VI) and c) 8wt% (Type 
VII) microcapsules of average size 45 μm 163 
 xiv 
Figure 6.17 Schematic of lay-up method showing accumulation of microcapsules at the tip of the 
teflon film insert (NPC crack front) of composite samples 165 
Figure 6.18 Effect of size of microcapsules on the NPC fracture toughness of modified composite 
samples (Type II-VII).  Error bars represent one standard deviation of measured values. 167 
Figure 6.19 PC fracture toughness of composite samples as a function of concentration of 
microcapsules of average size of 100 µm.  Error bars represent one standard deviation of 
measured values. 169 
Figure 6.20 Comparison of representative fracture surfaces of (a) regular and b) modified 
composite samples showing the differences in morphology and appearance between unhealed and 
healed fracture surfaces. 171 
Figure 6.21 PC fracture toughness of composite samples as a function of concentration of 
microcapsules of average size of 45 µm.  Error bars represent one standard deviation of 
measured values. 173 
Figure 6.22 SEM micrograph of the fracture surface of composite samples containing a) 5wt%, 
microcapsules (45 µm) showing insufficient number of microcapsules to cover the full fracture 
surface area and b) 8wt%, microcapsules (45 µm) showing sufficient number of microcapsules 
covering the full fracture surface area 175 
Figure 6.23 SEM micrograph of the fracture surfaces of modified composite sample containing 
microcapsules of average size 45 μm showing healed polymer layer. 176 
Figure 6.24 Effect of size of microcapsules on the PC fracture toughness of modified composite 
samples (Type II-VII).  Error bars represent one standard deviation of measured values. 177 
Figure 6.25 Comparison of NPC and PC fracture toughness of composite samples as a function 
of concentration of microcapsules of average size of 100 µm.  Error bars represent one standard 
deviation of measured values. 180 
Figure 6.26 Comparison of conventional healing efficiency and healing performance index of 
modified composite samples as a function of concentration of microcapsules of average size of 
100 µm. 181 
Figure 6.27 Comparison of NPC and PC fracture toughness of composite samples as a function 
of concentration of microcapsules of average size of 45 µm.  Error bars represent one standard 
deviation of measured values. 183 
Figure 6.28 Comparison of conventional healing efficiency and healing performance index of 
composite samples as a function of concentration of microcapsules of average size of 45 µm. 184 
Figure 6.29 Comparison of healing performance index (%) of all modified composite samples 
(Type II-VII) tested at room temperature 186 
Figure 7.1 A generalized example of ROMP reaction [112] 191 
Figure 7.2 Ring Opening Metathesis Polymerization of 5E2N 191 
Figure 7.3 A general mechanism to a typical ROMP reaction [112] 192 
Figure 7.4 Chemical structure of first generation Grubbs catalyst containing two neutral 
phosphines, two chlorides and one benzylidene ligands [115] 193 
Figure 7.5 Scheme for ROMP with Grubbs catalyst showing phosphine dissociation and olefin 
binding steps during coordination and subsequent metathesis [116] 193 
 xv 
Figure 7.6 Chemical structure of phosphine free second generation Hoveyda-Grubbs catalyst 
[118] 194 
Figure 7.7 a) Regular (without healing agents) and b) modified (with healing agents) epoxy 
samples 196 
Figure 7.8 a) Environmental chamber enclosing the fixtures in the MTS machine, and attached to 
liquid nitrogen supply. b) 3-point bending fixtures holding the composite samples inside the 
environmental chamber and extensions attached to MTS machine and c) The controller of the 
environmental chamber showing that the set temperature of -40oC has been reached 199 
Figure 7.9 a) Composite samples are put inside the zipped plastic bag which is kept inside the 
chamber containing dry ice pellets. b) A thermocouple wire is placed inside the zipped plastic 
bag in the dry ice chamber and is connected to a digital display to monitor the temperature c) 
The digital display showing that the temperature inside the zipped plastic bag where the 
composite samples are kept is maintained at a stable temperature of (41 ± 3) oC. 200 
Figure 7.10 Regular epoxy sample a) before the thermal shock cycles and b) after 5 thermal 
shock cycles between -196oC to +120oC 202 
Figure 7.11 Modified epoxy sample a) before the thermal shock cycles and b) after 15 thermal 
shock cycles between -196oC to +120oC 203 
Figure 7.12 Low temperature NPC fracture toughness of composite samples containing varying 
concentration of microcapsules of average size 100 µm. Error bars represent one standard 
deviation of measured values. 204 
Figure 7.13 Evidence of debonding of larger microcapsules (average size 100 µm) leaving a 
smooth deep impression on the matrix surface during NPC crack propagation at low temperature
 205 
Figure 7.14 Low temperature NPC fracture toughness of composite samples containing 8 wt% 
microcapsules of average size 45 µm (Type VII) compared with regular sample (Type I). Error 
bars represent one standard deviation of measured values. The scale and spacing of the graph is 
kept the same as previous for later comparison. 206 
Figure 7.15 Evidence of good bonding of smaller microcapsules (average size 45 µm) showing 
the rough inner surfaces of the lower halves of microcapsules still attached to the matrix after the 
crack propagation at low temperature. 207 
Figure 7.16 Low temperature PC fracture toughness of composite samples containing varying 
concentration of microcapsules of average size 100 µm. Error bars represent one standard 
deviation of measured values. The scale and spacing of the graph are kept the same as the 
previous graphs for later comparisons. 208 
Figure 7.17 Low temperature PC fracture toughness of composite samples containing 8wt% 
microcapsules of average size 45 µm compared with regular sample [(PC (0%)]. Error bars 
represent one standard deviation of measured values. 210 
Figure 7.18 Comparison of fracture surfaces of (a) regular (no microcapsules) and b) modified 
(with microcapsules) composite samples both fractured at -40oC.  Broken shells of microcapsules 
and layer of self-healed material [poly (5E2N)] is evident in the second micrograph. 211 
Figure 7.19 Comparison of low temperature NPC and PC fracture toughness of composite 
samples as a function of concentration of microcapsules of average size of 100 µm.  Error bars 
represent one standard deviation of measured values. 213 
 xvi 
Figure 7.20 Comparison of low temperature NPC and PC fracture toughness of composite 
samples of type I containing no microcapsules and type VII containing 8wt% of microcapsules of 
average size of 45 μm.  Error bars represent one standard deviation of measured values. 214 
Figure 7.21 Comparison of healing performance index, PI (%) of modified composite samples 
(Type II, III, IV and VII) tested at low temperature. 216 
Figure 7.22 Comparison of NPC fracture toughness of composite samples (Type I-IV) measured 
at room temperature and low temperature. 217 
Figure 7.23 Comparison of fracture surfaces of regular composite samples (Type I) measured at 
a) -40oC and b) room temperature 219 
Figure 7.24 Comparison of PC fracture toughness of composite samples (Type I-IV) measured at 
room temperature and low temperature. 220 
Figure 7.25 Comparison of a) NPC and b) PC fracture toughness of composite samples of type 





























List of tables  
Table 2-1. Summary of key studies investigating different category of healing and methods 
employed for evaluating healing performance 40 
Table 6-1. Categories of composite panels manufactured with mid layer teflon insert (NPC 
configuration) for mode II fracture tests (at room temperature and cold temperature) 139 
Table 6-2. Summary of the type of tests performed at RT and CT (-40oC) with different types of 
composite samples (I-VII) indicating the designation of individual test results 152 
Table 6-3. Comparison of changes in fracture toughness of modified composites (Type II, III and 
IV) compared with regular composites (Type I) containing no microcapsules 181 
Table 6-4. Comparison of changes in fracture toughness of modified composites (Type V, VI and 
VII) compared with regular composites (Type I) containing no microcapsules 184 
Table 7-1. Summary of the type of tests performed at CT (-40oC) with different types of composite 
samples (I-VII) indicating the designation of individual test results 201 
Table 7-2. Comparison of changes in low temperature fracture toughness of modified composites 





CHAPTER 1  
Framework and Scope of the Work 
1.1 Introduction 
Use of structures and parts made of Fiber Reinforced Polymer Composites (FRPC) in various 
engineering applications, especially, in space and aerospace field, is a very attractive option due 
to their high strength to weight ratio. Structures and parts made of FRPC are often subjected to 
low temperature in service. For example, external key structures and parts like the fuselage, 
wings and rotor blades of modern air planes and helicopters made of FRPC are subjected to cold 
temperatures (-40oC to -60oC) at cruising altitudes during in-flight operations. These air vehicles 
also often stay in mild cold temperatures in runways and tarmacs for a considerable time in 
colder regions on earth where the environment temperature remains as low as -40oC and less, 
especially, during the winter seasons. Further, after the inflight operations at high altitude, the air 
vehicles land in warmer environments thus might be subjected to thermal cycling. Further, 
damages in composite parts in aerospace structures can be caused by a simple drop weight 
impact or bending situations caused by artificial or environmental factors. Most of the modern 
satellites launched into earth orbit, and even some manned spacecraft are also constructed with 
specially designed composite panels as their primary load bearing elements [1]. They also serve 
as the protection systems for the internal critical parts like fuel tank, precision devices and 
sensitive equipment like optical sensors, mirrors etc. [2]. Modern satellites and their components 
made of FRPC are also exposed to extreme cold (down to -150oC) conditions and again return to 
extreme hot (up to +150oC) conditions during their orbiting in space. Further, the composite 
parts in the satellites or spacecraft structures are susceptible to damage caused by the impact of 
micrometeoroids and space debris with a wide range of sizes and velocities. These damages in 
aerospace and space structures can vary from very severe (where holes are punctured through the 
structure) to minor damages (where small dents are made into the structure). In-service manual 
repair of the damaged composite parts may be carried out but with a great cost and complexities. 
The concept of self-healing of structural polymeric materials using microencapsulated healing 
agents, first introduced and demonstrated by research group of White et al. [3], can be a potential 
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alternative to difficult manual repair of composites. Most of the studies of self-healing of 
polymer composites, however, involve different types of monomer and resin systems which are 
not suitable for low temperature applications. It is thus interesting to investigate the effect of low 
temperatures as well as effect of thermal cycling on self-healing of composites. The current work 
thus examines the effect of thermal cycling on self-healing of unreinforced epoxy samples and 
investigates in detail the effect of mild low temperature (-40oC) on the self-healing of Fiber 
Reinforced Polymer (FRP) composites.  
The damage behavior of FRPC is complex, especially, under realistic loading conditions like 
impact or bending. Even the apparently minor dents on the surface due to impact can actually 
result in internal subsurface critical damage. Unlike metals, FRPC consists of many types and 

























Study of damage mechanism of FRPC [4] reveals that the damage usually starts at the matrix 
as tiny micro cracks, which, depending upon the loading condition, may make branches, 
coalesce, grow and propagate finally causing severe damages or failure. Thus, if the damage can 
Figure 1.1 Damage modes in polymer composites. Indentation, impact, corrosive 
environments, ballistic punctures, surface scratching, and fatigue can lead to various 
damage modes in polymer composites, as shown here: The type of composite system, the 
nature of the polymer matrix, and the extent and rate of loading all influence the type and 
extent of damage modes [2] 
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be repaired at its very early stage, its development to severe damage can be retarded or even 
stopped ensuring reliable service of the component for longer lifetime. The primary limitation of 
this early repair idea is that it is extremely difficult to reliably detect the very initiation of 
damage which might be created at the subsurface locations of the FRPC. Even if the subsurface 
damage can be detected using the available damage detection techniques like dye penetrants, fiber 
optical sensor, ultrasonic, infrared thermography, X-ray tomography and electrical resistance 
measurements [5], its repair by external manual intervention can be impossible due to the lack of 
human access to the damage site. Even, if it is possible to do so, in-service manual repair may be 
carried out but with a great cost and complexities. An alternative and more recent concept in this 
regard is to impart a healing functionality to the matrix of the FRPC composites which upon the 
occurrence of a damage event can be stimulated immediately to repair by itself.  
Healing is a process by which a material can undergo the repair and restoration of the 
original functionality at a damage event by using only the materials that are inherently available 
to them [6]. The concept of autonomic self-healing in FRPC actually came from natural 
biological systems where the injuries/cut is healed by regeneration of cells at the site of injury. In 
fact, healing functionality can be observed or engineered to impart to any synthetic materials 
(ceramic, concrete and polymers). However, it was in the last two decades that the process of 
self-healing was seriously considered as a desirable function for man-made materials [7]. 
Research in autonomic self-healing of structural polymeric materials has gained momentum after 
White et al. [3] introduced and experimentally verified a microcapsule based healing concept 



































Among the various healing approaches (e.g. microcapsules, hollow fiber, hollow channel, 
microvascular network) discussed in the literature review section, the microcapsule based 
healing system has gained much attention because of its relative simplicity. Several 
microcapsules based healing systems involving different chemistries have been studied by 
several groups of researchers. Among these, Dicyclopentadiene (DCPD)/Grubbs catalyst based 
microencapsulated healing system has been studied more extensively. In fact, the quality of 
healing (capability of recovering mechanical properties under a damage event) directly depends 
on a number of physical and chemical properties of the chosen healing agent [8]. DCPD/Grubbs 
system although showed good potentials for some specific applications, it is not suitable for low 
temperature applications.  
In the current work, 5-ethylidene-2-norbornene (5E2N) which remains functional in a wider 
range of temperatures and possesses faster cure kinetics than DCPD, is selected for investigating 
the microcapsule based autonomic structural self-healing of Carbon Fiber Reinforced Polymer 
(CFRP) composites for low temperature applications.  
Figure 1.2 The autonomic healing concept. A microencapsulated healing agent is embedded 
in a structural composite matrix containing a) catalyst capable of polymerizing the healing 
agent. i) Cracks form in the matrix wherever damage occurs; ii) the crack ruptures the 
microcapsules, releasing the healing agent into the crack plane through capillary action; iii) 





Self-healing of polymers and their composites using microencapsulated DCPD 
monomer/Grubbs catalyst system have been widely investigated in literature. 5-Ethylidene-2-
Norbornene (5E2N) monomer, on the other hand, has several advantages over DCPD including 
much lower freezing point and higher reactivity with Grubbs catalyst making it an attractive 
candidate for self-healing, especially, for low temperature applications. However, 5E2N 
monomer is relatively unexplored as a healing agent for self-healing of polymer composites. The 
current work, thus, investigates the self-healing of microencapsulated 5E2N/Grubbs catalyst 
system for self-healing of composites both at room and cold temperatures. In order to study the 
effect of low temperature on the self-healing of FRPC, it is first necessary to understand the 
room temperature capability of the self-healing system. Thus, a variety of experiments involving 
resin only (without fibers) and fiber reinforced composite samples are intended to demonstrate 
the feasibility and effectiveness of the self-healing system at room temperature. A survey on the 
literature in this field reveals that there is also scope of improving the process of evaluating the 
healing performance of a self-healing system. Healing performance is widely evaluated by 
calculating the healing efficiency using a protocol based on measuring the mode I fracture 
toughness of unreinforced resin sample and FRPC sample. The protocol, however, involves 
some sort of manual intervention in the form of pressing the fractured surfaces together to 
achieve and influence healing. This condition influencing the self-healing might not be 
maintained in a real component in-service. Further, the healing efficiency in this protocol is 
determined by comparing the fracture toughness of samples already incorporated with healing 
agents. The healing efficiency value as determined by this protocol does not reflect the very 
likely toughening (or weakening) effect due to the incorporation of healing agents in to the neat 
sample (without any healing agents) as no comparison is made with it in the healing efficiency 
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definition. A simple scenario analysis of the existing protocol of determining healing efficiency 
reveals that it might provide unreliable indication in many likely situations. Furthermore, the 
process of determining the healing performance does not involve realistic loading conditions like 
impact or bending which the composites parts and structures are commonly subjected to, during 
its service and operations, especially, in space and aerospace environment. Thus, in order to 
evaluate the healing performance of a self-healing system a suitable protocol under a realistic 
loading condition and free from any manual intervention is searched for. Methods and processes 
are also intended to establish for producing quality microcapsules of intended average size, its 
dispersion into epoxy resin and manufacturing FRPC. Finally, the effect of average size of 
microcapsules, its concentration and cold temperature on the self-healing performance of CFRP 
is evaluated. The investigation is, thus believed to contribute to the advancement of knowledge 
in the field of microcapsule based structural self-healing of FRPC, especially, for low 
temperature applications. 
1.3 Objectives of the work 
The objectives of the work can be categorized into two types. One is the global objectives 
and the other is the local objectives. Local objectives are required to fulfil the global objectives. 
These are to: 
1) Offer a complete package of procedures for producing FRPC with optimal healing 
performance starting from the raw materials (i.e. fiber, resin, monomer, catalyst, 
encapsulating reagents etc.).  
The local objectives to achieve this are to 
a) Produce microcapsules and investigate the effect of processing parameters on the quality 
of microcapsules 
b) Establish procedures for manufacturing FRPC incorporating the healing agents 
(microcapsules and catalyst)  
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c) Investigate the effect of size and concentration of microcapsules on self-healing 
performance of FRPC 
2) Propose a suitable protocol for evaluating self-healing performance of FRPC under 
realistic loading conditions and without any requirement for assisting healing by manual 
interventions  
3) Investigate the effect of low temperature on self-healing performance of FRPC 
1.4 Scope of the Current Work 
Different strategies for the self-healing of structural polymer composites exist in literature. 
All these strategies commonly involve a storage system of reactive monomer assimilated into the 
matrix of the composite. These storage vessels are capable of delivering the reactive monomer 
into the damage site by breaking itself during a damage event triggering polymerization reaction 
to heal the damage. According to the type of storage vessels, the healing strategies are named 
which include hollow fiber, hollow channel, microvascular network and microcapsule based self-
healing system. Among the various existing strategies, the microcapsule based self-healing 
system is relatively simple, easy to assimilate into the composites and possesses significant 
potential for real applications. Thus, microcapsule based self-healing system is selected for the 
current work. 
Similar to the different self-healing strategies, several healing chemistry involving different 
reactive materials/monomers and catalyst capable of undergoing polymerization/crosslinking 
reaction to heal a damage is also present in the literature. These include DCPD/Grubbs, epoxy/ 
hardener, glycidyl methacrylate, styrene/initiator and monomer/solvent self-healing systems. 
Among these healing strategies, DCPD/Grubbs system capable of undergoing Ring Opening 
Metathesis Polymerization (ROMP) reaction is most widely investigated in the literature. One of 
the limitations of all of the above self-healing systems is that, none of them is really suitable for 
low temperature applications where the healing agents must remain sufficiently fluid at the low 
temperatures. For example, DCPD, the most widely investigated monomer, has a melting point 
of around 10oC, which means that the healing mechanism proposed may not work by freezing of 
the healing agent below the temperature. Development of suitable healing agent with low 
temperature freezing point is thus essential [9]. 5E2N, on the other hand, has a freezing point 
around -80oC and capable of undergoing ROMP reaction with Grubbs catalyst at a much faster 
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rate than DCPD. Microencapsulated 5E2N/Grubbs catalyst system is thus suitable for self-
healing at low temperature applications and thus is investigated in the current work. 
In order to understand the low temperature effect on the self-healing of 5E2N/Grubbs 
catalyst system, it is first necessary to investigate the effect of room temperature on self-healing. 
Thus the investigation is first carried out thoroughly at room temperature and later extended to 
the low temperature case. 
1.5 Construction of the thesis 
The thesis is organized by introducing the problem descriptions and the concept of 
microencapsulated self-healing followed by motivations behind the work. The objectives of the 
work are then enumerated. The scope of this research work is then discussed in the following 
subsections and the construction of the thesis is outlined. This constitutes the first introductory 
chapter of the thesis. A detailed review of the relevant literature is presented in chapter 2. The 
effects of the processing parameters on the quality characteristics of microcapsules are presented 
in chapter 3. The preliminary experiments carried out to demonstrate self-healing and the issues 
of the strength-based protocols followed to evaluate healing performance of FRP composites are 
discussed in chapter 4. In chapter 5, a mode II fracture based protocol for evaluating healing 
performance of FRP composites is proposed and compared with existing mode I fracture based 
protocol by theoretical scenario analysis. The relative features and advantages of the new 
protocol is summarized at the end of this chapter. Investigation of self-healing of FRP 
composites at room temperature is presented in chapter 6. The effects of average size and 
concentration of microcapsules on the self-healing performance of FRP composites evaluated 
based on the proposed mode II based protocol are presented  in this chapter. Investigation of self-
healing of FRP composites at low temperature is presented in chapter 7. The rational for 
choosing the value of low temperature and choosing the alternate catalyst (Hoveyda-Grubbs 
catalyst instead of Grubbs catalyst) for investigation in light of the ROMP reaction mechanism is 
also discussed in this chapter. The experimental set up for the low temperature tests and the self-
healing performance of the selected types of composite samples are evaluated based on the 
proposed mode II fracture protocol. Finally, the results are compared with the room temperature 
results in this chapter to extract the effects of low temperature. The last chapter constitutes the 




CHAPTER 2  
Literature Review 
2.1 Introduction 
Every material and structure is subjected to degradation and damage during its operation. 
Traditionally materials and structures when damaged are either repaired manually or replaced 
completely. Repair is attempted to ensure its safe intended operation and prolong its lifespan. 
Different established manual methods of repair are available for different classes of materials. 
Depending on various criteria including the quality, sophistication and precision requirement and 
the cost, the appropriate repair methods are selected.  
Metallic structures and components can simply be repaired by mechanical fastening (e.g. 
bolting, riveting), or by various forms of fusion bonding (e.g. welding, brazing, soldering) and 
adhesive bonding techniques. These repair methods for metallic components are well established 
and most of these techniques possess the required sophistication and reliability for advanced 
level applications. Further, the mode and mechanism of damage initiation and accumulation in 
metals are relatively simple and predictable compared to ceramics, polymers and their 
composites.  
A number of manual repair methods are also available for ceramic materials and their 
composites. Like metallic components and structures, they also include several forms of 
diffusion bonding (e.g. ceramic welding), adhesive bonding (e.g. high temperature curing of 
adhesives) and mechanical fastening techniques. Structural concretes are repaired by polymer 
injection, pre-stressing, geomembranes and polymer wraps [1]. However, the available manual 
repair technologies for ceramics are relatively new and less mature than metals. 
Similarly, the polymers and their composites are conventionally repaired by various forms of 
diffusion bonding, adhesive bonding (e.g. patching, scarfing, resin infusion) and mechanical 
fastening (e.g. bolting) methods. However, the complex nature of damages in FRPC made the 
manual repair much complex, time consuming and expensive. It often involves rigorous surface 
preparation and requires strong technical skill to perform the repair. Further, the reliability of 
these repair methods of FRPC for advanced applications is not well established. The choice 
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between the conventional bolted and bonded repair methods of primary airplane composite 
structures is still an important issue of debate among the certification authorities like Federal 
Aviation Administration (FAA) and European Aviation Safety Agency (EASA) [10]. Further, 
the available manual repair methods of FRPC are applicable to relatively severe damages only. 
While these conventional repair methods are applied to relatively severe damages of FRPC 
structures, efforts are ongoing to search methods for repairing the minor damages at their very 
early stage of development. 
The primary limitation of this early repair idea is that it is extremely difficult to reliably 
detect the very initiation of damage which might be created at the subsurface locations of the 
FRPC. Even when the subsurface damage can be detected using the available damage detection 
techniques [5] its in-service repair by external manual intervention can be impossible due to the 
lack of human access to the damage site, let alone in the space environment. Even when it is 
possible to do so, in-service manual repair may be carried out but with a great cost and complexities. 
Self-healing can be a potential simple solution to this complex problem.  
2.2 Category of healing concepts 
Theoretically, any synthetic material (metal, ceramic, polymers and their composites) can 
heal itself to some extent or can be engineered to do so. The phenomenon of autogenous (natural 
autonomous) healing in concrete water-retaining structures, culverts and pipes has been known 
for many years and according to Hearn [11], is first detected by French Academy of Science in 
1836. It has been observed that some cracks in old concrete structures are lined with white 
crystalline material suggesting the ability of concrete to self-seal the cracks with chemical 
products by itself, perhaps with the aid of rainwater and carbon dioxide in air [12]. According to 
Breugel [13], a systematic analysis of healing phenomenon in concrete, executed by Glanville, 
dates back to 1926. Already at that time a distinction was made between healing and sealing 
[13]. 
The modern concepts of healing in synthetic materials can be broadly categorized into semi-
autonomous and autonomous systems. Semi-autonomous healing system requires a minimal 
manual intervention often in the form of setting off some external stimulus like heating. 
Autonomous systems, on the other hand, can self-heal, i.e., requires no manual intervention at 
all. For the self-healing system, the damage event itself serves as the effective stimulus for 
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healing. Thus a healing system to be qualified for the self-healing category must be necessarily 
free from any kind of external manual intervention after the damage event occurs. This 
requirement has very important implications in terms of practical applications where the 
requirement of a seemingly casual manual intervention might not be feasible to ensure or 
maintain. For example, if a healing system requires some external pressure after the damage 
occurs, it should not be termed self-healing because it is not autonomous. For real applications, it 
might not be possible to maintain this required pressure whenever a damage event occurs. Many 
works reported in the literature in this field did not precisely differentiate between the semi-
autonomous and autonomous healing and confusingly termed both as self-healing. In the current 
work, it is essentially ensured that no manual intervention is carried out in order to trigger or 
influence healing after a damage event occurs. Thus, the current work can be categorized as truly 
autonomous self-healing of composites. 
The approach of healing might be divided into intrinsic and extrinsic approach. In intrinsic 
healing, the host material itself can close/heal the damage. No foreign healing agent is required 
to incorporate into the host material. In the case of intrinsic healing of polymers, the polymer 
matrix structure is modified in molecular level in order to include chemical groups that bond 
reversibly or dynamically [14]. In the extrinsic healing systems, on the other hand, foreign 
materials, solids or liquids as healing agent, is incorporated inside the host materials either 
physically or via microcapsules or tubes. The current work involves a microcapsule based 
extrinsic healing approach of FRPC.  
The available repair methods and the key conceptual healing strategies for advanced FRPC 































Healing can also be classified into structural and non-structural healing depending on their 
intended applications. Healing that can significantly restore the mechanical properties and 
structural integrity of materials after damage can be termed as structural healing. On the other 
hand, healing which can only restore other intended functionality (like filling, sealing, electrical 
conductivity, optical properties etc.) of the material other than its structural integrity can be 
termed as non-structural healing. While non-structural healing might be very important in some 
applications (e.g. maintaining containment of a sustaining atmosphere in space vessels and air 
planes through crack sealing, resisting corrosion of vehicles through paint healing), it is the 
structural healing which deserves the most attention considering its huge potential in ensuring 
the safety, reliability and prolonging the effective lifetime of a wide range of mobile structures 
and their critical components. The current work thus focuses on investigating the structural self-
healing of FRPC. 




























Most of the healing techniques are still in their early stage of development and requires 
continuous and dedicated efforts to make them feasible for many practical applications. Ongoing 
efforts are being made by the dedicated material scientists and researchers to impart the healing 
capability to synthetic materials including ceramics, polymers and their composites. The efforts 
generate, so far, some very promising concepts and techniques with successful demonstration of 
healing capability for some class of materials system.  Among them, the studies of healing in 
polymers and fiber reinforced composites are relatively more mature in comparison with efforts 
in ceramics, metals and other materials [6]. However, most of the efforts found in literature 
investigate the healing phenomenon at either room temperature or higher. Very few works are 
found dedicated to investigating self-healing at low temperatures.  
A detailed review of the research works dedicated to investigating the extrinsic healing 
strategies is discussed in the following sections because of their relevance to the current work. 
2.2.1 Hollow fiber approach 
Dry [15] developed a design in which hollow porous fibers containing crack closing 
chemicals are embedded into cementitious materials. The chemicals are released from the fiber 
when degraded by chemicals or broken by structural loading repairing the crack (figure 2.2). She 
also proposed a vacuum assisted external delivery system which replenishes the healing agent 









Dry and coworkers [ [16], [17], [18] ] explored this extrinsic healing concept in concrete 
specimens. They embedded methyl methacrylate (MMA) inside hollow porous polypropylene 
fibers within concrete. Bleeding of MMA from these fibers was shown to reduce concrete 
permeability. In their earlier works they used cyanoacrylate as the healing agents to repair cracks 
Figure 2.2 Fiber breaks due to loading; chemical is released at break [19] 
14 
 
in concrete. Li et al. [19], argued that, the proposed self-healing mechanism cannot work in 
normal concrete, cement or even fiber reinforced concrete. This is because the width of the 
tensile cracks in such materials cannot be easily tuned. Localized fracture leads to continued 
increases in crack width under decreasing tensile load, and rapidly exhausts the amount of 
chemical available for crack sealing and composite re-healing. Thus, for the proposed self-
healing concept to work, it is critical that the tensile crack width be controlled, and it must be 
limited to within tens of micrometers. Otherwise, very large hollow glass tubes will be needed, 
which in turn negatively modify the mechanical properties of the composite [19]. Further, 
according to Wu [20].  the requirement of external healing agent delivery system makes the 
casting of concrete difficult and can pose a severe problem if large amount of concrete needs to 
be cast on the construction site. 
Li et al. [19], however, independently investigated and confirmed the feasibility of this 
approach using ethyl cyanoacrylate as healing agent inside hollow glass fibers within Engineered 
Cementitous Composite (ECC), a class of specially designed ductile cementitous composites 
having improved properties and crack width control than normal concrete, without using any 
external healing agent delivery system. The effectiveness of this extrinsic approach of self-
healing was confirmed by measurement of the elastic modulus of the ECC. The elastic modulus 
was found to regain its original value in a repeat loading subsequent to damage in a first load 
cycle [13].  Several other groups of researchers [ [21], [22], [23], [24], [25], [26] ] explored this 
hollow fiber approach of self-healing in cementitious materials. Nishiwaki et al. [ [24], [25] ], for 
example, proposed and investigated an improved modification of hollow fiber approach of self-
healing of concrete (figure 2.3). They embedded a pipe made of heat-plasticity organic film 
containing repair agent and a heating device in the concrete specimen. The specimen, termed as 
self-diagnosis composite, was made with fiber reinforced composites and electro-conductive 
material. Partial strain caused by the crack generated in the concrete cause the partial increase in 
electrical resistance. This, in turn, provided the selective heating around the cracks which can 
melt the film to allow the repair agent to fill up the crack and harden the repair agent in the 
crack. The effect of incorporating those organic film pipe and heating device on the host material 





















Dry [27] also expanded this healing approach to polymeric matrix using hollow glass tubes 
containing single part cyanoacrylate resin and two part epoxy adhesives as healing agents. The 
healing agent was infiltrated into glass pipette tube using vacuum. The tubes were then 
incorporated into epoxy resin during molding. Controlled cracking of a single repair fiber and 
subsequent release of repair chemical into matrix cracks was verified using optical microscopy. 
Impact tests demonstrated the ability of repair adhesives to migrate along and heal the cracked 
matrix. Quantified impact tests demonstrated that internally delayed release of adhesive restores 
the impact strength and ability to deflect while carrying a load. Quantified bend tests verified that 
release of adhesive from fibers does repair cracks, create crack reopening resistance and impede 
or stop crack propagation. Cyanoacrylate containing tubes incorporated epoxy specimens under 
second (three point bend) loading created new crack instead of reopening the crack that occurred 
during the first loading which indicates a good repair. However, the allowed healing time was 
very long (8-12 months) for most of the tests. The initial feasibility of this healing approach was 
verified in this work. However, the issues like the effect of incorporating external tubes on the 
properties of host matrix, method of filling tubes for large scale applications and the quality of 
Figure 2.3 Self-healing system proposed and investigated by Nishiwaki et al. [24] 
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healing were not discussed in this work. Further the requirement for a very long healing time for 
the healing agent is not suitable for real applications in space environment. 
Following her [27] work, Motuku et al. [28], Belay et al. [29], Kousourakis and Mouritz [30] 
and group of Bond and coworkers [ [31], [32], [33] ] explored this concept and extended it to the 
healing of FRPC. Motuku et al. [28] studied the parameters that influence the low velocity (drop 
weight) impact response of resin filled hollow fibers incorporated GFRP composites fabricated 
by Vacuum Assisted Resin transfer Molding (VARTM). The material, number, type, diameter 
and spatial distribution of the repairing tubes, specimen thickness, matrix material and the impact 
energy level were found to influence the mechanical properties and healing behavior of the 
composites in the investigations [ [24], [26], and [29] ]. Among the borosilicate glass micro-
capillary pipets, flint glass pasteur pipets, copper tubing and aluminum tubing materials 
investigated in [28] work, the borosilicate glass micro-capillary pipets were found to be most 
suitable for the release of repairing solution to the damage site under impact loading. Higher 
number of repair tubes (more than 3), smaller spacing (less than 5 mm) among them and the 
higher outside diameter ( 1.5-1.6 mm) of the tubes were found to be reasons of non-uniform 
wetting of fibers adjacent to the tubes leading to formation of voids in the laminate during its 
fabrication by VARTM. An increased distance between the storage tubes and use of smaller 
diameter tubes eliminated the void problem. Repeatability of data improved with increased 
specimen thickness due to less micro-flaw sensitivity and the damage increased with impact 
energy as expected. Dry [27] and Motuku et al. [28] used large diameter (mm scale) repair tubes 
which might act as initiation sites for composite failure as pointed out by Belay et al. [29]. The 
work of Motuku et al. [28] thus confirms the fact that, modifying the host matrix by 
incorporating foreign materials and architecture in it might compromise the quality of the 
composites. 
Belay et al. [29], on the contrary, utilized hollow glass fibers (µm scale) both as 
reinforcements and containers for the healing agents. They introduced three variations of the 

























In first case, all fibers are filled with one part curing resin. In the second variation, a two part 
system is adapted where the resin is filled into some fibers and the hardener is filled into other 
fibers. In the last variation, one component is filled in hollow fibers and the other component is 
encapsulated and dispersed into the matrix. The authors investigated the first two cases in this 
work. They also introduced a method by which the repair resins were reported to be successfully 
infiltrated into the microscale hollow fibers in the composite. The filling method consisted of a 
rotary vacuum pump sealed along one edge of the composite panel with the other end resting in 



























The vacuum assisted in pulling the resin up through the fibers of the composite panel by 
capillary action. Complete filling of the fibers was reported by this method. The authors [29] 
recommended the use of solvent for quicker filling of finer tubes. 
Use of cyanoacrylate as the one part healing agent was unsuccessful as it cured quickly on 
contact with the mouth of the capillary tubes sealing the tubes. This material was thus not 
recommended as repair resin for small diameter hollow fiber systems. For the two part epoxy 
system, heating (60oC) and vacuum treatment was required after the impact damage of the 
specimen to draw the resin and hardener out of the fibers in order to achieve healing. The healing 
is thus not autonomic. Even then, only 10% improvement in the compression strength after 
impact was achieved compared to the impacted control specimens (no healing agents filled). 
Further, the healed strength was much less in relation to the strength of the undamaged 
composites. This work, although, showed the potential and feasibility of this approach, the 
Figure 2.5 Schematic diagram of the vacuum assisted capillary action filling technique [29] 
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quality of healing achieved was poor.  Further, the healing agent (cyanoacrylates and 
epoxy/hardener) used in these works may not be suitable for low temperature space applications.  
Pang and Bond [31] employed the second variation of Belay's work [29] in the cross ply 
GFRP composites. They achieved only 10% recovery of flexural strength in their flexure after 
impact (FAI) tests due to healing (room temperature, 24 hour) compared with the control (having 
hollow fiber layers without healing agent) specimens. The same group in another work [32] 
achieved 87% recovery of strength compared to undamaged control specimens as determined by 
four point bending tests when the healing treatment was carried out at 100C for 2 hours. 16% 
reduction of original flexural strength due to the inclusion of hollow glass fiber (60 µm dia) 
layers was also observed in their work. Placing individual hollow fibers with spacing distances 
70 µm and 200 µm between the layers of CFRP laminates reduced the original strength by 8% 
and 2% respectively. They also found evidence, as they mentioned, to suggest that if crack faces 
separate by more than 30 µm, capillary forces may be insufficient, or there may be inadequate 
resin volume released to fully infiltrate the damage. This work, thus confirms a quantitative 
weakening effect of incorporating foreign materials/architecture into the host matrix. This 
weakening effect, however, is not considered in the calculation of recovery of strength. Further, 
the achievement of significant healing in this work was not autonomic as they needed to heat up 
the specimens.  
Kousourakis and Mouritz [30] and Williams et al. [33] also studied the effect of hollow fibres 
on the mechanical properties of FRP composites. Williams et al. [33] found less than 10% loss in 
flexural strength to carbon/epoxy composites due to the incorporation of hollow fibers (60 µm 
dia). The studies of [33] showed that hollow fibres located along the mid-thickness plane of the 
composite material cause no change or a small loss (less than a few per cent) to the in-plane 
elastic modulus. The tension and compression strengths were not changed significantly when 
hollow fibres were aligned parallel to the loading direction. However, the strength properties 
were reduced when the fibres were normal to the load. The strength loss was caused by changes 
to the composite microstructure (e.g. increased ply waviness) [33]. Diameter of the hollow 
fibers, their orientation, fiber spacing and the percentage of the load-bearing area occupied by the 
hollow fibres were found to influence the mechanical properties of the composites significantly 
in these works. These weakening effects of incorporating foreign materials/architectures into the 
modified host matrix should always be considered in determining the healing efficiency of a self-
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healing system. Otherwise, an unreliable likely high value of healing efficiency might give a 
wrong perception about the healing performance. 
In recent years, studies of the hollow fiber approach tend to be shifted towards hollow 
channels and microvascular network approach of healing which is discussed in the following 
section. 
2.2.2 Hollow channel/microvascular network approach 
Therriault et al., the group of White and coworkers [34], demonstrated the fabrication of 
three-dimensional (3D) microvascular networks through direct-write assembly of a fugitive 
organic ink. This approach yielded a pervasive network of smooth cylindrical channels (~10–300 
μm) with defined connectivity. Recent advances in soft lithographic and direct write assembly 
methods have enabled the creation of materials with complex embedded microvascular networks 
[35]. Toohey et al. [35] first demonstrated the healing of damage of a coating-substrate 


















An epoxy coating was deposited on a more ductile substrate that contained the three-
dimensional (3D) microvascular network. The fabrication and healing characterization process as 
described in [35] is given here in detail for greater understanding of the work.  
Direct-write assembly was used to embed fully interconnected 3D microchannel network(s) 
in an epoxy matrix. First a 3D scaffolds were fabricated with a fugitive organic ink using a 
Figure 2.6 Schematic diagram of the self-healing structure composed of a microvascular 
substrate and a brittle epoxy coating containing embedded catalyst in a four-point bending 
configuration monitored with an acoustic-emission sensor [35] 
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robotic deposition apparatus in a layer wise scheme. After deposition, the ink scaffold was 
infiltrated with uncured EnviroTex Lite epoxy (ETI) and allowed to cure. After curing, beam 
substrates were cut to size and polished. The fugitive ink was then removed by heating the 
substrate to 75°C and applying a light vacuum. A more brittle epoxy coating (approximately 700 
μm thick) containing Grubbs’ catalyst particles was applied to the top surface of the 
microvascular substrate. The coated microvascular substrates were then filled with DCPD 
healing agent. Finally, the bottom and sides of the substrate were sealed by selectively 
polymerizing a photopolymer in the channels using a mercury source. A rectangular network 
design was chosen in which the vertical channels deliver monomer to the cracks in the coating, 
whereas the horizontal channels enable the network to be filled from the side. The chosen 
channel diameter was 200 μm to balance the requirement of minimizing the total pore volume, 
ease of fabrication and network operation [35].  
The coating–substrate beams were loaded in four-point bending placing the coating under 
tension to initiate a single crack in the coating without damaging the underlying microvascular 
substrate. With each loading cycle, the same crack reopened and was subsequently healed 
repeatedly. An acoustic-emission sensor was placed on the beam to detect the crack opening 
events during testing. The time at which the critical acoustic-emission event occurred was used 
to determine the loads of crack formation and reopening in the virgin and healed specimen tests. 
Quantitative healing tests were limited to a single crack by stopping the loading process after the 
first acoustic-emission signal was detected. After testing, the coating was healed at room 
temperature (approximately 25°C) for 12 h. The network was then replenished with monomer 
before carrying out the next bend test. This cycle was repeated until the crack could no longer 
heal. Healing efficiency was calculated for each healing cycle on the basis of the ratio of the 
critical loads for crack opening, =PHealed/PVirgin , where P is the applied critical load when the 
crack occurs [35]. The healing efficiency at different catalyst concentrations and various healing 
































Toohey et al. [36] pointed to another drawback of this design which is the restricted 
availability of the solid-phase catalyst that eventually became depleted upon repeated healing of 
the same crack [36]. They [36] overcame this difficulty by introducing a multi-network 
architecture for delivery of a two-part epoxy-based healing chemistry. Epoxy resin and amine-
based curing agents were transported to the crack plane through two sets of independent vascular 
networks embedded within a ductile polymer substrate beneath the coating. Two separate 
independent vascular networks were created by first creating a continuous, interconnected 
microvascular network using the direct-write (DW) method. Multiple networks were then 
isolated by infilling the network with a photo curable resin and selectively photo-polymerizing 
thin parallel sections of these resin-filled micro channels. Through this approach, isolated 
microvascular networks were produced that can independently house different healing agents 
within the substrate until a crack forms in the coating. Both healing components were wicked by 
capillary forces into the crack plane where they reacted and bonded the crack faces closed. Same 
test protocol as in [35] was followed in this work and healing efficiencies of over 60% were 
Figure 2.7 Healing efficiency for specimens with 2 wt%, 5 wt% and 10 wt% catalyst in the 
coating that exhibited healing. The white numbers at the bottom of each column denote the 
number of successfully healed specimens in the average and the error bars are one 
standard deviation [35] 
23 
 
achieved for up to 16 intermittent healing cycles of a single crack. According to [36], the 
specimens were required to be subjected to cyclic loading to enhance fluid flow into the crack 
and promote mixing of the components. Polymerized layer of materials formed in the crack 
during the initial healing cycles inhibit the ability of resin and curing agent to flow further and 
adequately mix for subsequent healing. Thus, multiple healing of crack could not be achieved in 
an autonomous way using the microvascular network approach in this work.  
Hansen et al. [ [37], [38]] extended the capabilities of Direct Ink Writing (DIW) technique to 
include dual ink writing to separate neighboring networks and vertical ink writing to provide 
fluid access from the underlying networks to the surface damage region. They used epoxy resins 
and its hardener as the healing agents in these two separate networks. The specimens were 
subjected to cyclic flexure loading (50 cycles at 100mm displacement; external intervention) to 
enhance mixing of the fluids in the crack plane prior to healing at 30C for 48 h. Up to 30 cycles 
of healing (recovery of fracture toughness as measured by the ratio of critical loads during four-
point bending) was achieved in this system. Clearly, the healing is not autonomic in this case. 
In another work, Hansen et al. [39] reported the assembly and characterization of self-healing 
materials with embedded ternary interpenetrating microvascular networks in an epoxy 
coating/substrate architecture ( figure 2.8). The networks were fabricated by direct-write 
assembly of two fugitive inks, in which one ink defines the three microvascular networks and the 
other ink functions solely as a spacer to isolate each network. Two of the microvascular networks 
were devoted to supplying the epoxy resin and hardener healing agents, while the third network 
circulates a thermally regulated fluid. The diameter of the microchannel networks for healing 
agent was 330 µm and the diameter of thermal fluid network was 200 µm. Each network had a 
single input and output connected to a macroscale reservoir that supplies the healing or thermal 
fluids, respectively. Heated water (30-70C) was circulated within the third network at a flow rate 
of 5 mL min − 1. Same test protocol as in [35] was followed to characterize healing. Healing 
times were reported to be reduced by over an order of magnitude by the localized heating in the 
damaged regions enabled by circulating temperature-controlled fluid through embedded 
microvasculature. Total healing times of 40, 4, and 1.5 hours were required for samples held at 


























Critically, several limitations of the process of evaluating healing performance can be 
deduced from the above works. Firstly, the repeated healing events are not autonomic. The 
microvascular network was replenished with monomer after each healing cycle. In real 
applications, it might not be feasible to replenish monomer at each damage event. Secondly, it 
might be difficult to precisely select the critical acoustic signal (when the quasi-static loading 
needed to be stopped immediately). The uncertainty might significantly affect the value of the 
critical loading of the virgin and healed specimen which is the basis of the healing efficiency 
measurement. Finally, the effect of embedded microvascular network architecture on the 
mechanical properties of the matrix is not discussed in these works [ [37], [38], [39] ]. The above 
limitations necessitate the establishment of a suitable protocol for evaluating healing 
performance. Further, the above investigations were carried out for non-structural applications 
(coating-substrate assembly). The current work, on the contrary, deals with structural self-
healing for low temperature applications. The healing agents (epoxy/hardener) investigated in the 
above works are also not suitable for low temperature applications. 
Bond and coworkers [ [40], [41] ] incorporated vasculature into FRP composites using solder 
wire preforms. The solder wire was either laid between plies (fabrication route A) or nested in 
Figure 2.8 Schematic view of epoxy coating/substrate architecture with embedded 
interpenetrating microvascular networks. Two of these networks house epoxy resin (blue) 
and hardener (red), while the third network provides thermal control (green) to accelerate 
healing kinetics after damage occurs [39] 
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pre-cut recesses within the plies (fabrication route B) during the stacking sequence. The solder 
was then removed for post-cure under the application of heat and vacuum in a ‘lost-wax’ type 
process. Based on the experimental results, they [ [40], [41] ] observed that fabrication route B 
offers the better potential for vascule-damage interactions, a pre-requisite for efficient healing 
[42]. Vascule orientation, diameter and location in the ply stack as well as the fabrication 
technique were found to be key factors in ensuring the integrity of the fiber architecture and 
maintaining the original mechanical properties of the laminate [ [40], [41] ]. These issues have 
also received significant attention from research groups studying the incorporation of Fibre Optic 
Sensors (FOS) into composite structures [41]. A compression after impact (CAI) test protocol 
was followed, with specimens tested in the undamaged, damaged (post 10J impact), and healed 
states. In the work of [40], syringes fitted with suitable gauge hypodermic needles were used to 
manually inject healing agent [100 pph DGEBA :EPON 828 as resin, 25 pph Ethyl Phenylacetate 
(EPA) as diluents to reduce resin viscosity and 12pph Diethylenetriamine (DETA) as curing 
agent for the resin]  into the vascules located within the damaged region only. More than 97% of 
the post impact compression strength was recovered due to healing when the samples were kept 
at room temperature for 7 days. The healing process, however, is not autonomic as the healing 
agents were manually injected into the damage sites. The effect of vasculature on the original 
mechanical properties of the laminate was not discussed in the work of [30]. Norris et al. [41] 
pointed out that in the case of vascular networks, the knockdown in mechanical performance has 
been negligible due to the host materials ability to form around the networks. However, 
orientation of the vascules off-axis led to significant fiber waviness and resin pocket regions for 
fabrication route A and terminated fibers with fabrication route B (shown in figure 2.9), both of 
which significantly reduced the subsequent load bearing ability of the FRP composite specimens 
[41]. Norris et al. [43] also anticipated that the inclusion of the vascules will result in a slight 























These approaches, offer the potential for connection to an external reservoir that could pump 
large volumes of a pressurized, mobile liquid phase (healing agents) to the regions of damage 
[41].  
Hamilton et al., the group of White [44] also investigated pressurized vascular systems for 
healing quasi-static and fatigue cracks. They overcame some limitations of capillary force 
induced delivery of healing agent to the crack site via micro channels by incorporating a 
pressurized healing agent delivery system. In this system, two micro channels having a diameter 
of 280 µm inside the sample matrix were filled separately with liquid resin and hardener as 
shown in figure 2.10. The micro channels were connected to pressurized reservoirs (case I- with 
static pressure head; case II- with computer controlled pumps) of healing agents via tubing and 
syringe tips inserted 1-2 mm into each microchannel. Healing efficiency as high as 100%, as 
measured by quasi-static fracture tests of the Double Cleavage Drilled Compression (DCDC) 
specimens, were reported even after 15 repeated healing cycles using dynamic pumping protocol. 
The specimens were kept clamped for certain period at the interval between the loadings to 
achieve healing. The increased degree of mixing resulting from the dynamic pumping protocols 
was attributed to the higher healing efficiencies as compared with the samples pumped using 
constant pressure or samples without pressurized vascular systems, in which capillary forces 



























Fatigue test of the same geometry specimen using two part epoxy adhesive components in 
the micro channels showed decrease in the rate of crack propagation using pressurized delivery 
system. They achieved better healing performance using pressurized vascular system that occupy 
only 0.1% specimen volume compared with a volume fraction of 1.3% in unpressurized system.  
As a concept, the healing system is interesting. However, the suitability of this healing approach 
in real applications is questionable as it requires a separate reservoir of healing agents and a 
delivery systems involving tubes, syringe tips and pumps. The healing process was also not 
autonomic as clamping of specimen was necessary to achieve significant healing.  
According to [ [45], [46] ], neither of the approaches of healing, namely, hollow fiber 
approach or microvascular network via the direct ink writing of a fugitive ink, are suitable for 
rapid, large-scale production of fiber-reinforced composites with complex vasculatures due to 
either incompatibility with existing composites manufacturing methods and materials or lack of 
scalability and vascular complexity of the fabrication approach.  
Group of White and Sottos [ [45], [46], [47], [48] ] demonstrated other interesting 
approaches in integrating the microvascular networks in commercial composite materials. In the 
epoxy matrix they embedded sacrificial polymer fibers which depolymerizes when heated, 
Figure 2.10 Image of the fracture sample and schematic detailing microchannel position 
and content [44] 
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resulting in a vaporization of fiber material. Vacuum removal of the depolymerized gaseous 
monomer produces hollow channels as inverse replica of the fiber diameter in the matrix as 















Inside epoxy matrix, they embedded catalyst treated commercial poly lactic acid (PLA) 
fibers which can convert into gas at temperatures above 180oC. Removal of the gas produced 
micro vascularized matrix. However, infiltration of commercial PLA fibers into the matrix poses 
a serious problem caused by incomplete removal of sacrificial fibers introducing imperfections 
(plugs, necks, etc.) that block the micro channels. In order to overcome this problem they 
introduced an alternative fiber manufacturing method which combines the preparation of viscous 
PLA solution mixed with metal catalysts and the traditional dry fiber spinning technique. In [46] 
they followed this approach and fabricated microvascular fiber-reinforced composites with 
channels over one meter in length that can be subsequently filled with a variety of liquids 
including aqueous solutions, organic solvents, and liquid metals , as shown in figure 2.12, for 






Figure 2.11 Schematic images of sacrificial fibers embedded in a matrix and 

















Clearly, the hollow channel/microvascular network approach holds great promise for healing 
of polymer composites. However, the issues related to the fabrication of fiber reinforced 
composites with embedded microvascular networks, autonomic refilling of the network with 
liquid healing agents, their effect on the properties of the host material and the achievement of 
healing in an autonomic manner during a damage event need to be investigated elaborately to 
make this approach suitable for commercial applications. This is to be reminded here that none 
of the healing agents investigated in the above works were suitable for low temperature 
applications. Especially, the issues like the self-healing at low temperatures and evaluation of 
self-healing performance of FRPC are not settled. These issues are thus investigated in the 
current work. 
As the current work deals with the microcapsule based autonomic structural self-healing of 
polymer composite materials, the available literatures associated are reviewed in greater details 
in the following sections.  
2.2.3 Microencapsulation approach 
 
a) Dicylopentadiene (DCPD)/Grubbs catalyst system 
Numerous works have been carried out by the research groups of White and Sottos [3] to 
investigate the microcapsule based DCPD/Grubbs healing system. Keller and Sottos [49], Brown 
et al. [ [50], [51] ] and Rule et al. [52] investigated the effect of microcapsule properties on the 
modified (healing agent incorporated) epoxy specimen. They found that microcapsules if 
Figure 2.12 Micro CT image of glass/epoxy composite embedded with Ga-In filled 3D 
microvascular network [45] 
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adequately bonded to the matrix can actually improve its fracture toughness contrary to the 
presence of voids or other poorly bonded particles which tend to reduce the same. Keller and 
Sottos [49] found that geometry and fill content of microcapsules also influences the toughening 
mechanism of the matrix. However, they found a continuous reduction in strength of the epoxy 
specimen with increasing wt% of microcapsules. They pointed out that good adhesion of the 
microcapsules with the matrix is essential for encounter of microcapsules and its subsequent 
rupture by the approaching matrix crack triggering self-healing. The work of [51] revealed that 
the catalysts size and concentration has also significant effect on the properties of the matrix. 
Further, they suggested choosing the mixing order of the healing agents such that the amine 
curing agent does not come in direct contact with the Grubbs catalyst to prevent its degradation. 
To avoid degradation of catalyst, Rule et al. [52] incorporated wax protected catalyst into 
modified epoxy. 
The research group of White and coworkers [ [3], [49], [50], [51], [52], [53], [54] ] employed 
the fracture-heal-fracture approach in fracture testing protocol with Tapered Double Cantilever 
Beam (TDCB) geometry, developed by Mostovoy et al. [55], to determine the healing efficiency 
of epoxy specimen. Brown et al. in [50] achieved over 70% healing efficiency with 5 wt% 180 
m (average diameter) microcapsules and 20 wt% 50 m capsules with 2.5 wt% catalyst for both 
cases. Brown et al. in other work [51] achieved up to 90% healing efficiency of epoxy specimen 
with 5 wt% 180 m capsules and 2.5 wt% catalyst after 10 hours of healing.  Rule et al. [52] 
observed that the healing performance was maximized when sufficient volume of monomer was 
present to fill the cracks completely. Also they showed a linear relationship between the amount 
of monomer delivered to the crack site and the average diameter of microcapsules for a given 
weight fraction. It is to be noted here that the fracture testing protocol of TDCB specimens 
employed by the researchers in the group of White and coworkers to evaluate the healing 
efficiency is not a perfectly autonomic process of achieving healing. It involves keeping the 
cracked faces of the specimens in contact by external intervention after the first loading for 
certain periods before subsequent loading. Further, healing efficiency as determined by the mode 
I fracture test protocol of TDCB resin samples in [ [3], [49], [50], [51], [52], [53], [54] ], 
involves calculating the ratio of critical loads of the same modified sample (incorporated with 
healing agents) during the first (virgin) and second (healed) loading. No comparison is made 
with respect to neat regular samples (not incorporated with healing agents) in the definition of 
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healing efficiency in these works. Incorporation of foreign materials like microcapsules and 
catalysts can alter the base mechanical property of the neat sample. Depending on the various 
factors, the base mechanical properties might improve or degrade compared with the neat 
samples due to the inclusion of foreign materials as found in [ [50], [51] ]. This likely alterations 
in the base mechanical property reflected in the first (termed as virgin) loading of the modified 
sample (incorporated with healing agents) might give a wrong perception about the true healing 
performance. This is discussed in detail with different possible scenario analysis in chapter 5.  
Kirkby et al. [54], researchers in the same group of White and Sottos [3], instead, 
investigated healing of epoxy aided by embedded shape memory alloy (SMA) wires. The 
embedded SMA wires that bridged the fracture plane of the TDCB specimens (as shown in 














The activation of the SMA wires increased the temperature of the local matrix to 80oC and 
generated an axial recovery force to close the crack during the healing period which substituted 
the requirement of manual clamping of the cracked surfaces to achieve significant healing. The 
comparison in healing performance with and without embedded SMA wires is shown in figure 
2.14. The improvement was attributed to the reduction in crack volume due to the axial forces 
generated by activated SMA wires. They also observed that an over-delivery of healing agent of 
at least a factor of two is required to ensure complete filling of the crack and the highest healing 
Figure 2.13 TDCB geometry; samples were prepared with three SMA wires perpendicular to 
the crack plane, spaced uniformly. The distance units are mm [54] 
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efficiency [54]. The healing process investigated, however, is not autonomic as manual 














One of the earliest investigations dealing with the healing (DCPD/Grubbs system) of fiber 
reinforced composites (FRC) was carried out by Kessler et al. [ [56], [57] ], in the research group 
of White and Sottos [3]. They employed the fracture-heal-fracture approach in the fracture 
testing of double cantilever beam (DCB) geometry (figure 2.15 a) specimen [56] and width-
tapered double cantilever beam (WTDCB) geometry (figure 2.15 b) specimen [57] to evaluate 











Figure 2.15 a) DCB specimen during testing [56] and b) schematic of WTDCB specimen 
[57] 
Figure 2.14 Load-displacement curve of the epoxy TDCB fracture specimen containing 
DCPD microcapsules, Grubbs catalyst and SMA wires [54]. Virgin sample actually refers to 







Fracture testing of DCB specimens [56] involves the direct measurement of fracture 
toughness through several calculation steps using approximations estimating the initial crack 
lengths. Healing efficiency is evaluated by comparing the fracture toughness of the modified 
specimens during the first and second loadings. Fracture testing of (WTDCB) geometry 
specimens [57], on the other hand, is perceived to make the energy release rate independent of 
crack lengths leading to direct evaluation of healing efficiency simply by comparing the critical 
loads during the first and second loadings according to equation 1. 












𝑉𝑖𝑟𝑔𝑖𝑛  ……………………………………………… (1) [57] 
Where, G, K and P values represent the critical strain energy release rate, critical stress intensity 
factor and the critical loads during the first (termed as virgin) loading and second (termed as 
healed) loading respectively. 
Three groups of specimens were manufactured and tested in these works as shown and 
















Figure 2.16 a) Reference specimen where catalyzed healing agent is manually injected into the 
delamination after first loading; b) Self-activated specimen where catalyst is already embedded 
in the matrix and only monomer is manually injected into the delamination and c) Self-healing 
specimen where both encapsulated monomer and catalyst are embedded into the matrix [57] 
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During the fracture testing of the specimens, the delaminated faces after the first loading was 
kept clamped with modest pressure during the healing period (48 hours) before the second 
loading. A maximum healing efficiency of 67% for reference specimens (manually injected 
catalyzed DCPD) and a maximum of only 19% healing efficiency for the self-activated GFRP 
specimens (manually injected uncatalyzed DCPD), were achieved in [56].  In another work [57], 
an average healing efficiency of 99% for reference specimens and 73% for self-activated CFRP 
specimens, based on equation 1, was reported. Clearly, the demonstrated healing for the 
reference and self-activated specimens is completely manual. Even for the 'self-healing' 
specimens the delaminated faces were kept clamped during the healing period which is a form of 
considerable manual intervention and the healing efficiency was only 38% [57]. The 
achievement of healing in these works is thus not autonomic. 
Further, the efficiency values reported in [ [56], [57] ] were based on comparing the averages 
of the critical parameters (fracture toughness [56], critical loads [57]) of the same category 
specimens (e.g self-activated modified specimens) during the first and second loading which, in 
fact, is not the true index of the healing performance. The true index of healing performance 
should be realized by comparing the critical parameters between the modified (with healing 
agent) and regular (without healing agents) specimens.  
Patel et al. [58], the researchers in the same group of White and Sottos [3], investigated the 
healing performance of glass/epoxy composite panels subjected to drop weight impact loads. 
Healing was first evaluated by fluorescent labeling of damage and image processing and then by 
compression after impact (CAI) testing. A 51% reduction in crack length and 97% recovery of 
residual compressive strength (quality) is reported in the work. However, the healing 
performance was calculated by comparing the values with the modified non healing control 
specimen (C-III) which was already incorporated with DCPD microcapsules and wax 
microspheres without catalyst; not with the neat regular specimens as shown in figure 2.17. 
Incorporation of foreign materials into CIII specimens might reduce the properties of the host 
material furnishing high efficiency values.  From a practical point of view, the comparison of 
performance of self-healing specimens (SH) to neat regular specimens is more fair in a sense that 
it represents the true index of improvement due to healing. Further, it was not clear whether the 
characteristic mechanical properties of the regular panels was sacrificed, in this work, with lower 
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compaction pressure (4.8 kPa for regular panels compared to 95.8 kPa for modified panels) 
















O’Brien and White [59] assessed the healing of microencapsulated DCPD/Grubbs system for 










They [59] employed an interlayer approach to produce the modified prepregs in order to 
fabricate the specimens. In the interlayer approach, the microcapsules (10-100 m) and catalyst 
Figure 2.18 Skin/stiffener flange debond specimen configuration [59] 
Figure 2.17 Residual compressive strength (RCS) for non-healing control panels (C-III, 
micro-encapsulated DCPD and wax microsphere, no catalyst) and self-healing panels (SH, 
microencapsulated DCPD and catalyst) versus nominal incident impact energy. Error bars 
are ±one standard deviation. Also plotted is a fit to RCS [58] 
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were dispersed in the regular base resin bath to produce modified resin. The modified resin was 
then deposited onto a carrier fabric on the top of each composite layer (containing the regular 












With the flexure-heal-flexure approach they [59] found no considerable recovery of 
structural properties in the specimens in which the cracked faces were not pressed together 
during the healing period before the second loading. Even no visual evidence of healing was 
observed in this case. They achieved up to 96% recovery of original peak loads for the 
specimens for which the cracked faces were kept closed by reverse bending for 48 hours.  The 
interleaf layer of the modified resin was shown to increase the thickness and weight of the 
laminate reducing its fiber volume fraction. The delamination cracks were also seen to be 
migrated to the top of the interface layer limiting the encounter mechanism necessary to initiate 
self-healing. They pointed out that a significant time and pressure was necessary to achieve a 
considerable recovery of properties with this DCPD/Grubbs system. They suggested exploring 
new healing agents that can heal rapidly under load with minimal contact (no external pressure) 
and can survive autoclave temperature and pressure cure cycles. They also suggested reducing 
the microcapsule size that can be incorporated into the interstices of fibers in the FRPC instead 
of adding an interleaf layer.  
It is again to be reminded here that DCPD may not be suitable for low temperature 
applications as it freezes around 10oC.  This is probably the reason that no work involving low 
temperature self-healing using DCPD monomer alone is found in literature.  
Figure 2.19 Self-healing (modified) prepreg [59] 
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The interesting observations and recommendations made in [59] along with the 
unsatisfactory healing performance of microencapsulated DCPD/Grubbs system in several other 
studies discussed above, with regards to autonomic structural healing of FRPC, prompts the 
researchers to search for alternative healing agents with superior properties. The following 
section reviews some of these studies found in literature.  
b) Healing agents other than DCPD/Grubbs system 
Jin et al. [60] investigated a dual microcapsule epoxy-amine based healing system of high 
temperature epoxy samples. One type of microcapusules contained curing agent and the other 
contained diluted epoxy resin. Quality of healing was characterized by the recovery of fracture 
strength using modified TDCB epoxy specimens. Specimens were allowed to heal for 48 hours 
at room temperature following the virgin fracture test without any external intervention as 
mentioned in [60]. A maximum of 91% healing efficiency at 15 wt% (6wt% epoxy, 4wt% curing 
agent) microcapsules concentration was reported in the work. However, the efficiency of healing 
was observed to be reduced significantly with increasing time after healing the reason of which 
was attributed to the possible leakage/instability of amine microcapsules. This drawback might 
limit the use of the healing agents for practical applications.  
Group of Zhang et al. in several works [ [61], [62], [63], [64], [65] ] explored different 
healing agents for studying healing of thermosets. They encapsulated epoxy [ [61], [62], [63] ] 
and hardener [63] as healing agents and used dispersed hardener [61] and catalyst [62] to impart 
healing capability to GFRP [ [61], [63] ] and epoxy matrix [62].  However, quality encapsulation 
of epoxy and its subsequent flow into the crack plane at room temperature might become 
difficult due to its high viscosity as they mentioned. In [64], they encapsulated a single 
component healing agent, glycidyl methacrylate (GMA) which remains as a low viscosity liquid 
at ambient temperature. Fracture tests of TDCB epoxy specimens revealed nearly full recovery 























Recently, in another work, they [65] successfully microencapsulated styrene (much lower 
viscosity than epoxy monomer) as well as benzoyl peroxide (BPO), the initiator of styrene 
polymerization, which were incorporated into epoxy matrix. Significant healing (more than 60%) 
was reported to be achieved at room temperature without any manual intervention in [ [62], [63], 
[64], [65] ]. 
Caruso et al. [ [66], [67] ] investigated healing of epoxy resins using encapsulated solvents. 
In their preliminary work [66], they demonstrated healing of epoxy matrix incorporated with 
encapsulated chlorobenzene solvent with 82% healing efficiency measured by fracture test of 
TDCB specimens where the fractured surfaces were manually kept intimately closed.  In a later 
work [67], they encapsulated epoxy monomer in solvents and found better efficiency of healing 
than in the previous case [66] that consisted microcapsules containing solvent only. In a more 
recent work, Neuser et al. [68] observed that the residual reactivity of host epoxy matrix which is 
a prerequisite for solvent assisted healing of thermosets, decreases significantly with exposure 
and increasing uptake of solvent. Almost no residual reactivity was found for the epoxy samples 
prepared at the saturation level of the solvent [68]. It thus seems that the host epoxy matrix 
requires remaining partially cured for the solvent assisted healing to be achieved. In other words, 
Figure 2.20 Typical load-displacement curves recorded during TDCB tests. The fracture 
loads of both unfilled epoxy and manually healed unfilled epoxy specimens are shown in 
the form of horizontal lines as references. Healing of the fractured specimens was 
conducted at 25 C for 72 h. [64] 
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the mechanical properties of the host matrix are possibly compromised in order to impart healing 
functionality to the matrix through solvent healing.  
It is to be noted here that, in the above studies by other research groups, healing efficiency is 
also evaluated by the same protocol as in [ [3], [49], [50], [51], [52], [53], [54], [56], [57] ] 
where there is a scope for improving the protocol. In the current work, a suitable protocol for 
evaluating the healing performance under realistic loading condition is developed. 
The alternative healing agents explored in the above works [ [61], [62], [63], [64], [65], [66], 
[67] ] although showed autonomic structural healing for some cases, none of them are really 
suitable for low temperature applications where the healing agents must remain liquid at the low 
temperatures. Thus, in the current work, 5E2N which is known to have low freezing point (-
80oC), is being investigated for autonomic structural self-healing for low temperature 
applications.  
Besides the number of healing approaches discussed above, several other healing approaches 
like utilizing reversible Diels-Alder reaction scheme [ [69], [70], [71], [72], [73] ] and 
embedding materials in the form of particles (or fibers) as healing agent into the thermoset 
matrix [ [74], [75], [76] ] has been investigated by different groups of researchers. However, 
these approaches require external heating to initiate healing, thus are not autonomic. Many of the 
other studies, like [ [77], [78], [79], [80], [81], [82], [83], [84] ], found in literature were 
dedicated to exploring non-structural healing using various healing strategies. Further 
discussions on these studies are not covered as the current work deals with autonomic structural 
healing of FRPC composites.  
Table 1 summarizes the key studies of healing discussed in the literature review section, in 
terms of different category of healing and methods employed to evaluate its performance.  The 









































































Flexure-Heal-Flexure Repeated cyclic 
loading to enhance 











TDCB Epoxy Fracture-Heal-Fracture Fractured surfaces 
kept into contact 
Up to 90%1 Semi- 
autonomic 
Structural [49], [50], 
[51]. [52]  
DCPD 
/Grubbs 
TDCB Epoxy  
 









Fracture-Heal-Fracture Clamping of 
delaminated faces 
Up to 38%1 Semi- 
autonomic 







- Up to 97%1 Autonomic Structural [58] 
DCPD 
/Grubbs 
CFRP Flexure-Heal-Flexure Cracked faces kept 
closed manually 
Up to 96%1 Semi- 
autonomic 
Structural [59] 
1 Not calculated based on comparing the values with regular specimens (i.e. neat specimens without any healing agents and its 
containers). 2 Healing agents are not suitable for low temperature applications. 
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Table 2.1 Summary of key studies investigating different category of healing and methods employed for evaluating healing 
performance (cont’d) 
Healing approach Healing 
agents 








































Epoxy FAI Cracked surfaces 



































1 Not calculated based on comparing the values with regular specimens (i.e. neat specimens without any healing agents and its 
containers) 
2 Healing agents are not suitable for low temperature applications 
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Analyzing the above table, it can be observed that the studies exploring the hollow fiber 
approach mainly deal with structural healing but the method of achieving healing is not 
autonomic [ [25], [28] ]. In contrast, the quality of autonomic structural healing achieved in [29] 
was poor (only 10%). On the other hand, the demonstrations of healing for the hollow 
channel/microvascular network approach [ [31], [32], [33], [34] ] were mostly for non-structural 
semi-autonomic healing. The demonstration of healing for microencapsulation approach using 
DCPD/Grubbs system [ [40], [41], [42], [43], [44], [45], [46], [47], [48], [49] ] are mostly for 
semi-autonomic structural healing. Conversely, autonomic structural healing with high healing 
efficiency [97%] was claimed to be achieved in [3] for unreinforced modified (incorporated with 
healing agents) epoxy samples. However, the efficiency value was not based on comparison with 
the regular samples (i.e. neat specimens without any foreign materials) similar as in many other 
studies [ [49], [50], [51]. [52], [54], [56], [57], [58], [59], [60] ]. This prompts for establishing a 
suitable protocol for evaluating the healing performance of FRPC based on comparing with the 
regular samples under realistic loading conditions in a truly autonomic fashion without any 
manual intervention. Autonomic structural healing with high healing efficiency was achieved in 
some studies [ [62], [63], [64] ] exploring microencapsulation approach using alternative healing 
agents other than DCPD/Grubbs system. However, the alternative healing agents, like epoxy, 
possess some limitations including great difficulties in quality encapsulation, reduced flow 
ability in the crack plane due to high viscosity and consequently, for its unsuitability for low 
temperature applications where the healing agents must remain liquid at the low temperatures. 
Thus, it is noted that none of the healing systems studied in various investigations really 
demonstrated the potential for autonomous structural healing for low temperature applications. In 
the current work, autonomic structural healing of microencapsulated 5E2N/Grubbs system is 
being investigated for its known superior properties than DCPD/Grubbs system and suitability 
for low temperature applications.  
2.3 5-Ethylidene-2-norbornene (5E2N) as a candidate for 
microencapsulated healing agent 
DCPD/Grubbs catalyst based microencapsulated healing system has been investigated 
extensively by the group of White and coworkers [ [49]- [54]; [56]- [59] ]. DCPD used as the 
healing agent in these studies requires to be cured for around 48 hours at the presence of 
comparatively large amount (up to 5%) of catalyst to achieve substantial healing efficiency. The 
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large amount of expensive Grubbs catalyst and the long period of cure time are not desirable in 
practical applications. DCPD also has a melting point of around 10oC, which means that the 
healing mechanism proposed may not work by freezing of the healing agent below the 
temperature. Development of healing agent with low freezing point is thus essential [9]. 
According to Yin et al. [61], higher temperature and longer lasting time might result in 
polymerization of DCPD monomer leading to its invalidation. Further, the rate of healing is 
compromised in the usual case where inhibitors are used to prevent early polymerization [8].  
Lee et al. [9] characterized DCPD as well as 5E2N as healing agent for polymer composites 
using differential scanning calorimetry (DSC), TGA and dynamic mechanical analysis (DMA). 
In the study, they found that 5E2N have advantages as a healing agent because, when cured 
under same conditions as DCPD, it reacts much faster in the presence of a much lower amount of 
catalyst, has low freezing point, and produces a resin that has a higher value of glass transition 
temperature (Tg). The characteristics of the low freezing point and high reactivity of 5E2N are 
essential for further development of self-healing concept toward practical use in polymeric 
composites [9]. 
Mauldin et al. [8] showed, as in figure 2.21, that ethylene norbornene (ENB) monomers has 
much superior shear storage modulus than DCPD and gain its maximum shear storage modulus 













Figure 2.21 Evolution of shear storage modulus (G’) of various healing agents using a 
modified rheokinetic technique (ENB = Ethylidene Norbornene, NBE-MeBr = 5-Norbornene-




Liu et al. [85] investigated the blend of various proportions of DCPD and 5E2N (ENB) as 
candidates for healing of polymer composites using DSC and DMA. They observed that DCPD 
and ENB are miscible in all proportions and the blending results in the desired lowering of the 
melting point of DCPD. They have suggested a blend of DCPD and 5E2N at a ratio of 1:3 to be a 
potential candidate for healing agent which can combine high rigidity of DCPD after cure and 
fast reaction rate, much lower catalyst requirement and low temperature capabilities of 5E2N. 
Recently, Raimondo et al. [86] showed that a blend of ENB with up to 5% DCPD was not phase 
separated at low temperature (-50oC).  However, in this work, no mechanical test was carried out 
at low temperature. Unfortunately, no other published paper investigating the effect of low 
temperature on self-healing of composites is found in literature. 
The 5E2N/Grubbs catalyst healing system can thus overcome some of the limitations of 
extensively studied DCPD/Grubbs system and possesses a great potential for a wide range of 
applications including in the low temperature environment. The current work, thus investigates 
the 5E2N/Grubbs system for the autonomic structural self-healing of CFRP composites for low 



















CHAPTER 3  
Synthesis of Microcapsules and Investigation 
of the Effect of Processing Parameters on 
their Quality Characteristics 
3.1   Introduction 
The current research is aimed at evaluating the self-healing performance of CFRP composite 
both at room and low temperatures using microencapsulated 5-Ethylidene-2-norbornene (5E2N) 
and Grubbs catalyst as healing agents. To accomplish the objective, three major stages are 
envisaged. These steps are the fabrication of samples, creating controlled damage to the samples 
and observing the effect of healing. Each of these stages is subjected to various issues, 
challenges and constraints. For the fabrication stage, the first issue is to synthesize the 
microcapsules and the challenge is to control their quality characteristics.  
In this chapter, the procedure of synthesis of microcapsules and the associated issues and 
challenges are discussed. The role of different ingredients used in the microencapsulation 
process was studied. The effect of agitation speed and SLS concentration on the quality of 
microcapsules are investigated. Finally, an optimum combination of agitation speed-SLS 
concentration is established through numerous synthesis trials. 
3.2 Synthesis of microcapsules and the key roles of different 
ingredients used in the encapsulation process 
The first and one of the most important tasks of this work is to encapsulate the self-healing 
monomer in suitable polymeric shells and establishing control on their quality in terms of their 
average size, size distribution, thermal stability, monomer content, shell thickness, surface 
morphology et cetera. These characteristics of microcapsules are known to influence capsule 
rupture behavior, healing agent release and the healing performance of composites [87]. 
Preliminary synthesis runs of microcapsules were carried out to be familiar with different steps 
of the process and the mechanism and the roles of different ingredients used were studied 
through literature survey. The materials, processes, and the outcome of the preliminary synthesis 
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Figure 3.1 Procedure to synthesize the MUF microcapsules containing Ethylidene-
norbornene (ENB). [88] 
 
runs as well as the mechanism and the roles of different ingredients used in the 
microencapsulation process are described below.  
3.2.1 Materials, processes and preliminary synthesis runs 
The core material 5E2N, the shell materials melamine, urea and formaldehyde (37 wt%) and 
the stabilizing agent polyvinyl alcohol (PVA) and the surfactant sodium dodecyl sulphate (SDS 
or SLS) were purchased from Sigma-Aldrich, Canada.  
5E2N is encapsulated in poly melamine urea formaldehyde (PMUF) shells using in-situ 














The procedure described in [88] was followed during the preliminary runs to be familiar with 
different steps of the process. The encapsulation procedure in accordance with [88] is described 
below. 
Aqueous SLS (0.5%) and PVA (6.3 wt%) solution was first prepared in beakers by heating at 
70oC for 20 minutes and 2 hours, respectively, on a hot plate with magnetic stirrer. Specified 
amount (as in figure 3.1) of melamine and formaldehyde was then taken in 70 ml deionized 
water in a 250 ml beaker. The ingredients were then mixed and heated for 25 minutes at 70oC to 
form melamine-formaldehyde prepolymer. The prepolymer was cooled down to room 
temperature for subsequent use. In another reaction beaker partially submerged in an oil bath 
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kept on a hot plate, specified amount of urea, SLS and PVA (as in figure 3.1) were mixed with 
30 ml deionized water using a three-bladed stirrer at a speed of 300 rpm.  
The melamine-formaldehyde prepolymer was then added to the mixture together which 
constitute the microcapsule shell materials in hydrophilic aqueous phase. The microcapsule core 
material, 5E2N, which is hydrophobic, was then added to the mixture in a slow stream under 
continuous stirring to form oil-in-water emulsion. The stirring speed was then raised to the 
desired value. At this stage, the emulsion was optionally ultra-sonicated to form fine emulsion. 
The emulsion was then allowed for some time to become stable and kept under continuous stirrer 
agitation. Heat was then applied to the emulsion in the reaction beaker through the oil bath kept 
on a hot plate equipped with a temperature controller. The heating rate was adjusted in the hot 
plate and specified temperature [86oC] was set in the temperature controller.  The set-up is 





























Figure 3.2 Set-up for the synthesis of microcapsules by in-situ polymerization method 
[sonication is introduced optionally].   
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Figure 3.3 Accumulation of microcapsules on the top of the mixture  
After the temperature reached to the desired value, the emulsion was kept at this temperature 
for 5 hours with continuous agitation to complete the polymerization reaction. After that, the 
heating and stirring was stopped and the reaction product was cooled down to room temperature.  
Fresh deionized water was then added to it and kept for some time. The spherical microcapsules 
containing the 5E2N monomer in its core were then accumulated on the top of the mixture due to 
the density differences as shown in figure 3.3. Most of the dross produced during the in situ 















 The microcapsules were collected from the top of the mixture and washed and filtered 
repeatedly before drying in the air to obtain free flowing individually separated microcapsules as 









microcapsules on the top of 




Figure 3.4 a) Filtering of microcapsules after washing and b) freely flowing 













After repeating several synthesis runs according to figure 1, microcapsules were obtained 
with 500 rpm agitation speed. The microcapsules were taken on a glass slide and observed under 
optical microscope. The images of the microcapsules were examined with image analysis 
software ImageJ [89] and the diameter of the individual microcapsules were measured. More 
than 500 microcapsules were individually measured to obtain its average diameter and the 
distribution of its sizes. The optical image of microcapsules produced with 500 rpm agitation 
















Figure 3.5 a) Microcapsule synthesized according to flowchart in figure 1 and with 500 





































The optical image in figure 3.5(a) confirms that separated individual microcapsules having 
solid spherical shells with different sizes are successfully produced in the encapsulation process 
as described in figure 3.1. The vertical bars in the graph (figure 3.5(b)) indicate the percentage of 
total microcapsules available in a specific size range. For example, from the graph, it can be seen 
that about 28% of the total microcapsules are larger than 200 µm. About 30% (15 +15) of 
microcapsules falls within the size range 120-160 µm. The connected lines in the graph, on the 
other hand, indicates the cumulative percentage of the microcapsules in the specified size ranges. 
For example, it can be observed from the cumulative percentage that about 15% of the 
microcapsules are less than 100 µm. Thus, from figure 3.5(b), it is observed that microcapsule 
synthesized with 500 rpm agitation speed produces microcapsules of average diameter 165 µm 
with relatively wide distribution of sizes ranging from 20 µm to more than 200 µm. 
3.2.2 Understanding the mechanism and the role of different ingredients used 
in the encapsulation process 
In order to establish control on the quality of microcapsules produced by the above 
procedure, it is necessary to understand the mechanism and roles of different ingredients used in 
the encapsulation process. This is realized by a brief survey of literature involving similar 
encapsulation process. 
The microencapsulation process is carried out using the principles of in-situ polymerization 
taking place in oil-in-water emulsions [90]. Broadly, the formation of microcapsules involves 
two key steps. The first key step is the creation of oil-in-water emulsion (emulsification) and the 
second key step is the formation of microcapsule shells (shell formation) [91]. In the first step, 
the hydrophobic core material (5E2N) is emulsified with the hydrophilic aqueous solution of 
shell materials (Urea, Melamine and Formaldehyde) using mechanical stirring (or ultra-
sonication, homogenizer etc.) with suitable emulsifier (SLS) and stabilizing agent (PVA). In the 
emulsion, liquid 5E2N remains as the dispersed phase and the aqueous solution of shell materials 
(with water, surfactant and stabilizer) remains as the continuous phase. In the second step, 
polymerization of shell materials is carried out preferentially at the interface of the emulsion 
bubbles producing a film as microcapsule shells [91] around the liquid droplet of 5E2N. The size 
distribution of the microcapsules is determined in the emulsification step. However, the 
morphology and other physical properties of microcapsules are determined in the shell formation 




Figure 3.6 5-ethylidene-2-norbornene (5E2N) [94] 
Figure 3.8 Melamine [95] 
The role of different reagents used in the microencapsulation process is described below.  
5E2N 
5E2N is a colorless liquid (at room temperature) monomer which is capable of undergoing 
Ring Opening Metathesis Polymerization (ROMP) reaction with Grubbs catalyst (described in 
other chapter) for self-healing applications. It has a freezing point around -80oC [93] and boiling 
point around 146oC [94]. 5E2N has the formula C9H12 and its chemical structure is shown in 







The liquid 5E2N acts as the hydrophobic oil phase in the oil-in-water emulsion in the 
microencapsulation process and it is the core material of the microcapsules. 
Urea, Melamine and Formaldehyde 
Urea is a white solid crystalline substance obtained as small granular particles from supplier 
(Sigma Aldrich). Its melting point is 132oC. It is highly soluble in water [94]. Urea has the 





Melamine is a white solid substance obtained as powdered form from supplier (Sigma 
Aldrich). Its melting point is 300oC [94]. It is moderately soluble in water. Melamine has a 










Formaldehyde solution (37 wt %) is obtained as a colorless clear liquid (at room temperature). It 
is completely soluble in water. Fromaldehyde has a formula HCHO and its chemical structure is 






The mixture of the three above reagents (together with water, surfactant and stabilizing agents) 
constitute the continuous hydrophilic phase in the oil-in-water emulsion and undergoes 
polymerization upon heating [8] to form the shell of the microcapsules during the 
microencapsulation process. The polymerization of the reagents is a poly condensation reaction 





















Figure 3.10 Reaction scheme of PMUF   [95] 
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Urea, melamine and formaldehyde together form the shell of the microcapsules during the 
microencapsulation process. 
Sodium Lauryl Sulphate (SLS) 
SLS is received as white solid with small rod like structures. It is soluble in water. Different 
concentrations of aqueous SLS solution (0.5 wt% - 3 wt%) were prepared by dissolving specified 
amount of SLS with deionized water at 70oC for 20 minutes under continuous stirring. SLS has a 








SLS is used as an emulsifying agent and surfactant in the microencapsulation process. SLS, 
like other emulsifying agents, has both hydrophilic and hydrophobic part in their chemical 
structure. The sulphate head group in the structure [shown in figure 3.11] is hydrophilic and 
water soluble, while, the 12 carbon long chain in the tail is hydrophobic and water insoluble [96]. 
The hydrophilic part is thus attracted to the aqueous phase (made of shell materials) and the 
hydrophobic part is attracted to the oil phase (made of 5E2N) of the oil-in-water emulsion thus 
maintaining a hydrophilic-hydrophobic balance of the emulsion. The emulsifying agent, SLS, 
concentrates at and is adsorbed onto the oil:water interface to provide a protective barrier around 
the dispersed hydrophobic droplets [97] of 5E2N in the emulsion. SLS, having a negative charge 
at the sulphate head group which is sufficiently soluble in water, is also classified as anionic 
surfactant [96]. In addition to the protective barrier, SLS stabilizes the emulsion by reducing the 
interfacial tension between oil and aqueous phase. It also enhances the emulsion stability by 
imparting a charge on the droplet surface thus reducing the physical contact between the droplets 
and decreasing the potential for coalescence [ [92], [97] ]. The formation and quality of 
microcapsules is thus greatly affected by the presence of SLS in the microencapsulation process. 
 
 
Figure 3.11 Sodium Lauryl Sulphate (SLS) [96] 
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Polyvinyl alcohol (PVA) 
PVA having molecular weight of 85000-124000 is a crystalline colorless solid obtained from 
sigma aldrich. 6.3 wt% of aqueous PVA solution was prepared by dissolving specified amount of 
PVA and deionized water at 70oC for 2 hours under continuous stirring. 







PVA is also an excellent emulsifying agent and used in conjunction with SLS to aid in the 
emulsification of the oil-in-water emulsion in the microencapsulation process. Aqueous solution 
of PVA with high molecular weight increases the viscosity of the emulsion and contributes in 
stabilizing the emulsion droplets.  
The combination of PVA and SLS solution used in the microencapsulation process is 
believed to have significant effect on the average size, size distribution and the overall quality of 
the microcapsules. 
3.3 Investigating the effect of processing parameters on the quality 
of microcapsules  
Numerous synthesis runs of microcapsules were carried out primarily in order to establish 
control on the quality characteristics of microcapsules. The intention here is to establish 
sufficient control on the process of encapsulation so as to produce quality microcapsules with 
desired properties. This is achieved by understanding the effect of process variables on the 
quality of microcapsules. The microcapsule size, for example, is shown to be controlled by 
agitation rate during the similar microencapsulation process in several earlier works [ [98], [99], 
[100], [101] ]. However, the core and shell materials as well as the emulsion system (e.g. the 
emulsifying agents, stabilizing agents etc.) used in those works were different for different 
applications. As the current encapsulation process involves different emulsion systems with 
different core and shell materials for self-healing applications, the effect of processing variables 
Figure 3.12 Polyvinyl alcohol (PVA)   [94] 
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should be different. The 5E2N monomer is first encapsulated in PMUF shells by Liu et al. [88] 
with mechanical impeller and later with porous glass emulsification technique by the same group 
of researchers [102]. However, the effect of stirring speed and the concentration of emulsifier 
(SLS) on the quality of microcapsules were not studied in those works. The effect of these two 
variables on the quality of microcapsules containing 5E2N monomer in PMUF shells are thus 
studied in the current work. The agitation speed of the impeller and the concentration of SLS 
were varied, one at a time, while keeping all other processing conditions same as in figure 3.1, 
during the encapsulation process, to understand their effect on the quality of microcapsules. 
Finally, an optimum combination of agitation speed-SLS concentration is established through 
numerous synthesis trials. The results are discussed below. 
3.3.1 Effect of agitation speed  
Increasing the rotation speed of stirrer in the emulsion during the microencapsulation of 
5E2N in PMUF shells is expected to produce smaller size microcapsules as observed in similar 
other works [ [98], [99], [100], [101] ]. In order to verify this, agitation speed was increased from 
500 rpm to 1000 rpm while keeping the SLS concentration fixed at 0.5 wt% and all other 
processing conditions same as in figure 3.1. The resulting microcapsules were observed under 
optical microscopes and SEM to determine their average size, size distribution and surface 
morphology. The results are discussed below.  
500 rpm (0.5 wt% SLS) 
The microcapsules produced at 500 rpm during the preliminary runs are already shown in 













































Figure 3.5. a) Microcapsules produced with 500 rpm agitation speed keeping the 
SLS concentration fixed at 0.5 wt% and b) their size distribution  
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The microcapsules produced have a core-shell structure with smooth inner surface and rough 














The inner and outer surface morphology of the microcapsules as observed under SEM is shown 















Figure 3.5. d) Smooth inner surface of microcapsules 
shell  
















The inner surface of the microcapsules was smooth and the outer surface was observed to be 
rough and patterned with relatively coarse nanoparticles deposits. The nanoparticles attached to 
the outer surface of the microcapsules are believed to be made of PMUF which has been formed 
during the in situ polymerization of the shell materials as observed in other works [ [87], [103] ] 














Figure 3.5. e) Rough outer surface of microcapsule shell  
Figure 3.5. f) Thickness of the microcapsule shell  
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The shell thickness of the microcapsules were measured to be in the range of 500-700 nm as 
shown in figure 3.5 (f). A shell thickness of urea formaldehyde (UF) microcapsules in the range 
of 220 nm found in the work of [87] was perceived to be sufficiently robust to survive handling, 
manufacture of self-healing polymer providing excellent storage and release properties for self-
healing applications [87]. The range of shell thickness of PMUF microcapsules obtained in [102] 
was 400-600 nm and obtained in [88] was 700-900 nm.  
600 rpm (0.5 wt% SLS) 
Microcapsules were produced by increasing the agitation speed to 600 rpm while keeping the 
SLS concentration fixed at 0.5 wt% and all other processing conditions same as in figure 3.1. 
The microcapsules produced are shown in figure 3.13 (a) with their size distribution shown in 




















































Figure 3.13 a) Microcapsules produced with 600 rpm agitation speed keeping the SLS 
concentration fixed at 0.5 wt% and b) their size distribution 
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From figure 3.13 b), it can be seen that the average size of the microcapsules is 105 µm with 
more than 30% of the microcapsules have diameters between 100 µm-120 µm. It is also 
interesting to note that more than 75% (31 +23+23) of the microcapsules produced are within the 
size range of 80 µm-140 µm which can be considered roughly as a fair distribution of sizes 
around the average value. Thus, by comparing the figures 3.5 b) and 3.13 b), it can be seen that 
increasing the agitation speed from 500 rpm to 600 rpm, the average size of the microcapsules 
reduces from 165 µm to 105 µm. The increase in agitation speed also improves the distribution 
of sizes with a larger percentage of microcapsules remain in the vicinity of the average value of 
diameter. 
Obtaining individually separated smaller microcapsules with 600 rpm agitation speed, 
however, required increased number of washing cycles to remove the dross from the 
microcapsule compared to microcapsules obtained with 500 rpm agitation speed. This implies 
that more dross are produced with increasing agitation speed which makes it difficult to wash 
and filter out the individually separated microcapsules. Dross, produced during the encapsulation 
process, is the sticky materials which is found on the surface of the microcapsules and tends to 
hold several microcapsule glued together. This makes it difficult to separate out the individual 
microcapsules, even, by increased number of washing cycles.  
The surface morphology of the microcapsules was observed similar as in figure 3.5 (e) with 
less coarse nanoparticles attached at the outer surface. The shell thickness was also observed to 
be in the range of 500-700 nm, similar as in the case of 500 rpm microcapsules as shown in 
figure 3.5 (f). 
800 rpm (0.5 wt% SLS) 
Attempts to further reducing the average size of the microcapsules by merely increasing the 
agitation speed did not work as expected. Microcapsules were produced by increasing the 
agitation speed to 800 rpm while keeping the SLS concentration fixed at 0.5 wt% and all other 








Figure 3.14 Microcapsules obtained with 800 rpm agitation speed keeping the SLS 
concentration fixed at 0.5 wt% showing lot of dross produced during the in situ 














As the average size of the microcapsules further decreases with increasing agitation speed, 
the dross produced during the polymerization reaction of the shell materials in the emulsion 
system tends to stick to the microcapsule surface as shown in the SEM image in figure 3.14. This 
dross could not be cleared even with multiple washing cycles. With decreasing size, the tendency 
of agglomeration among the microcapsule increases rapidly and it becomes extremely difficult to 
individually separate them out. Even some modified washing methods (like using fine spray of 
water, washing with SLS solution, washing in a sonicating bath, vacuum centrifugation etc.) did 
not contribute much in separating the individual microcapsules once the microcapsules were 
synthesized. The sticky dross attached to the microcapsule surface can act as impurities and can 
create many problems including poor dispersion into resin, improper adhesion to the matrix, and 
insufficient release of the core content during self-healing applications. The microcapsules, thus, 
cannot be used for self-healing applications and, hence, the other quality characteristics of the 
microcapsules are not investigated further. Further increase of agitation speed have similar 
results and agglomeration of microcapsules was observed. 
The possible explanation of producing more dross and increasing difficulty with washing and 
filtering of microcapsules produced by increasing agitation speed at a fixed low SLS 
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concentration (0.5 wt%) can be realized by understanding the function of SLS in the process. As 
discussed earlier, SLS, as an emulsifier and surfactant, serves two main purposes. One is to form 
a protective layer around the core droplets stabilizing the emulsion and other is to reduce the 
interfacial tension between the core material (oil phase) and shell material (aqueous phase) 
interface. The SLS also can give negative charges to the core droplets which repulse each other 
to stay separated in the emulsion and prevent coalescence. As the speed of agitation increases, 
the average sizes of the emulsion droplets decrease which means that the total surface area of the 
droplet increases. However, a fixed concentration of SLS supplies a fixed number of SLS 
molecules in the emulsion which might not be sufficient to entirely cover up the increased 
surface area of the emulsion droplets. Thus, the emulsifier and surfactant function of SLS might 
not be properly served due to the lack of sufficient SLS molecules present in the emulsion 
causing coalescence of droplets and instability in the emulsion. 
Thus, for a given SLS concentration, the main effect of increasing agitation speed is the 
reduction of average size of microcapsules with improved size distribution. The surface 
morphology and shell thickness remains similar as at lower speeds. However, microcapsules 
become increasingly sticky and difficult to separate as their average size decreases with 
increasing agitation speeds. 
3.3.2 Effect of SLS concentration  
In order to find the effect of SLS concentration, microcapsules were produced at a fixed 
agitation speed of 600 rpm with increasing the concentration of SLS from 0.5 to 1.5 wt% while 
keeping all other processing conditions same as in figure 3.1. The resulting microcapsules were 
observed under optical microscopes and SEM to determine their average size, size distribution 
and surface morphology. The results are discussed below. 
0.5 wt% SLS (600 rpm) 
The characteristics quality of microcapsules produced with 0.5 wt% SLS concentration at a 
fixed agitation speed of 600 rpm is already discussed in section 3.3.1. The characteristics quality 
of microcapsules produced with other concentrations of SLS studied is described below. 
1 wt% SLS (600 rpm) 
Microcapsules produced with SLS concentration of 1 wt% at a fixed agitation speed of 600 

































Figure 3.15 a) Microcapsules produced with SLS concentration of 1 wt% keeping 
the agitation speed fixed at 600 rpm and b) their size distribution 
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(a) 600 rpm (0.5 wt% SLS)  (b) 600 rpm (1 wt% SLS)  
From figure 3.15 b), it can be seen that the average size of the microcapsules is 50 µm with 
more than 30% of the microcapsules have diameters between 40 µm-60 µm. It is also interesting 
to note that more than 86% (29 +33+24) of the microcapsules produced are within the size range 
of 20 µm-80 µm which can be considered as a fair distribution of sizes around the average value. 
Thus, by comparing the figures 3.13 b) and 3.15 b), it can be seen that increasing the SLS 
concentration from 0.5 wt% to 1 wt% while keeping the agitation speed fixed at 600 rpm, the 
average size of the microcapsules produced reduces from 105 µm to 50 µm. The distribution of 
sizes of microcapsules remains similar as in 0.5 wt% with the average value shifted to the 
smaller microcapsule diameters. Increased concentration of SLS offers greater reduction of 
interfacial tension between the oil and aqueous phases of the emulsion which possibly allows the 
formation of smaller emulsion droplets leading to the formation of smaller microcapsules [6].    
The surface morphology of microcapsules obtained with 0.5 wt% and 1 wt% of SLS at the 












The outer surface of the microcapsules produced with 0.5 wt% SLS, as shown in figure 3.16 
(a) is patterned with relatively coarse nanoparticles. The surface also looks more compact than 
that of 1 wt% microcapsule surface. The outer surface of microcapsules produced with 1 wt% 
SLS, as shown in figure 3.16 (b), on the other hand, are patterned with finer nanoparticles but 
with more cracks. Core liquid monomers can diffuse through the crack networks of the outer 
surface of microcapsule shells. Thus, increasing the concentration of SLS at a lower agitation 
Figure 3.16 Comparison of surface morphology of microcapsules produced with 
600 rpm agitation speed with a) 0.5 wt% SLS and b) 1 wt% SLS 
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(a) 600 rpm (0.5 wt% SLS)  (b) 600 rpm (1 wt% SLS)  
speed can actually degrade the microcapsule quality. Compact surface morphology and rough 
out surface with finer attached nanoparticles is beneficial for self-healing applications due to 
improved containment capability and improved adhesion properties to the matrix.  
The shell thickness of microcapsules obtained with 0.5 wt% and 1 wt% of SLS at the given 











The shell of the microcapsules produced with 0.5 wt% SLS is observed thicker (614 nm) than 
that of the microcapsules produced with 1 wt% SLS (402 nm) as can be seen in figure 3.17 (a) 
and (b).   
Thus, the clear effect of increasing the concentration of SLS at a given agitation speed is the 
reduction of the average size of microcapsules with decreasing shell thickness. However, the 
shell thickness remains within the desirable range as discussed in [87].  Increasing SLS 
concentration at a lower speed (600 rpm) also tends to produce microcapsule with cracks on the 
surface which is not desirable for self-healing applications.  
1.5 wt% SLS (600 rpm) 
Further increase of SLS concentration to 1.5 wt% at the given speed of 600 rpm led to 





Figure 3.17 Comparison of shell thickness of microcapsules produced with 600 rpm 
















It can be explained by understanding the role of SLS in the microencapsulation process. As 
discussed in section 3.2.2, the hydrophilic head and the hydrophobic tail of the SLS molecule are 
attracted, respectively, to the aqueous and oil phase of the emulsion thus maintaining a 
hydrophilic-hydrophobic balance of the emulsion. Increasing the SLS concentration possibly 
shifts the balance to the hydrophilic side of the emulsion due to the surfactant properties of SLS. 
The aqueous phase, being too much hydrophilic with increasing SLS concentration, possibly 
limits sufficient wetting of the oil phase droplets resulting in unsuccessful encapsulation. More 
investigation is necessary to confirm the explanation. 
From the above results it is concluded that for a given SLS concentration, increasing 
agitation speed reduces the average size of microcapsules. However, microcapsules become 
increasingly sticky and difficult to separate as their average size decreases. On the other hand, 
for a given low agitation speed, increasing SLS concentration to some limit also reduces the 
average size of microcapsules while affecting the surface morphology of the microcapsules. 
Further, increase of SLS concentration beyond this limit at a given speed led to unsuccessful 
encapsulation. The above results led to the assessment that there might be an optimum 
concentration of SLS for a given speed range in order to have successful encapsulation of the 
core 5E2N with PMUF shells with desired quality characteristics of the microcapsules.  
Figure 3.18 Unsuccessful microencapsulation with 1.5 wt% SLS at 600 rpm 
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Numerous synthesis trials of microencapsulation led to the establishment of the optimum 
combination of agitation speed and SLS concentration. The optimum combination of speed-SLS 
concentration possibly gives the correct hydrophilic-hydrophobic balance of the emulsion 
leading to successful encapsulation with desired quality of microcapsules. The microcapsules 
successfully produced with those optimum combinations of speed-SLS concentration and their 
quality characteristics are shown and discussed in the subsequent sections.  
3.3.3 Optimum combinations of agitation speed and SLS concentration  
 
Efforts were made in reducing the average size (diameter) of the microcapsules while 
maintaining the desired quality characteristics of microcapsules. The effect of different average 
size on the healing performance of composites is intended to be investigated in this work. 
Agitation speed of the stirrer and the SLS concentration are found to be the main controlling 
factors in reducing the average size of the microcapsules. With numerous trials of microcapsule 
synthesis, it was found that increasing the concentration of SLS and slightly decreasing the 
amount of PVA solve the problem of stickiness and agglomeration of microcapsule as its average 
size decreases with increasing agitation speed while maintaining the desired quality of 
microcapsules. The microcapsules successfully produced with those optimum combinations of 
speed-SLS concentration found through this investigation are discussed below. 
850 rpm-1 wt% SLS 
Figure 3.19 (a) and (b) show microcapsules along with their distribution of sizes produced 
with 850 rpm, using 1wt% SLS and a slightly decreased amount of PVA (28ml instead of 30 ml), 












Figure 3.19 a) Individually separated small microcapsules (average diameter 40 µm) 




































Figure 3.19 (a) shows that the combination of 850 rpm-1wt% SLS with a slight decrease in 
the amount of PVA solved the problem of stickiness and produced individually separated free 
flowing smaller microcapsules of average size 40 micron. The distribution of sizes in figure 3.19 
(b) shows that about 65% of microcapsules fall in the size range of 20-60 µm which is in the 
close vicinity of the average value (40 µm). It can be further observed from the graph  in 3.19 (b) 
that about 16% of the microcapsules have sizes below 20 µm while about 80% of microcapsules 
are smaller than 60 µm which indicate a good and desired narrow size distribution. 
950 rpm-1.5 wt% SLS 
Figure 3.20 (a) and (b) show successful synthesis of microcapsules of average size 30 µm 
























Figure 3.20 a) Successful synthesis of small microcapsules (average diameter 30 µm) 




































The distribution of sizes in figure 3.20 (b) show a very good narrow distribution where most 
of the microcapsules remain in the close vicinity of average value. This again confirms that, 
increasing the agitation speed along with increasing the concentration of surfactant successfully 
reduces the average size of microcapsules while solving the problem of stickiness and 
agglomeration with improved the distribution of sizes. 
1200 rpm-2 wt% SLS 
Figure 3.21 (a) and (b) show the microcapsules produced with 1200 rpm agitation speed 


























Figure 3.21 a) Successful synthesis of small microcapsules (average diameter 12 µm) 




































(a) 600 rpm 0.5 wt% SLS 
(b) 850 rpm 1 wt% SLS (c) 1200 rpm 2 wt% 
SLS 
Figure 3.22 Comparison of surface morphology of microcapsules obtained with 
optimum agitation speed-SLS concentration a) 600 rpm-0.5 wt%, b) 850 rpm-1 wt% and 
c) 1200 rpm-2wt% 
The average size of the microcapsules with this combination of processing parameters was 
found to be 12 µm. The distribution of sizes, as shown in figure 3.21 (b), is excellent with almost 
all the microcapsules remain in the same size range (0-20 µm).  
The surface morphology of the microcapsules obtained with the optimum combination of 























The surface of the microcapsules are observed to be compact and patterned with precipitated 
PMUF nanoparticles. With the combined increase in agitation speed and SLS concentration, the 
nanoparticles on the outer surface of microcapsules become finer and the compactness of the 
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(a) 600 rpm 0.5 wt% SLS 
(b) 850 rpm 1 wt% SLS (c) 1200 rpm 2 wt% SLS 
Figure 3.23 Comparison of shell thickness of microcapsules obtained with optimum 
agitation speed-SLS concentration a) 600 rpm-0.5 wt%, b) 850 rpm-1 wt% and c) 1200 
rpm-2wt% 
microcapsules tends to be increased with less porosity which is desirable for good adhesion 
properties and self-healing performance. 
The shell thickness of the microcapsules obtained with the optimum agitation speed-SLS 
























With increasing speed-SLS concentration, the shell thickness of the microcapsules decreases 
with decreasing average size of microcapsules. The shell thicknesses of microcapsules obtained 
with 600 rpm-0.5 wt% SLS, 800 rpm-1wt% SLS and 1200 rpm-2wt% SLS combinations are in 
the range of 500-700 nm, 400-500 nm and 300-400 nm respectively. The lowest shell thickness 
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Figure 3.24 Optimum combination of agitation speed-SLS concentration for successful 
production of free-flowing individually separated microcapsules with desired quality 
characteristics 
obtained with 1200 rpm-2 wt% SLS combination is still in the desired range for handling and 
manufacturing of composites for self-healing applications.  
Thus, with the numerous trials of synthesis runs, the optimum combination of agitation speed 
and SLS concentration for producing individually separated free flowing microcapsules of 
average size ranging from around 200 µm down to 15 µm with desired quality characteristics is 
established through this investigation.  
Figure 3.24 shows the relationship between the average size of microcapsules, agitation 
speed and concentration of surfactant (SLS) for obtaining individually separated free flowing 
























The average size of the microcapsules could not be significantly reduced further by simply 
increasing the agitation speed of the stirrer. Sonication with certain power and duration was 
needed to further reduce the average size of the microcapsules. However, individually separated 
free flowing small microcapsules (in the vicinity of average size 1 µm) could not be obtained in a 
similar way by increasing the concentration of the SLS during the encapsulation process.  The 
small microcapsules (in the vicinity of average size 1 µm) formed in the reaction were not 
accumulated at the top of the mixture due to the density differences and it was extremely difficult 
to filter out the whole emulsion. Further efforts are necessary to obtain free flowing 
microcapsules of average size in the vicinity of 1 µm and less.   
3.4 Thermal stability and core monomer content of microcapsules  
Thermal stability of microcapsules and the monomer content inside the microcapsule shells 
are two key quality characteristics of microcapsules. Thermogravimetric Analysis (TGA) was 
carried out for the microcapsules synthesized by the encapsulation process with the established 
optimal combinations of agitation speed-SLS concentration to investigate its thermal stability 
and core monomer content. About 20 mg of microcapsule sample was put into the TGA (TA 
Q50 series) cell and the parameters are set in the program using a heat and hold method. The 
program is run under controlled nitrogen flow and the changes is sample mass is continuously 



































The temperature is increased up to 700oC with a heating rate of 20oC/min. The temperature is 
held constant at this temperature for about one hour to finish the analysis. The curve shows that 
the weight of microcapsules remains almost same until the temperature reached 100oC. About 
15% loss of weight was observed between 100oC and 285oC which might be associated with the 
diffusion and evaporation of the core materials through the microcapsule shells due to its thermal 
degradation with increasing temperature as observed by Liu et al. [88]. A small portion of the 
weight loss at this temperature range might also be due to the evaporation of high volatile 
compounds from the PMUF shell materials [104]. It is to be noted here that the core 5E2N has a 
boiling point of around 146oC [94]. That means, after the temperature is reached to the boiling 
point of the core materials, vapor pressure inside the microcapsule continues to build-up with 
increasing temperature and put pressures on the wall of the microcapsules. This results in an 
additional 60% rapid loss of weight between 285oC and 325oC which, according to [88], might 
be associated with sudden rupture or explosion of the shells causing rapid release of the 
vaporized core materials. The rate of weight loss slows down between around 325oC to 460oC 
and the residue is decomposed beyond this temperature. Thus from the TGA analysis it is found 
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that the microcapsules are fairly stable up to the rupture and release of the vaporized core 
materials. Based on the above analysis, more than 75% of the total weight of microcapsule is 
estimated to be the monomer contained within the microcapsules. 
3. 5 Concluding remarks  
Microcapsules containing liquid 5E2N in the core with PMUF shells have been synthesized 
using the established procedure in literature. The key role of each ingredients used in the 
emulsion microencapsulation process is understood through literature studies. Melamine, urea 
and formaldehyde reacts to form the shells of the microcapsules around the liquid 5E2N droplets 
which forms the core of the microcapsule in the microencapsulation process. SLS serves as an 
excellent emulsifying agent and surfactant and used in conjunction with PVA to aid in the 
emulsification of the oil-in-water emulsion in the microencapsulation process. The effect of 
agitation speed and SLS concentration on the quality characteristics of microcapsules is 
investigated. The quality of produced microcapsules in terms of average size, size distribution, 
surface morphology and shell thickness are compared. For a given SLS concentration, the main 
effect of increasing agitation speed is found to be the reduction of average size of microcapsules 
with improved size distribution. The surface morphology and shell thickness remains similar as 
at lower speeds. However, microcapsules become increasingly sticky and difficult to separate as 
their average size decreases with increasing agitation speeds. On the other hand, the clear effect 
of increasing the concentration of SLS at a given agitation speed is the reduction of the average 
size of microcapsules with decreasing shell thickness. Surface morphology is also affected with 
SLS concentration. The outer shell of microcapsules are found to be patterned with finer 
nanoparticles with more cracks on it when produced with relatively high concentration of SLS at 
a lower fixed agitation speed. Finally, an optimum combination of speed-SLS concentration is 
established through numerous synthesis trials in the investigation. 
Microcapsules produced with optimum process parameters (agitation speed and SLS 
concentration) meets the desired quality standard of microcapsules with good thermal stability 
and core monomer content. The results of the investigation can be utilized to produce 
microcapsules of required average size with desired quality characteristics.  Among these 
microcapsules two different average sizes are selected to investigate their effect on self-healing 




CHAPTER 4  
Preliminary Experiments 
4.1   Introduction 
Numerous trials of synthesis of microcapsules were carried out to study the effects of 
different processing parameters and to establish control on the quality characteristics of 
microcapsules. After successfully establishing control on the quality characteristics of the 
microcapsules, the next key issues were to demonstrate the feasibility of self-healing with the 
current materials system (5E2N and Grubbs catalyst) and to find a suitable protocol to evaluate 
the self-healing performance of fiber reinforced polymer (FRP) composites subjected to realistic 
loadings. Several preliminary experiments were carried out to address the issues.  
The feasibility of self-healing with the current materials system was first demonstrated by 
visually observing the healing of crack network that was created on unreinforced epoxy samples 
impacted with high velocity projectiles.  Once, the self-healing of cracks on unreinforced epoxy 
sample created with realistic loadings (such as impact of projectiles) was demonstrated with the 
current materials system, the next issues were how to quantify it realistically, especially, for the 
FRP composite systems. Initiatives to quantify the self-healing of unreinforced epoxy sample 
involved measuring the fraction of the length of the crack networks that was observed to be 
healed under optical microscope. This is described in detail in the following sections. 
For the fiber reinforced composites, however, it was not practically possible to visually 
observe and measure the fraction of healed region in the composites as the cracks created on the 
FRP composites mostly remained in the sub-surface locations in the form of delamination and 
other forms of damages. Further, it is necessary to measure how much of a selected mechanical 
property (e.g. strength or stiffness) is recovered through self-healing. The alternative initiatives 
to quantify self-healing, thus, involved measuring some mechanical properties of regular (not 
incorporated with microcapsules and catalysts) and modified (incorporated with microcapsules 
and catalysts) FRP composites of different architectures subjected to some damages under 
realistic loadings (like impact, bending etc.) and later compare those properties after being 
allowed to heal. Several methods were implemented in the preliminary experiments for this 
purpose. The methods and the preliminary results are discussed in this chapter.  
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Figure 4.1 Single stage gas launcher [105] 
4.2  Demonstration of self-healing of resin sample (without 
reinforcement) 
In order to demonstrate the feasibility of self-healing with the microencapsulated 
5E2N/Grubbs catalyst system, cured resin samples (without fibers) incorporated with 
microcapsules and catalyst were impacted with high velocity projectiles. The damage created 
and the subsequent healing is visually observed and analyzed using image reconstruction 
method. 
4.2.1 Fabrication of modified resin sample and impact condition 
Modified resin samples were prepared by mixing epoxy (EPON 828), curing agent, microcapsules 
and Grubbs catalyst using vacuum centrifugation method. The mixture was then poured into a silicone 
mold and cured. The cured sample was then polished and shot with projectile using a high velocity gas 
















The dimensions of the resin sample and shot conditions are given as follows: 
Dimensions of the resin sample: 50.8 mm X 50.8 mm X 4.8 mm 
Projectile material: Aluminum  
Projectile dia: 1.8 mm 
Projectile mass: 15 mg 





Figure 4.2 Photograph of the modified resin sample after impact a) side of the impact 
and b) opposite side of the impact 
b) a) 
The high velocity projectile impact on the modified resin sample created a crater on one side and a 

















After allowing certain time for healing, the crack network thus created on the opposite side of 
the sample was observed under Optical Microscope (OM) for analysis. 
4.2.2 Observation and analysis of self-healing 
Encounter of microcapsules with propagating cracks and filling of the cracks with self-healed 













Figure 4.3 Optical micrographs of the crack networks on the impacted modified resin 
sample showing examples of a) encounter of microcapsules with a propagated crack and b-




































Figure 4.4 Reconstructed image of the damaged region under 6.3X magnification  
The optical micrographs in figure 4.3 demonstrate, successfully, the self-healing of cracks 
created on the resin samples under realistic loading and without any manual assistance for 
healing. 
In order to make a quantitative analysis, it was necessary to have a sufficiently enlarged 
image of the damaged region of the sample on the opposite side of the impact as shown in figure 
4.2 b). For this purpose, the damaged region was observed at a fixed magnifications under OM 
and series of images captured were reconstructed to reproduce the entire damaged region all 
together.  
The lowest magnification used for this purpose was 6.3X. With this magnification, only a 
portion of the damaged region could be captured at a time. Several images (8-10) were then 
captured in order to cover the whole damaged region. Every image represents a certain portion of 
the damaged region and contains some overlapped region. These images were then carefully 
arranged in order to reconstruct the image of the entire damaged region. The reconstructed image 
of the damaged region on the opposite side of the sample at magnification of 6.3X is shown in 



















Figure 4.5 Reconstructed image (downsized to accommodate to the paper) of the damaged 
region at the opposite side of the impacted modified resin sample. Each crack branched 
out from the centre is indicated by letters (B-H) and the crack in the outer circumference 
is indicated by letter A.   
Figure 4.4 shows better view of the damaged region compared to the digital photograph 
shown in figure 4.2 b) although it was not sufficient to make a quantitative analysis. Thus, the 
same procedures were followed with higher magnifications (10X, 16X, 25X). With increasing 
magnifications, each captured image could only capture a decreasing area/portion of the 
damaged region and requires an increasing number of images to be captured to reconstruct the 
entire region making the reconstruction tedious. However, it was found that, even with 25X 
magnification, the crack network could not be observed satisfactorily to make a quantitative 
analysis. 
The details of the cracks can, however, are observed with a minimum 50X magnification. 
With this magnification, more than 200 images were captured to cover the entire damaged 
region. The images were then reduced to 25% relative to the original size while maintaining the 
aspect ratio. These images were then arranged on a 3ft X 3ft power point slide (which is 
equivalent to a poster size paper) to reconstruct the whole damaged region in a single image. The 




























With the reconstructed image, each individual crack could be identified on the damaged 
region. The damaged region is surrounded by a major crack which is designated as crack A. The 
crack at the center of the region is designated as crack O. The other cracks are designated 
similarly from crack B to crack H. The network of cracks, illustrated with letters (A-H) in figure 
4.5, was then analyzed and their dimensions (length) were obtained using image analysis 
software (ImageJ) [89].  
Healing of the cracks, as shown in figure 4.3 and the smaller dimension (width) of the cracks, 
however, could not still be satisfactorily observed with this reconstructed image. Thus, each 
crack identified on the reconstructed image was again followed under OM at higher 
magnifications to find the healed portions and to measure the width of the cracks at different 
locations. Self-healing of the resin sample was then quantified by determining the fraction of the 
total crack length that was visibly filled with healed polymer.  
With reference to the reconstructed image in figure 4.5, the quantitative measurements and 
analysis of the cracks are given below: 
Crack A 
Between cracks H and B (see figure 4.5) 
Length = 9.9 mm 
Average width = 9 µm 
Healed length = 0.8 mm 
Between cracks B and C 
Length = 7.7 mm 
Average width = 9 µm 
Healed length = Not observed 
Between cracks C and D 
Length = 1.6 mm 
Average width = 7 µm 
Healed length = Not observed 
Between cracks D and E 
Length = 5.5 mm 
Average width = 9 µm 
Healed length = Not observed 
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Between cracks E and F 
Length = 5.7 mm 
Average width = 5 µm 
Healed length = 0.3 mm 
Between cracks F and G 
Length = 6 mm 
Average width = 12 µm 
Healed length = 0.5 mm 
Between cracks G and H 
Length = 5 mm 
Average width = 11 µm 
Healed length = 0.4 mm 
The total circumferential length of crack A = 41.5 mm.  
Total healed length of crack A = 2.3 mm 
Percentage of healed length = 5 % 
To measure the length of the cracks, the curves were divided into small segments and the 
lengths of each segment were measured. Similarly, average width of the cracks were calculated 
by measuring width in various locations of a crack.  
Crack B 
Length = 5.4 mm 
Average width = 3 µm 
Healed length = 1.1 mm 
Percentage of healed length = 20.4% 
Crack C 
Length = 6.2 mm 
Average width up to the mid length (measured from the center to the outer circumference of the 
damaged region) = 12 µm 
Average width from the mid length to the end of the crack (measured from the center to the outer 
circumference of the damaged region) = 4 µm 
Healed length = 5.8 mm 




Length = 7.4 mm 
Average width = 10 µm 
Healed length = 2.2 mm 
Percentage of healed length = 29.7 % 
Crack E 
Length = 4.2 mm 
Average width = 2 µm 
Healed length = 1.2 mm 
Percentage of healed length = 28.6 % 
Crack F 
Length = 5.1 mm 
Average width = 18 µm 
Healed length = 0.1 mm 
Percentage of healed length = 2 % 
Crack G 
Length = 2.6 mm 
Average width = 3 µm 
Healed length = 0.3 mm 
Percentage of healed length = 11.5 % 
Crack H 
Length = 5.4 mm 
Average width up to the mid length (measured from the center to the outer circumference of the 
damaged region) = 7 µm 
Average width from the mid length to the end of the crack (measured from the center to the outer 
circumference of the damaged region) = 2 µm 
Healed length = 2.1 mm 
Percentage of healed length = 38.9 % 
Crack O 
Length = 6.3 mm 
Average width = 9 µm 
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Healed length = 1 mm 
Percentage of healed length = 15.9% 
In summary,  
Total number of cracks observed = 9 
Total crack length = (41.5 + 5.4 + 6.2 + 7.4 + 4.2 + 5.1 + 2.6 + 5.4 + 6.3) mm = 84.1 mm 
Total healed length = (2.3 + 1.1 + 5.8 + 2.2 + 1.2 + 0.1 + 0.3 + 2.1 + 1) mm = 16.1 mm 
Healing efficiency defined as the fraction/percentage of the total crack length that was healed = 
19 % 
In addition to demonstrating and quantifying self-healing, the investigation also led to the 
observations that self-healing seems to perform better when 
i)  The propagating cracks intersect as many microcapsules as possible releasing sufficient 
amount of monomer into the crack to fill it up, and 
ii) The crack width is in the order of around 10-15 μm. 
After the successful demonstration of self-healing in resin (without reinforcement) sample 
with the current healing agents (5E2N/Grubbs catalyst), the next issues were to determine how 
much of a selected mechanical property (e.g. strength and stiffness) of FRP composite is 
provided by the healed material. Further, it was necessary to investigate and establish realistic 
methods of imparting damage to the composites and loading procedures to evaluate self-healing 
performance. Several methods were preliminary investigated for this purpose and are discussed 
in the following sections. 
4.3  Investigation of self-healing of FRP composites  
Several methods were employed to investigate the self-healing of FRP composites. The 
methods involve fabrication of regular (without healing agents) and modified (with healing 
agents) FRP composites, creation of controlled damages to it with realistic loadings and 
measuring the mechanical properties after allowing to heal the damages. These are discussed in 
the following sections.  
4.3.1 Flexure After Impact (FAI) 
This procedure can also be termed as impact-heal-flexure approach. In this approach, 
damages in the FRP composite samples were first created by controlled impact of projectiles shot 
from the available high velocity gas gun. Delaminations created in the samples were then 
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analyzed by visual observations. The damages created on the sample were then allowed to heal 
after which it is loaded in flexure using standard testing methods (ASTM D7264 [106]) to 
measure its flexural properties. Flexural properties of the undamaged control samples were also 
measured to compare it with the properties of healed samples. 
Fabrication of composite samples and impact conditions 
Regular (without healing agents) and modified (with healing agents) composite panels were 
manufactured using the hand lay-up method with autoclave molding. For the manufacturing of 
regular composite panel, layers of the carbon fabric were impregnated with regular epoxy matrix 
(containing epoxy and curing agent only). On the other hand, layers of the carbon fabric were 
impregnated with modified epoxy matrix (containing epoxy, microcapsules, catalyst and curing 
agent) for manufacturing modified composite panel. During the lay-up, a thin strip of teflon was 
introduced in between the 4th and 5th layer of the [02/902]S laminate. This teflon strip acts as an 
artificial flaw which is introduced in order to stimulate controlled delamination in the samples 














From these composite laminates, the 3-point bending samples were prepared according to the 













Figure 4.6 [02/902]S Laminate construction with artificial flaws. Projectiles travel 












The modified composite samples were typically 60% thicker than the regular composite 
samples due to the incorporation of healing agents into the matrix. The modified samples were 
thus cut longer than the regular samples (as shown in figure 4.7) to keep the same span to 
thickness ratio according to the ASTM standard. Some of these composite samples were shot 
with projectiles with varying impact energy using a high pressure gas gun.  
The samples were attached between two rigid supports with sealant tape as shown in figure 
4.8. The samples were then shot by projectiles (made of aluminum and polycarbonate) with 















Figure 4.7 3-point bending samples prepared from regular and modified 
carbon/epoxy composite panels 
Figure 4.8 Shooting set up for the composite samples  
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The impact energy was calculated according to  
𝐸𝑖𝑚 =  
1
2
𝑚𝑣2 ----------------------------------------------------------------------------------- (4.1) 
where, 
𝐸𝑖𝑚 represents the impact energy (joule); 
𝑚 represents the mass of projectile (gm/1000), 
𝑣 represents the velocity of projectiles (m/s) which was controlled by varying the diaphragm 
thickness.   


























Analysis of damage created on the samples by the impact of projectiles 
The delamination created on the composite samples due to the impact of high velocity 
projectiles were first analyzed by visual observations. Close observations of the edges of the 
composite samples revealed a systematic pattern of delamination created by the impact of 















At relatively lower impact energy, the delamination is mainly observed at the 0/90 interfaces 
and the interface of the induced flaw (teflon insert). Relatively minor delamination is created at 
the 0/90 interface (between 2nd and 3rd layer) which is closer to the site of impact (bottom surface 
in figure). An independent delamination is also created in the mid layer interface (between 4th 
and 5th layer) where the teflon strip is located. This delamination jumps from both ends of the 
teflon insert up (from bottom to top direction in which the shot projectile travels) to the next 0/90 
interface (between 6th and 7th layer) which is furthest away from the site of impact. The 
delamination at this interface (between 6th and 7th layer) then travels along the length of the 
sample in both directions away from the induced flaw. The most severe delamination (in terms of 
length and width of separation between the layers) is always observed at the farthest 0/90 










Figure 4.10 Typical delamination pattern of regular [02/902]S  composite sample with 
artificial mid-layer flaw under high velocity impact. Projectiles travel from bottom to top. 
Layers are also counted in the same direction; bottom (1), top (8).  
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The modified composites (incorporated with healing agents), on the other hand, show 
somewhat similar pattern but less severe delamination under comparable and relatively small 
impact energy. Further, no jumps of the cracks which connects two delaminations between two 
different interfaces is observed for modified samples. Incorporation of healing agents into the 
modified composites possibly make it more ductile to absorb more strains before delamination 
jumps to the next interface. The schematic of typical delamination pattern for modified shot 













After allowing the damaged composite samples to heal, the samples were loaded in flexure 
according to ASTM D7264 to measure their residual flexural properties (strength and stiffness).  
Flexural properties of the undamaged control samples were also measured to compare with the 
properties of healed samples.  
 
3-point bending test 
Figure 4.12 shows a composite sample undergoing flexural test on  MTS machine equiped 





Figure 4.11 Typical delamination pattern of modified [02/902]S composite sample with 
artificial mid-layer flaw under high velocity impact. Projectiles travel from bottom to top. 

























The load-displacement curves for the regular and modified composite samples shot with 

















Figure 4.12 A composite sample undergoing flexural test on MTS machine equipped 
with three-point bending fixture  
Figure 4.13 Load-displacement curves for regular composite samples after being shot 
























It is obvious from figures 4.13 and 4.14 that for both regular and modified composites, the 
no- shot samples have the highest load carrying capacity. As the impact energy increases the load 
carrying capacity decreases. Also, the slopes of the curves, which points to the stiffness of the 
samples, decrease with increasing impact energy. It is due to the fact that the increasing impact 
energy produces progressively larger amount of damages which, correspondingly, reduces the 
load carrying capacity and the stiffness of the samples.  For the no-shot specimens, initially, the 
load increases with increasing displacement. At the peak load (point 1), delamination is created 
(initiation) at the middle layer of the samples where the artificial flaw (teflon film) is located 
(figure 4.10). The delamination at the middle layer then propagates along the length of the 
sample and the load continues to drop. The propagation of delamination at the mid layer is 
stopped near the ends of the teflon insert marking the end of the propagation stage (point 2). The 
slope of the 1-2 line depends on the speed of propagation of delamination at the middle layer. 
For high speed of the propagation, this slope is almost vertical. At point 2, the load continues to 
increase a bit with ongoing displacement up to point 3 until the delamination appears at the outer 
Figure 4.14 Load-displacement curves for modified composite samples after being shot 







0/90 interface. The line 3-4 is the result of propagation of delamination at the outer 0/90 interface 
along the length of the samples. Again, the slope of line 3-4 depends on how fast the 
delamination is propagating at this layer. At point 4, the delamination is arrested at one of the 
support pins. If the loading is continued after point 4, the load continues to increase a bit until the 
delamination overcomes the resistance at the support pin and propagates to the end of the sample 
length separating two faces completely at one of its ends. Other shot samples under three-point 
bending shows similar stages of load-displacement curves as shown in figures 4.13 and 4.14.  
The absolute values of the peak loads in figure 4.13 and 4.14, however, should not be compared 
as the modified samples are significantly thicker than the regular samples caused by the 
incorporation of healing agents (microcapsules and catalyst) into the modified composites. 





Where, 𝐸 is the residual modulus of the sample (GPa),  
𝑚 is the slope of the load-displacement curve (N/mm).  
𝑏 is width of the samples which is kept the same for both regular and modified samples (mm),  
ℎ is the thickness of the samples (mm) and  
𝐿 is the span length (mm) 
The ratio (𝐿/ℎ) is also kept fixed for both regular and modified composite samples according to 
the ASTM D7264 standard. 
From equation, (4.2), it can be understood that residual modulus of the samples (𝐸) is 
directly proportional to the corresponding slope of the load-displacement curves(𝑚) as the other 
parameters (𝐿/ℎ)  and 𝑏 are kept constant for the regular and modified samples. Thus the 
comparison of the values of (𝐸) between regular and modified composites might be fairer even 
the thicknesses of the two types of the samples are significantly different. 
Thus, the residual stiffness retained by the composite samples after subjected to impact of 
projectiles with varying impact energy and subsequent healing (for modified composites) 






















Figure 4.15 shows that stiffness of the modified no-shot (impact energy = 0) composite 
sample closely matches the stiffness of the regular no-shot composite sample. It indicates that 
incorporation of healing agents into the modified composites does not affect its stiffness. 
However, the residual stiffness retained by the modified samples after healing is greater than the 
residual stiffness retained by the regular samples subjected to projectile shot up to the impact 
energy of 15J. This improved retention of residual stiffness of modified composites is possibly 
due to the self-healing of cracks by the healing agents incorporated into the modified composites. 
The residual strength, on the other hand, is calculated according to 
𝜎 =  
3𝑝𝐿
𝑏ℎ2
 ---------------------------------------------------------------------------------------------- (4.3) 
Where, 𝜎 is the residual flexural strength (MPa) and, 
𝑝 is the peak load (N) in the load-displacement curve. 
Figure 4.15 Residual stiffness retained by the composite samples after subjected to 
damage by impact and subsequent healing (modified composites) compared with 
regular samples (no healing ability) 
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From equation, (4.3), it can be realized that, even the parameters (𝐿/ℎ)  and 𝑏 are kept 
constant for the regular and modified samples, the residual strength of the samples (𝜎) is still a 
function of the parameter (
𝑝
ℎ
) which is not independent of thickness(ℎ). Thus, comparison of 
the values of (𝜎) between regular and modified composites might not be fair. Instead, the 
values of the parameter (
𝑝
ℎ
) is plotted against the impact energy in figure 4.16, for the regular 















Figure 4.16 Peak loads per unit thickness (p/h) retained by the composite samples after 
subjected to damages by impact and subsequent healing (modified composites) compared with 
regular samples 
Figure 4.16 indicates that the values of the parameter (
𝑝
ℎ
) for the modified composite 
samples remained lower than that of regular samples at a given impact energy. However, due to 
the dependence of the flexural loads on the geometry (thickness) of the samples [106], the effect 
of self-healing could not be clearly extracted from the above figure.  
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Residual flexural strengths of the composites, further, could not be directly compared 
because of its dependence on the thickness of the samples [even the parameters (𝐿/ℎ) are kept 
constant] which are significantly different in the regular and modified composite samples. Thus, 
it is concluded that the effect of self-healing might not be extracted accurately from the strength 
based approach. A fracture based approach which usually deals with determining material 
properties independent of geometry (thickness) of samples would probably, be a better choice for 
the evaluation of healing performance of FRP composites.  
4.3.2 Flexure after Flexure (FAF) 
As one of the objectives of the current work is to evaluate the self-healing performance of 
composites by a realistic loading procedure, the other procedure that was followed during the 
preliminary investigations also involved strength based approach while trying to minimize the 
difference in thickness between the regular and modified samples. The procedure can also be 
termed as flexure-heal-flexure approach. In this approach, damages in the FRP composite 
samples were first created by controlled bending of the composites instead of impact of 
projectiles. Delaminations created by the bending of the samples were then allowed to heal by 
unloading after which the samples are loaded again in three point bending according to ASTM 
D7264 [106] to measure its residual flexural properties. The difference in the fabrication of 
composite samples and the test procedures that followed are described in the following sections. 
Fabrication of composite samples  
New regular and modified composite samples were fabricated using the same method 
described in the previous section except the fact that only layers containing the dissimilar 
interfaces (i.e. only the 0/90 interfaces) and the mid 90/90 interface (where the teflon film was 
inserted) in the modified samples were impregnated with modified resin containing relatively 
high concentration (15 wt%) of microcapsules (see figure 4.6). The other layers (like the 0/0 and 
90/90 interfaces) of the modified samples were impregnated with regular resin. This was done to 
minimize the difference in thickness between the regular and modified composite samples and 
the delaminations were found to operate mainly on the dissimilar interfaces of the composites. 
Even with this modification, the modified composite samples were found to be about 45% 
thicker than the regular samples. The span to thickness ratio of the two types of samples were 
thus kept constant according to ASTM D7264 [106] for measuring the flexural properties of the 
samples with the new test schemes. 
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The FAF test schemes that were employed in the preliminary investigation are described 
below. 
Test scheme 1 
The first test scheme that was employed for the evaluation of healing performance is depicted 















In the test scheme 1 under the FAF protocol, it was proposed that the modified samples 
would be first loaded under 3-point bending test arrangement according to ASTM.  The load 
would continue to increase with increasing displacement. At the instant, the initiation of 
delamination is observed, the same load would be maintained on the sample by halting the 
displacement for a while to allow time for self-healing as shown in figure 4.17. After certain 
time, the load would be increased again with increasing displacement. Intuitively, 100% self-
healing would be assigned if the load continues to increase maintaining the same slope during 
the second loading. On the other hand, no healing (0%) would be assigned if the load drops 
vertically down when loading continues. Anything in between this envelope would be assigned 
proportionate percentage of self-healing. 
Several tests were made following the above scheme. The typical load-displacement curve 
with this test scheme 1 is shown in figure 4.18. 





















Figure 4.18 indicates that, the proposed test scheme was not possible to maintain in practice. 
It was intended that, the load would be held constant (by halting the displacement) at the instant 
when the delamination is just initiated. The displacement was halted at the peak load but the 
delamination propagated very fast reducing the load as evidenced in the vertical drop of the load 
in figures 4.18. The effect of self-healing could not be demonstrated in this case as large 
delamination already occurred in the composite sample. In order to better control the fast 
propagation of delamination, the displacement rate was reduced from a typical 1 mm/min down 
to 0.1 mm/min. Even, with this low displacement rate, the propagation of delamination could not 
be controlled by halting the displacement of the sample at the peak load.  Thus the test scheme 




Figure 4.18 Typical load-displacement curve with the proposed test scheme 1 under FAF 
protocol for evaluation of self-healing performance 
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Test scheme 2 
















According to the new test scheme 2, as depicted in figure 4.19, it was proposed that the 
modified samples would be first loaded until a delamination is initiated. The sample would be 
video recorded to look for the event of initiation of delamination during the first loading. The 
samples would then be unloaded immediately instead of keeping under the same load as in 
scheme 1. After unloading, certain time would be allowed to heal the delamination. After 
healing, the samples would be loaded again. The flexural properties (residual strength and 
stiffness) would be determined and compared for the regular and modified samples for the first 
and second loading using the equations (4.2) and (4.3) to evaluate the self-healing performance. 
Several tests were made following the new test scheme 2 under FAF protocol. The typical 
load-displacement curves for the regular and modified composite samples with this test scheme 2 









































Figure 4.20 Typical load-displacement curves for a) regular samples and b) modified 
samples with the proposed test scheme 2  
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During running the test of the regular and modified samples under the test scheme 2, the 
video of the test was monitored to detect the initiation of delamination in the samples. As soon as 
the delamination was observed in the video, the samples were unloaded. A duration of 24 hours 
was allowed for modified samples for healing without any manual intervention before it was 
reloaded. Comparing figures 4.20 a) and b) it can be observed that, the slope of the load-
displacement line in the second loading decreased more drastically in the regular samples than in 
the modified samples which is possibly due to the self-healing of delamination. The residual 
stiffness’s of the samples were calculated according to equations (4.2) and compared between the 
regular and modified composites as shown in figure 4.21. The comparison of residual stiffness 
between regular and modified samples according to equation (4.2) might be fairer even the 
modified samples were significantly thicker (about 45%) than the regular samples for reasons 


















Figure 4.21 shows that the original stiffness of modified sample in first loading closely 
matches the original stiffness of regular sample in first loading. This indicates that the 
Figure 4.21 Comparison of stiffness of the regular and modified composite samples 
during the first loading and second loading under the test scheme 2. M refers to modified 
and R refers to regular composite samples. Error bars represent one standard deviation. 
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incorporation of healing agents into modified composites did not reduce its stiffness. The figure 
also shows that residual stiffness of the regular sample in 2nd loading is about 50% less than its 
original stiffness in first loading. On the other hand, residual stiffness of the modified sample in 
2nd loading is only about 15% less than its original stiffness in first loading. This improved 
retention of residual stiffness of modified composites might be due to the self-healing of cracks 
by the healing agents incorporated into the modified composites. However, it should be noted 
that, during the first loading of the composite samples, the amount of extension of delamination 
from the pre-implanted teflon insert could not be controlled as desired. Thus, the length of 
delamination in the regular and modified samples was not equal which also might affect the 
residual stiffness value obtained during the second loading.  Thus, the effect of self-healing 
might not be accurately extracted from the test scheme.  
Further comparing figures 4.20 a) and b) it can be observed that the modified composite 
samples under second loading can retain most of the peak load of the 1st loading. The absolute 
values of the peak loads in figure 4.20 a) and b), however, should not be compared as the 
modified samples are significantly thicker than the regular samples caused by the incorporation 




) versus displacement might give an incorrect comparison of slopes of the lines for regular 




) is calculated for the peak loads achieved during the tests for the regular and modified 












Figure 4.22 Peak loads per unit thickness (p/h) retained by the regular and modified 
composite samples during the first and second loading under the test scheme 2. M refers to 



















The values of the term, (
𝑝
ℎ
) in the first loading are found to be significantly less in the 
modified composite samples than regular samples tested under test scheme 2. This might be due 
to the incorporation of relatively high concentration (15 wt%) of microcapsules in the modified 
composite samples. The values of the term, (
𝑝
ℎ
), however, remains similar in the second loading 
for the regular and modified samples as can be seen in figure 4.22. Similarly as discussed earlier, 
the effect of self-healing could not be clearly extracted from the above figure due to the 
dependence of the flexural loads on the geometry (thickness) of the samples [106].  A fracture 
based approach which usually deals with determining material properties independent of 
geometry (thickness) of samples would probably, be a better choice for the evaluation of healing 
performance of FRP composites 
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4.4 Concluding remarks 
It is concluded from the above preliminary investigations that the effect of self-healing of 
FRP composites might not be extracted accurately from the strength based approach. A fracture 
based approach which usually deals with material properties independent of geometry of samples 
would probably, be a better choice for the evaluation of healing performance. 
In 2014, ASTM international formally approved a new standard test method for the 
determination of mode II interlaminar fracture, or delamination, toughness of unidirectional FRP 
composites [107]. The method is based on calibration of compliance of the composite sample 
with crack lengths under three point bending set up and provides values of mode II fracture 
toughness (𝐺𝐼𝐼
𝐶) which is independent of geometry of the samples. It was shown that the 
compliance calibration method produces 𝐺𝐼𝐼
𝐶  values with accuracies of ±1.5% for carbon epoxy 
samples with 21≤ 𝐿/ℎ ≤47 where 𝐿 and ℎ are the span length and thickness of the samples 
[107]. The fracture based approach thus resolves the key issues (like the variation of thickness of 
samples, possible crack length dependence of flexural stiffness etc.) of the strength based 
approach investigated in the preliminary experiments.  This method of determining 𝐺𝐼𝐼
𝐶  of the 
FRP composites, thus, matches well within the framework of the current work one of the 
objectives of which is to establish a protocol of evaluating the healing performance of 
composites under realistic loading conditions. Thus a new protocol based on the measurement of 
𝐺𝐼𝐼
𝐶  according to ASTM D7905/7905M-14 [108] is proposed to evaluate the healing 















CHAPTER 5  
Protocol for Evaluating Self-Healing 
Performance of FRPC and Scenario Analysis 
5.1   Introduction 
Self-healing performance of polymer composite samples is evaluated by different protocols 
by different groups of researchers. These include impact-healing-compression approach in a 
Compression After Impact (CAI) test [ [29], [58] ], impact-healing-flexure approach in Flexure 
After Impact (FAI) test [ [31], [32] ], flexure-healing-flexure approach in flexure test [59]and 
fracture-healing-fracture approach in mode I fracture test protocol [ [56]- [61] ]. As the study of 
healing in composites involves cracks to be healed, it might be more relevant to analyze it based 
on fracture mechanics approach rather than strength of materials approach. Thus, the comparison 
of fracture properties of the composites might be more appropriate in determining and comparing 
its healing performance. While, mode I type crack propagation is common during interlaminar 
fracture of laminated composites, mode II type fracture is more relevant in many cases 
depending on the actual load conditions. Mode II delamination in laminates is a major matrix-
controlled failure mode induced by out-of-plane shear stresses frequently encountered in 
composite structures. As a fundamental failure mode, mode II delamination strongly influences a 
wide range of structural behavior under out-of-plane loading, especially that due to surface 
loading such as impact [109]. Further, three-point bending of sample with crack is the load 
scenario that typically induces mode II fracture [110]. In current work, healing performance of 
CFRP composites is thus finally evaluated by measuring and comparing the mode II fracture 
toughness representing realistic loading conditions with and without healing.  
5.2 Assessment of the mode I fracture test protocol and definition 
of a new protocol 
In most of the research works studying the microencapsulated self-healing of polymers, 
healing efficiency is used as a parameter to indicate and compare the healing performance of 




Figure 5.1 Mode I fracture testing of a) resin (without reinforcement) sample [51] and b) 
FRPC sample [56] 
release rates (independent of crack length achieved by suitable geometry of samples) of resin 
(without fibers) samples [ [49]- [66] ] and FRPC samples [ [56], [57]] in mode I fracture during 











Specified time is allowed after the first loading to achieve healing after which the second 
loading is carried out.  After the crack propagates in the first loading, the two crack surfaces are 
brought into contact to allow for healing for certain duration before the second loading [52]. In 
[57], the cracked surfaces of the FRPC samples were held together by a bar clamp after the first 
loading, to achieve healing. Healing efficiency is determined according to the following 
equation: 












𝑉𝑖𝑟𝑔𝑖𝑛  …………………………………………………(5.1) [57] 
Where, G, K and P values represent the critical strain energy release rate, critical stress 
intensity factor and the critical loads during the first (termed as virgin) loading and second 
(termed as healed) loading, respectively, of the same specimen [57].  
It is to be noted here that in the process of determining healing efficiency, it was required to 
manually bring the crack surfaces together after the crack propagates in the first loading in order 
to achieve significant healing. Kirkby et al. [54], researchers in the same group of White and 
Sottos [3], investigated healing of epoxy specimen aided by embedded shape memory alloy 
(SMA) wires. The embedded SMA wires that bridged the fracture plane of the TDCB specimens 
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were activated after first loading by passing DC current through it. The activation of the SMA 
wires increased the temperature of the local matrix to 80oC and generated an axial recovery force 
to close the crack during the healing period which substituted the requirement of manual 
clamping of the cracked surfaces to achieve significant healing. O’Brien and White [59]assessed 
the healing of microencapsulated DCPD/Grubbs system for the delamination of fiber reinforced 
composite skin/stringer flange debond specimen. With the flexure-heal-flexure approach they 
found no considerable recovery of structural properties in the specimens in which the cracked 
faces were not pressed together during the healing period. Even no visual evidence of healing 
was observed in this case. They achieved up to 96% recovery of original peak loads for the 
specimens for which the cracked faces were kept closed by reverse bending for 48 hours.   In real 
applications, it might not be feasible to bring two cracked surfaces of a part in contact in order to 
achieve healing. Practically, the process of achieving self-healing should be free from any 
manual intervention to fall into the type of autonomic self-healing.   
Another point to be noted here that healing efficiency is determined , as in equation (1), by 
the ratio of critical loads of the same modified sample (incorporated with healing agents) during 
the first (virgin) and second (healed) loading. No comparison is made with respect to neat 
samples (with no incorporation of foreign materials like the healing agents). Incorporation of 
foreign materials like microcapsules and catalysts can alter the base mechanical property of the 
neat sample. Depending on the various factors, the base mechanical properties might improve or 
degrade due to the inclusion of foreign materials. Keller and Sottos [49], Brown et al. [ [50], 
[51]] and Rule et al. [52] investigated the effect of microcapsule properties on the modified 
(healing agent incorporated) epoxy specimen. They found that microcapsules if adequately 
bonded to the matrix can actually improve its fracture toughness contrary to the presence of 
voids or other poorly bonded particles which tend to reduce the same. Keller and Sottos [49] 
found that geometry and fill content of microcapsules also influence the toughening mechanism 
of the matrix. However, they found a continuous reduction in strength of the epoxy specimen 
with increasing wt% of microcapsules. They pointed out that good adhesion of the microcapsules 
with the matrix is essential for encounter of microcapsules and its subsequent rupture by the 
approaching matrix crack triggering self-healing [49]. These possible changes in the base 
mechanical properties of the matrix due to the inclusion of healing agents are not reflected in the 
healing efficiency equation (equation 1) as it only compares the critical loads of the same 
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modified sample (incorporated with healing agents) during the first (virgin) and second (healed) 
loading.  
In the current work, mode II fracture toughness of CFRP composites are directly measured 
according to ASTM D7905-7905M-14 standard using a compliance calibration method [108]. 
Two values of fracture toughness were measured from each sample. The fracture toughness 
obtained with the propagation of delamination from the pre-implanted insert (acting as 
artificially introduced initial crack) is termed as NPC (Non-pre-cracked) fracture toughness. The 
fracture toughness obtained afterwards with the propagation of delamination from the naturally 
occurred initial crack is termed as PC (Pre-cracked) fracture toughness. The specimens are 
arranged in a three point bending fixture according to the arrangements in figure 5.2. For the 
NPC (No precrack) test, one end of the teflon insert acts as the starter crack tip. The crack length 
is measured from the left support roller to the crack tip. This crack length is kept the same for the 
subsequent PC (precrack) test. During the first (NPC) loading, the crack extends from the end of 
the teflon insert as shown in figure 5.2 (a). After the crack extension during NPC loading, the 
sample is unloaded and allowed for healing. After healing period, second (PC) loading is carried 
out. During the second loading (PC test), the sample is repositioned to keep the new crack tip at a 
same distance from the left support roller (Figure 5.2 c). Fracture toughness is then calculated 















Figure 5.2 Schematic of the composite sample showing the relative positions of the tip of 
the crack a) before the NPC fracture loading b) After the NPC fracture loading and c) 
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In the new proposed protocol, healing performance is evaluated by measuring and comparing 
the mode II fracture toughness of regular neat (no foreign materials incorporated) and modified 
(healing agents incorporated) FRPC samples during the first (NPC) and second (PC) loadings 
without any manual intervention for achieving healing. Healing performance index, instead of 
healing efficiency, is defined as in equations (2)-(4), by comparing the fracture toughness of 
regular and modified samples during the first and second loading. 
Self-healing performance is evaluated using the following equations: 
𝑃𝐼 = 𝜂ℎ − ∆𝜑          (2) 
Where 
PI  refers to performance index of healing 
ηh  refers to relative healing efficiency and 
∆𝜑 refers to toughening (or weakening) effect 

























         (4) 
Here,  
𝐺𝐼𝐼
𝐶  refers to strain energy release rate measured during the NPC and PC tests, and 
R and M refer to regular (without healing agents) and modified (with healing agents) specimens 
respectively. The elaboration of the equations is given in the following subsections. 
The notable differences between the new protocol and the existing protocol for evaluating 
healing performance can be summarized as follows: 
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a) The new protocol involves mode II fracture which composite structures are frequently 
encountered with under realistic loading conditions (like impact or bending)  
b) In this protocol, healing is achieved in an autonomic manner after the NPC (crack generation) 
test. No external intervention (like pressing the cracked surfaces together) was made to influence 
or trigger self-healing. 
c) The new protocol calculates relative healing efficiency which is obtained by comparing the 
fracture performances of both the regular and modified composite samples after healing. It 
involves testing of two types of samples (regular and modified) in NPC and PC configurations. 
That is, a total of four measurements of the fracture toughness is necessary to evaluate the 
healing performance. In the existing protocol, only two measurements of fracture toughness of 
one type of sample (modified) are required to evaluate healing performance. 
d) The new protocol includes the toughening (or weakening) effect of incorporating healing 
agents into composite samples in the definition of healing performance index. The existing 
protocol does not include this effect in the healing efficiency definition. It should be realized 
that, in an actual multi-layered composite part, healing agents need to be incorporated in every 
interface as the exact location of crack initiation might not be known. However, during a test of a 
coupon sample, healing agents is usually incorporated into the known weaker interface. Thus, in 
a composite test coupon, the effect of incorporating healing agents might not be too evident in 
contrast to the actual composite part. Thus, this effect should always be considered in the 
evaluation of healing performance for practical applications. 
5.2.1 Elaboration of healing performance index and definition of 
conventional healing efficiency  
The ultimate purpose of imparting self-healing functionality to regular (the matrix without 
healing agents) composite parts is to regain its original mechanical properties when cracks form 
in it due to some damage events. A regular composite part will only be replaced with a modified 
(the matrix incorporated with healing agents) composite part, when it is expected to show better 
fracture performance. In other words, self-healing application will be deemed attractive only 
when the overall fracture performance of modified composite parts (replacing the regular 
composite parts) is improved compared to regular composite parts. Healing efficiency, as defined 
in equation (1), does not consider this comparative improvement of fracture performance. It only 
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indicates the ratio of critical loads when a crack first propagates through the modified matrix 
(first loading) and when it propagates through the healed matrix (second loading) of the same 
modified composite samples. That means, even if the healing efficiency has a large value, 96% 
e.g. as in [59], it might not guarantee that it is an attractive and desired result. This is specially, 
true, if the initial mechanical properties of the modified composite part is significantly degraded 
due to the inclusion of healing agents. As discussed previously, the inclusion of healing agents 
can either degrade or improve initial mechanical properties depending on various factors like 
size, concentration, mechanical properties and bonding effectiveness of the healing agents 
(microcapsules and catalysts). These effects cannot be seen in the current healing efficiency 
value.  
Healing performance index, as in equation (2), on the contrary, has two terms. One is relative 
healing efficiency term defined in equation (3). The other is the toughening (or weakening) 
effect defined in equation (4). In order to realize the advantages of the new protocol, it is 
necessary to define the conventional healing efficiency based on mode II fracture toughness 
which is the counterpart of existing protocol. Thus, 








          (5) 
Where, M refers to modified (with healing agents) composite samples. 
 
Conventional healing efficiency as defined by equation (5) is equivalent to the healing 
efficiency defined in equation 1 based on mode I fracture toughness. From here on, the symbol 
GII
C  will be omitted for simplicity. A qualitative comparison of the conventional healing 









5.3 Qualitative comparisons of healing performance index and 
conventional healing efficiency  
 

























In figure 5.3, horizontal axis represents wt% of microcapsules used in composite samples. 
Vertical axis represents the mode II fracture toughness during first loading (NPC) and second 
loading (PC-after time allowed for healing).  Rectangles and triangles represent the measured 
values (qualitatively) of the NPC and PC fracture toughness, respectively. The composite 
samples containing no healing agents (0 wt% microcapsules) are termed as regular samples and 
the composite samples which contain healing agents (certain wt% of microcapsules) are termed 
as modified samples. Figure 5.3 thus represents one regular and one modified sample tested for 
NPC and PC fracture toughness. Equations (2)-(5) are rewritten in simpler forms (omitting the 
common symbol GII
C  ) below. 
 
𝑷𝑰 = 𝜼𝒉 − ∆𝝋          (2) 
 







        (4´) 
 
𝜼𝒉 =  
(𝑃𝐶)𝑴−(𝑃𝐶)𝑹
(𝑁𝑃𝐶)𝑹−(𝑃𝐶)𝑹





         (5´) 
 
It is to be noted that PC fracture toughness of regular sample [(𝑃𝐶)𝑹] is usually always lower 
than NPC fracture toughness of regular sample [(𝑁𝑃𝐶)𝑹] as indicated in figure 5.3. This is 
because, the sample already contains a real sharp precrack during the PC test while there was no 
real precrack (teflon insert) during the preceding NPC test as shown in figure 5.2.  
For a comparative scenario analysis, let us assume that, the PC fracture toughness of regular 
sample is (m*100) % of NPC fracture toughness. i.e.  
 
(𝑃𝐶)𝑹 = 𝑚(𝑁𝑃𝐶)𝑹  where, 0 < m < 1       (7) 
 
As there are no healing agents (microcapsules or catalysts) in regular samples, this value 
remains fixed. The NPC and PC fracture toughness of modified samples, however, will vary 
according to the wt% of microcapsules used in the samples. Let us again assume that, the 
fracture toughness values of modified samples will either remain the same, will increase or 
decrease a certain percentage compared to regular samples. This variation of NPC fracture 
toughness of modified samples with respect to regular samples is due to the toughening (or 
weakening) mechanisms in effect for the inclusion of healing agents. This is, however, not 
directly related to the Ring Opening Metathesis Polymerization (ROMP) reaction between the 
5E2N monomer and Grubbs catalyst (self-healing) as the monomer still remains encapsulated 
within the unbroken microcapsules during the NPC test. On the contrary, the variation of PC 
fracture toughness of modified samples with respect to regular samples is the direct effect of 
self-healing, i.e., the ROMP reaction between the monomer released from the broken 
microcapsules and catalyst dispersed in the sample. The effect of these possible variations on the 





5.3.1 Scenario analysis  
Case I:   
Let in the first case, we assume that NPC fracture toughness of modified samples remain the 
same as NPC fracture toughness of regular samples. That is, 
 (𝑁𝑃𝐶)𝑴 = (𝑁𝑃𝐶)𝑹          (8) 
 
and PC fracture toughness varies according to following scenario 
 
a) PC of modified sample also remains the same as regular sample 
 
(𝑃𝐶)𝑴 = (𝑃𝐶)𝑹          (9) 
 
In this scenario both, NPC and PC fracture toughness remain the same as NPC and PC 
fracture toughness of regular samples, respectively. That means, the modified samples have 
exactly the same fracture performance as regular samples. It implies that, there is no need to 
replace the regular composite part as there is no advantage of incorporating healing agents in it. 
Now, let us see what the healing efficiencies defined by equations (2)-(5) tell us about this 
scenario. 
 
From equation (7) and (9), we get 
 
(𝑃𝐶)𝑴 = 𝑚(𝑁𝑃𝐶)𝑹         (9a) 
 
By definition, relative healing efficiency is given by  
 
𝜂ℎ =  
(𝑃𝐶)𝑴−(𝑃𝐶)𝑹
(𝑁𝑃𝐶)𝑹−(𝑃𝐶)𝑹
          (3) 
 
Replacing the relations from equations (7) and (9a) in equation (3), we get 
 
𝜂ℎ =  
𝑚(𝑁𝑃𝐶)𝑹−𝑚(𝑁𝑃𝐶)𝑹
(𝑁𝑃𝐶)𝑹−𝒎(𝑁𝑃𝐶)𝑹
= 0       (3a) 
 





        (4) 
 







= 0       (4a) 
 
Further, by definition, healing performance index is given by 
 
𝑃𝐼 = 𝜂ℎ − ∆𝜑         (2) 
 
Replacing the values from (3a) and (4a), in equation (2), we finally get 
 
𝑃𝐼 = 𝜂ℎ − ∆𝜑 = 0        (2a) 
 





         (5) 
 





= 𝑚         (5a) 
 
 
Thus, healing performance index gives the correct signal in this scenario (PI =0) indicating 
that there is no need to replace the regular composite part as there is no advantages of 
incorporating healing agents in it. Conventional healing efficiency, on the contrary, show a 
positive healing efficiency value (= m), in this scenario, indicating advantages of incorporating 
healing agents and suggesting for a possible replacement of regular composite part with modified 
ones. It is an inappropriate signal, in this scenario, given by the conventional healing efficiency 
based on the previous argument that the modified sample has exactly the same NPC and PC 
fracture performance as that of NPC and PC fracture performance of regular sample, 
respectively. As an example, for a likely value of m =0.4, equation (5a) indicates that 
conventional healing efficiency is 40%. Equation (2a), on the contrary, indicates that the healing 
performance index is still zero in this scenario defined by equations (8) and (9).  
 
b) PC of modified sample increases (n*100) % compared to PC of  regular sample, i.e. 
 
(𝑃𝐶)𝑴 = (1 + 𝑛)(𝑃𝐶)𝑹  where,  0 < n < (1-m)/m    (10) 
 




(𝑃𝐶)𝑴 = 𝑚 (1 + 𝑛)(𝑁𝑃𝐶)𝑹               (10a) 
 
By definition, relative healing efficiency is given by  
 
𝜂ℎ =  
(𝑃𝐶)𝑴−(𝑃𝐶)𝑹
(𝑁𝑃𝐶)𝑹−(𝑃𝐶)𝑹
          (3) 
 
Replacing the relations from equations (7) and (10a) in equation (3), we get 
 
 𝜂ℎ =  
𝑚(1+𝑛)(𝑁𝑃𝐶)𝑹−𝑚(𝑁𝑃𝐶)𝑹
(𝑁𝑃𝐶)𝑹−𝒎(𝑁𝑃𝐶)𝑹
      
 
Or,  𝜂ℎ =  
𝑚(𝑁𝑃𝐶)𝑹{𝟏+𝒏−𝟏}
(𝑁𝑃𝐶)𝑹(𝟏−𝒎)
   
    
Or,  𝜂ℎ =  
𝑚𝑛
(𝟏−𝒎)
          (3b) 
 





        (4) 
 





= 0       (4b) 
 
Further, by definition, healing performance index is given by 
 
𝑃𝐼 = 𝜂ℎ − ∆𝜑         (2) 
 





− 0    
Or,  𝑃𝐼 =
𝑚𝑛
(𝟏−𝒎)
          (2b) 
 







         (5) 
 





        
 
Or, ηh,c = 𝑚(1 + 𝑛)         (5b) 
 
For the cases of 0 < m <1 and 0 < n < (1-m)/m,  conventional healing efficiency in equation 
(5b) always gives higher values than healing performance index in equation (2b). For some 
likely fixed values of m (m= 0.3 to 0.5), figure 5.4 (a)-(c) show the comparison of conventional 
healing efficiency and healing performance index for increasing values of n as given by 















































Figure 5.4 Comparison of conventional healing efficiency, 𝜼𝒉,𝒄 Vs healing performance 
index 𝑷𝑰, for fixed values of m equals to a) 0.3, b) 0.4 and c) 0.5 according to equations 
(2b) and (5b). m is the % decrease of NPC fracture toughness of regular sample when a 



















































































Comparing the figures in 5.4 (a)-(c), it can be observed that, conventional healing 
efficiency,ηh,c significantly overestimates the healing performance as compared to healing 
performance index (PI) until PC fracture toughness of modified sample [(𝑃𝐶)M] equals the NPC 
fracture toughness of regular sample [(𝑁𝑃𝐶)R]. This situation [(𝑃𝐶)M = (𝑁𝑃𝐶)R], in fact, 
implies that the modified cracked sample is capable of restoring the original fracture toughness 
of a regular uncracked sample after healing.  
 
c) PC of modified sample decreases (n*100) % compared to PC of regular sample, i.e. 
 
(𝑃𝐶)𝑴 = (1 − 𝑛)(𝑃𝐶)𝑹  where,    0 < n < 1     (11) 
 
Similar to scenario (b), it can be shown that, for the current scenario, 
 
Relative healing efficiency as defined by equation (3) becomes 
    
𝜂ℎ =  
−𝑚𝑛
(𝟏−𝒎)
          (3c) 
 
The toughening effect as defined by equation (4) becomes 
 
∆𝜑 = 0          (4c) 
 
Further, the healing performance index as defined by equation (2) becomes 




          (2c) 
 
Finally, the conventional healing efficiency as defined by equation (5) becomes  
 
 ηh,c = m(1 − n)         (5c) 
 
For the likely cases of 0 < m <1 and 0 < n < 1,  conventional healing efficiency as in 
equations (5c) always give a positive value while healing performance index as in equation (2c) 
always gives a negative value. The ultimate purpose of imparting healing functionality to 
modified composite parts is to achieve better PC fracture toughness than a regular sample after a 
crack has been formed in it. If the opposite happens, that is, if the PC fracture toughness of 
modified sample becomes less than PC fracture toughness of regular sample, the purpose of 
incorporating healing agents in composites is failed. This is an undesired situation in terms of 
self-healing. In this scenario, healing performance index and relative healing efficiency as 
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defined by equations (2) and (3) give a negative value effectively signaling an undesired 
situation. In other words, getting a negative value of relative healing efficiency and healing 
performance index would suggest that there is no reason to replace a regular composite part with 
modified ones. Even in this scenario, the conventional healing efficiency defined in equations (5) 
shows a positive value which might give rise to a confusion about the decision to replace an 
existing regular composite part.  
Thus, in all of the above scenarios, the healing performance index effectively aids in making 
a go/no go decision for a possible replacement of an existing regular composite part with a 
modified composite part incorporated with healing agents. 
Case II:  
Let in the second case, we assume that PC fracture toughness of modified samples remain the 
same as PC fracture toughness of regular samples, i.e., 
 
 (𝑃𝐶)𝑴 = (𝑃𝐶)𝑹          (12) 
 
and, NPC fracture toughness of modified sample varies according to scenario described below. It 
is to be reminded here that, equation (12) itself indicates an undesired situation in terms of self-
healing, as the ultimate purpose of self-healing is to have improved fracture performance 
compared to regular composites when a crack is generated in the composite part. That is, the PC 
fracture toughness of modified sample should always be higher than PC fracture toughness of 
regular sample in order for the self-healing to be an attractive option. In the following scenario 
analysis, we can see how the healing performance indicators handle this undesired situation.  
 
d) NPC of modified sample increases (p*100) % compared to NPC of regular sample, i.e. 
 
(𝑁𝑃𝐶)𝑴 = (1 + 𝑝)(𝑁𝑃𝐶)𝑹  where, 0 < p <1      (13) 
  
From equation (7) and (12), we get 
 
(𝑃𝐶)𝑴 = 𝑚(𝑁𝑃𝐶)𝑹                (13a) 
 
By definition, relative healing efficiency is given by 
 
𝜂ℎ =  
(𝑃𝐶)𝑀−(𝑃𝐶)𝑅
(𝑁𝑃𝐶)𝑅−(𝑃𝐶)𝑅




Replacing the relations from equations (7) and (13a) in equation (3), we get 
  
𝜂ℎ =  
𝑚(𝑁𝑃𝐶)𝑹−𝑚(𝑁𝑃𝐶)𝑹
(𝑁𝑃𝐶)𝑹−𝑚(𝑁𝑃𝐶)𝑹
= 0       (3d) 





        (4) 
 












Or, ∆𝜑 = −𝑝          (4d) 
 
Further, by definition, healing performance index is given by 
 
𝑃𝐼 = 𝜂ℎ − ∆𝜑         (2) 
 
Replacing the values from (3d) and (4d), in equation (2), we finally get 
 
𝑃𝐼 = 0 − (−𝑝)        
 
Or, 𝑃𝐼 = 𝑝           (2d) 
  
In this scenario, we can see that the improvement in fracture performance due to self-healing 
(achieved by the ROMP reactions of monomer and catalyst), as indicated by the relative healing 
efficiency term 𝜼𝒉, is zero. The positive value of healing performance index (𝑃𝐼), however, 
indicates the overall improvement of fracture performance which is due to the toughening 
mechanisms of the healing agents in effect. The improvement of this fracture performance (equal 
to 𝑝) is, however, the sole contribution of the toughening mechanisms of the microcapsules as 
indicated by the value of ∆𝝋(= −𝑝) and not related to the self-healing (polymerization reaction 
of monomer and catalyst) reaction. Intuitively, a negative value of ∆𝝋 indicates toughening 
effect whereas a positive value of ∆𝝋 indicates weakening effect of healing agents incorporated 









         (5) 
 










          (5d) 
 
For a likely fixed value of m (m= 0.4), figure 5.5 shows the comparison of conventional 
healing efficiency and healing performance index for increasing values of p as given by 
























Figure 5.5 Comparison of conventional healing efficiency, 𝜼𝒉,𝒄 Vs healing 
performance index 𝑷𝑰, for fixed values of m according to equations (2d) and (5d). m is 
the % decrease of NPC fracture toughness of regular sample when a real precrack is 
present.  





From figure 5.5, it can be observed that, as the NPC fracture toughness of modified sample 
improves compared to regular sample (i.e. p increases), the conventional healing efficiency 
decreases. This is a wrong signal and counter-intuitive. Healing performance index,𝑃𝐼, on the 
other hand, increases with the increase in p which is expected. That means, it accounts for the 
toughening effect of the healing agents which expectedly translates into higher PI values.  
Further, it can be realized here that positive values of conventional healing efficiency, in this 
scenario, neither signifies an improvement of fracture performance due to the self-healing 
reaction (as the PC fracture toughness of modified sample remains the same as the PC fracture 
toughness of regular sample in this scenario) nor due to the toughening effect of the healing 
agents. On the other hand, positive values of performance index (PI = p) along with the zero 
values of relative healing efficiency (𝜼𝒉 = 0 ), in this scenario, confirm the fact that there is no 
contribution of self-healing (due to ROMP reaction) although there is an overall improvement in 
fracture performance due to the toughening effect of healing agents incorporated into the 
modified sample. Thus, the performance index, as defined in equation (2), can effectively 
differentiate the contributions from self-healing reaction and toughening effect.  
 
e) NPC of modified sample decreases (p*100) % compared to regular sample, i.e. 
 
(𝑁𝑃𝐶)𝑴 = (1 − 𝑝)(𝑁𝑃𝐶)𝑹  where, 0 < p <1      (14) 
  
Similar to scenario (d), it can be shown that, for the current scenario, 
 
Relative healing efficiency as defined by equation (3) becomes 
 
𝜂ℎ = 0           (3e) 
 
The toughening effect as defined by equation (4) becomes 
 
∆𝜑 = 𝑝          (4e) 
 
Further, the healing performance index as defined by equation (2) becomes 
 
𝑃𝐼 = −𝑝          (2e) 
 
In this scenario, the negative healing performance index (𝑃𝐼) value indicates that there is an 
overall degradation of fracture performance due to the weakening effect (∆𝝋 = 𝑝 ) of the healing 
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agents incorporated in the modified samples.  





          (5e) 
 
For a likely fixed value of m (m= 0.4), figure 5.6 shows the comparison of conventional 
healing efficiency and healing performance index for increasing values of p as given by 


























Figure 5.6 shows that as the NPC fracture toughness degrades (i.e. p increases), the value of 
conventional healing efficiency increases. The more the NPC fracture toughness degrades, more 
the value of conventional healing efficiency increases. This is, in fact, happens in any other 
scenario for a fixed value of PC fracture toughness of modified sample. This is one of the 
greatest limitations of the conventional healing efficiency. The degradation of NPC fracture 
Figure 5.6 Comparison of conventional healing efficiency, 𝜼𝒉,𝒄Vs healing performance 
index 𝑷𝑰, for fixed values of m according to equations (2e) and (5e). m is the % 
decrease of NPC fracture toughness of regular sample when a real precrack is present. 





toughness due to the incorporation of healing agents is a very likely situation in many cases and 
conventional healing efficiency gives an opposite signal indicating that the healing situation is 
actually improved. This is indeed, a wrong signal and counter-intuitive. Healing performance 
index,𝑃𝐼, on the other hand, decreases with the increase in p, as shown in figure 5.6, which is 
expected. That means, it accounts for the weakening effect of the healing agents which 
expectedly translates into lower PI values. Again, positive values of conventional healing 
efficiency, in this scenario, neither signifies an improvement of fracture performance due to the 
self-healing reaction (as the PC fracture toughness of modified sample remains the same as the 
PC fracture toughness of regular sample in this scenario) nor due to the weakening effect of the 
healing agents. On the other hand, negative values of performance index (PI = -p) along with the 
zero values of relative healing efficiency (𝜼𝒉 = 0 ), in this scenario, confirm the fact that there is 
no contribution of self-healing (due to ROMP reaction) although there is an overall degradation 
in fracture performance due to the weakening effect of healing agents incorporated into the 
modified sample.  
Thus, it can be realized from the above discussions that, healing performance index, unlike 
the conventional healing efficiency, always gives a correct signal representing the desired or 
undesired situations in terms of self-healing.  
In reality, composite parts may not perform exactly according to the above scenarios. Rather, 
a combination of the above scenarios would be operative practically.  The NPC fracture 
toughness may increase or decrease in combination with the increase or decrease of the PC 
fracture toughness of the modified sample. The results discussed above would then be 
superimposed depending on the actual scenario in effect. 
5.4 Summary of the distinguishing features of the new protocol 
versus existing protocol for evaluating healing performance 
 
From the analysis of the basic scenarios discussed above, it is clear that healing performance 
index as defined by equations (2)-(4) handles all the above possible scenarios better than 
conventional healing efficiency definitions. The characteristic features and advantages of healing 
performance index over the conventional healing efficiency can be summarized as follows: 
i) Any positive value of performance index always represents an improvement in fracture 
performance over regular composites. A negative value of performance index, on the other 
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hand, warns that there is no advantage of incorporating healing agents into composites. On 
the contrary, conventional healing efficiency always gives a positive value which may or 
may not represent an improvement of fracture performance over regular samples. 
ii) Healing performance index separates the contribution of self-healing (ROMP reaction of 
monomer and catalyst) and toughening (or weakening) effect of incorporating healing agents 
(microcapsules and catalyst particles) in the composite sample. The contribution of self-
healing is demonstrated by the relative healing efficiency term, 𝜼𝒉,as defined by equation (3). 
The contribution of toughening (or weakening) effect is demonstrated by ∆𝝋 as defined by 
equation (4). The numerical values of healing performance index thus represents real 
physical phenomena. Conventional healing efficiency, on the other hand, cannot differentiate 
these effects and its numerical value may not represent a real physical phenomenon.  
iii) Relative healing efficiency term in healing performance index sets up a threshold value for 
PC fracture toughness of modified sample (equals to PC fracture toughness of regular 
sample) at or below which the healing performance is not acceptable as indicated by its zero 
or negative values [scenario (a), (c)-(e)]. Conventional healing efficiency, on the other hand, 
always shows a positive healing efficiency and can, in fact, show a significantly high value 
even if the healing performance is not attractive as discussed in scenario (e) and indicated in 
figure 5.6. 
iv) A possible toughening or weakening effect of incorporating healing agents into the modified 
sample is correctly translated into higher or lower values, respectively, of healing 
performance index. Conventional healing efficiency, on the contrary, resolves these effects in 
opposite way. That is, a toughening effect reduces the healing efficiency, and more 
alarmingly, a likely weakening effect increases the healing efficiency as discussed in 
scenario (d) and (e) and indicated in figures 5.5 and 5.6. The more the weakening effect, the 
higher is the conventional healing efficiency (figure 5.6). This fact can make the 
conventional healing efficiency an unreliable index indicating self-healing performance. 
v) Conventional healing efficiency always gives higher values than healing performance index 
in neutral cases where there is no significant weakening or toughening effect as discussed in 
scenario (b) and indicated in figures 5.4 (a)-(c). 
vi) The healing performance index, unlike the conventional healing efficiency, always gives a 
correct signal representing the desired or undesired situations in terms of self-healing. It thus 
133 
 
effectively aids in making a go/no go decision for a possible replacement of an existing 
regular composite part with a modified composite part incorporated with healing agents. 
vii) Finally, in the new protocol, no manual intervention is made to trigger or influence healing 
after the crack is generated in the sample. 
Thus, a better protocol of evaluating healing performance of composites which represents the 
true improvement of healing performance over regular composites under realistic loading 























CHAPTER 6  
Investigation of Self-healing of FRP 
Composites at Room Temperature 
6.1   Introduction 
Mode II delamination in laminates is a major matrix-controlled failure mode induced by out-
of-plane shear stresses frequently encountered in Fiber Reinforced Polymer (FRP) composite 
structures. As a fundamental failure mode, mode II delamination strongly influences a wide 
range of structural behavior under out-of-plane loading, especially that due to surface loading 
such as impact [109]. Further, three-point bending of sample with crack is the load scenario that 
typically induces mode II fracture [110]. In current work, healing performance of FRP 
composites is thus evaluated by measuring and comparing the mode II fracture toughness 
representing realistic loading conditions with and without healing. This chapter describes the 
procedure of measuring the mode II fracture toughness of regular (without healing agents) and 
modified composites (with healing agents) and discusses the obtained results in relation to self-
healing. Fractographic analysis was done by a series of observations of fracture surfaces of 
composites to understand the self-healing behavior. 
6.2  Fabrication of composite samples 
Fiber reinforced carbon/epoxy samples were fabricated for self-healing experiments. Two 
types of fiber reinforced carbon/epoxy composite samples were fabricated. Regular composite 
samples do not contain any healing agents. Modified, composite samples, on the other hand, 
contains healing agents. The fiber reinforced composite samples were used for mode II fracture 
tests. 
The formulation of regular (without healing agents) and modified (with healing agents) 
epoxy matrix and the procedure of fabricating fiber reinforced composite samples are discussed 
in details below. 
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6.2.1 Formulation of epoxy matrix 
Two types of epoxy matrix were formulated for manufacturing epoxy (without 
reinforcement) samples and fiber reinforced composite laminates. These are the regular epoxy 
matrix (without healing agents) and modified epoxy matrix (with healing agents). Regular epoxy 
matrix was formulated by mixing EPON 828 (a bisphenol-A based epoxide resin, Miller 
Stephenson Chemical Co.) and Epicure 3046 (an amidoamine room temperature curing agent, 
Miller Stephenson Chemical Co.) at a concentration of 100:47 (by weight).  Epicure 3046 curing 
agent provides a working life of several hours, yet cures to handling strength overnight at room 
temperature. Good strength properties are achieved within three days and essentially complete 
cure is obtained within two weeks at room temperature. According to the manufacturer 
recommendation, comparable mechanical properties are also obtained when cured for 16 hours at 
25oC and post cured for 2 hours at 100oC. For the formulation of regular (no healing agents) 
epoxy matrix, an appropriate amount of the resin and the curing agent were mixed in a container 
by stirring first with a wooden stick. The container was then placed in a vacuum mixer and the 
rotation speed of the mixer, time and vacuum were set. Mixing of the resin and curing agent was 
carried out with vacuum applied for several minutes intermittently (to avoid raising the 
temperature of the mixture) until a smooth, transparent, air bubble free mixture was obtained. 
For the formulation of modified epoxy matrix, a modified route of mixing was followed in order 
to incorporate the healing agents (microcapsules and catalysts) into it. For the modified epoxy 
matrix, appropriate amount of catalyst (1 wt% of the total weight of epoxy and curing agent) was 
first dispersed into the EPON 828 resin in a container by stirring it with a wooden stick for 
several minutes. The container was then placed in the vacuum mixer and spun at a relatively high 
set speed (up to 2000 rpm) intermittently for several minutes to disperse the catalyst uniformly in 
the resin. Appropriate amount of microcapsules were then added into the catalyst-resin mixture, 
stirred and dispersed in the same way in the vacuum mixer but with relatively low rotation speed 
(up to 1200 rpm) to avoid breaking of microcapsules due to high shear. At the last step, 
appropriate amount of the curing agent was added to the catalyst-resin-microcapsule mixture, 
stirred and spun with the same speed (1200 rpm) as with the microcapsules with vacuum applied 
for several minutes intermittently until a smooth, air bubble free mixture was obtained. The 
regular (without healing agents) and modified (with healing agents) epoxy matrix thus 
formulated were used to fabricate fiber reinforced composite samples. 
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6.2.2 Fabrication of FRP composite samples 
As stated earlier, two types of fiber reinforced carbon/epoxy composite samples were 
manufactured. One type is the regular carbon/epoxy composite samples without self-healing 
capabilities. The other type is the modified carbon/epoxy composite samples with self-healing 
capabilities. Fiber reinforced carbon/epoxy composite panels were manufactured by hand lay-up 
with autoclave molding process. Unidirectional carbon fabric (Fiber Glast Development Corp.) 
was used as reinforcement. Twelve 300 X 200 mm rectangles were first cut from the carbon 
fabric. For the manufacturing of regular composite panel, each of the twelve layers of the carbon 
fabric was impregnated with regular epoxy matrix (formulation is described in the previous 
section) using a plastic applicator and stacked on top of one another on an aluminum flat tool 
surface kept on a lay-up table. A Teflon (polytetrafluoroethylene, PTFE) film strip was placed at 
one edge at the middle of the twelve layers (i.e. between the sixth and seventh layer interfaces) 
across its width to act as a site of crack initiation. The configuration of the composite samples 
with pre-implanted teflon insert is termed as NPC (Non-pre-cracked) configuration. After 
finishing the stacking of twelve layers, a porous release film was placed on top of it followed by 
a bleeder layer to allow the excess resin to bleed during compaction. A breather layer was placed 
on top of it to facilitate vacuum. A caul plate was then placed on top of the laminate to distribute 
the vacuum and the subsequent applied pressure evenly on the composite. The entire assembly 
was sealed with vacuum bag using sealant tape. A vacuum valve was installed on the vacuum 
bag on the tool surface slightly away from the stacked composite layers to avoid jamming of the 





















The aluminum plate with the vacuum bagged assembly was then connected to the vacuum 
line and put inside the autoclave. The composite was initially cured in the autoclave at room 
temperature for 72 hours with the vacuum and pressure (50 psi) applied. The panel was then 
removed from the autoclave and kept at room temperature for another two weeks for complete 
curing according to the recommendations of the supplier of the curing agent. The panel was then 
post cured at 100oC in an oven for 2 hours. Epicure 3046, used as the curing agent in this work, 
is a room temperature curing agent and according to the supplier recommendation, a complete 
cure is obtained within two weeks at room temperature. Further, the composites were chosen to 
be cured at room temperature to avoid degradation of Grubbs catalyst which is known to be 
sensitive to prolonged exposure to high temperature. In the Differential Scanning Calorimetry 
(DSC) analysis of the composite samples as shown in figure 6.2, no major heat flow event is 












































The same procedure was followed to manufacture the modified composite panels (with self-
healing capability) except that the center two layers were impregnated with modified epoxy 
matrix (incorporated with healing agents. Its formulation is described in the previous section).  
Besides the regular (contained no microcapsules) composite panels, different modified 
composite panels (incorporated with microcapsules and catalyst) were fabricated varying the 
average size and concentration of microcapsules. Two different average sizes (100 µm and 45 
μm) and 3 different concentrations [2 wt% (2.3 vol%), 5 wt% (5.7 vol%) and 8 wt% (9.1 vol%) 
of the modified epoxy] of microcapsules were chosen for investigation. The viscosity of 
modified epoxy increases with increasing concentration of microcapsules and above 8wt% it 
becomes very difficult to process and uniformly disperse it during the lay-up leading to poor 
quality of composite laminate. Table 6.1 indicates the different  types of composite panels that 




Table 6-1. Categories of composite panels manufactured with mid layer teflon insert 
(NPC configuration) for mode II fracture tests (at room temperature and cold 
temperature) 
MC: Microcapsules; RT: Room Temperature; CT: Cold (-40oC) temperature;  





Samples with specified dimensions according to ASTM D7905-7905M-14 standard [108] 
were cut from each panel manufactured using water-cooled diamond saw. All composite samples 
fabricated were, thus, of NPC configuration (contained a pre-implanted teflon film insert). The 
schematic of NPC configuration of the sample is shown in section 6.3. 
6.3 Fracture test procedure and measurement of mode II fracture 
toughness of composites 
Mode II fracture toughness of fiber reinforced composites was directly measured according 
to ASTM D7905-7905M-14 standard using a compliance calibration method [108]. Fracture 
testing of the composite samples was conducted on a standard MTS machine equipped with a 
three point bending fixture. Data for the instantaneous loads and displacements are continuously 
recorded at a specified interval during the progression of the test through the data acquisition 
system. Two values of fracture toughness were measured from each sample. The fracture 
toughness obtained with the propagation of delamination from the pre-implanted insert (acting as 
artificially introduced initial crack) is termed as NPC (Non-pre-cracked) fracture toughness. The 
Designation of the types 
of composite panels  
(NPC configuration) 
manufactured 















I 0 (0) - 01 01 02 
II 2 (2.3) 100 01  01 02 
III 5 (5.7) 100 01 01 02 
IV 8 (9.1) 100 01 01 02 
V 2 (2.3) 45 01 - 01 
VI 5 (5.7) 45 01 - 01 
VII 8 (9.1) 45 01 01 02 
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Figure 6.3 Composite sample, fixture and dimensions for NPC test [108] 
fracture toughness obtained afterwards with the propagation of delamination from the naturally 
occurred initial crack is termed as PC (Pre-cracked) fracture toughness. The corresponding 
configurations of the cracks are termed as NPC configuration and PC configuration, respectively. 
The displacement controlled loadings during the tests are similarly termed here as NPC loading 
for NPC test and PC loading for PC test, respectively. The samples are allowed to heal for 24 
hours in-between the completion of the NPC test and beginning of PC test. 
The teflon film insert at the mid plane of the composite sample (which was introduced during 
manufacturing) acts as an artificial initial crack for NPC test. NPC fracture toughness is 
determined by propagating this artificial initial crack during the displacement controlled first 
fracture loading (NPC loading) of the sample. Thus, after the NPC test, a naturally occurred 
crack is present in the composite sample. PC fracture toughness is determined by further 
propagating this naturally occurred crack during the displacement controlled second fracture 
loading (PC fracture loading) of the same sample. 
The configurations of composite samples and the procedure of determining the two values of 
fracture toughness are explained, separately, in detail below. 
NPC (Non pre-cracked) test  
NPC fracture toughness is calculated using the load and displacement data obtained during 
the NPC test of the composite sample in a three point bending set up as shown in figure 6.3 using 




































Before starting the NPC test, the relative positions of the loading and support rollers in the 
fixture are adjusted such that the loading roller remains exactly at the center/middle of the 
support span (distance between the support rollers, 2L =101mm in figure 6.3). Before placing the 
sample on the fixture, the tip of the teflon insert (acting as an artificial crack) on the sample is 
first marked at its edge with a vertical line using a marker. The other three compliance 
calibration markings are done similarly at a distance of  𝑎0 (= 35 mm), (𝑎0 + 10) mm, and 
(𝑎0 − 10) mm from the tip of the teflon insert as shown in figure 6.3. The composite sample is 
then placed between the support rollers such that the left support roller touches the marking at 
(𝑎0 − 10) mm on the sample (see figure 6.3; the crack length is defined as the distance between 
the tip of the artificial crack and the middle of the left support roller). The sample is then loaded 
at this crack length (= 25 mm) with the displacement control mode at a rate of 0.5 mm/min until 
a certain predetermined load (equal to 50% of the expected critical load at this crack length) is 
reached and then unloaded. This concludes the first NPC compliance loading. The sample is then 
repositioned in the fixture such that the left support roller touches the marking at (𝑎0 + 10) mm 
on the sample (see figure 6.3). The sample is loaded similarly at this crack length (=45 mm) until 
a certain predetermined load (equal to 50% of the expected critical load at this crack length) is 
reached and unloaded. This concludes the second NPC compliance loading. It is to be noted that 
during the two compliance loadings of the sample with two different crack lengths, the artificial 
crack is not allowed to propagate. Finally, the sample is repositioned again in the fixture such 
that the left support roller touches the marking at 𝑎0 on the sample. The sample is loaded at this 
crack length (=35 mm) until the artificial crack propagates and then unloaded at the same 
displacement rate of 0.5 mm/min. Data for the instantaneous loads and displacements for this 
final unloading is also recorded to determine the unloading compliance (i.e. slope of the 
displacement vs load line). This concludes the NPC fracture loading and marks the end of the 
NPC test. As an example, a typical calculation procedure for determining the NPC fracture 
toughness is discussed here with actual data obtained during the NPC test of a composite sample. 
A typical displacement Vs load data obtained through the NPC test of a composite sample are 






Figure 6.4 Typical plot of displacement Vs load data obtained in a NPC test of a 
composite sample to determine the compliances at different crack lengths. The sample 
configuration for the NPC test is shown in the inset of the graph. The peak load 
achieved during the compliance and fracture loadings are highlighted with star 
symbols. The calculated compliance value for each crack length is also shown encircled 























The compliances determined from the plot (circled values in figure 6.4) were then plotted vs 















Figure 6.5 Plot of compliance Vs crack length cubed (𝒂𝟑) to determine the compliance 
parameters. The compliance values (y-axis values) indicated in the graph are taken 
from the previous graph in figure 6.4. The compliance parameters are calculated from 





















The compliance relationship with crack length of the sample is expressed in the form 
𝐶 = 𝐴 + 𝑚𝑎3 ………………………………………………………………(6.1 a) [108] 
Where,  
𝐶-------------------------Compliance; (mm/N) 
𝐴-------------------------y-axis intercept of the plot of compliance Vs 𝑎3; (mm/N)  
𝑚-------------------------Slope of the line in the plot of compliance Vs 𝑎3; [1/(N.mm2)] 
𝑎--------------------------Crack length (mm) 
𝐴, and 𝑚 are termed as the compliance calibration parameters. 
















 --------------------Strain energy release rate (N/mm) 
𝑝 ----------------------- Peak load (N) achieved during the NPC fracture loading 
𝐵 -----------------------Width of the sample (mm) 
𝑎0 ---------------------Crack length at which the fracture loading is carried out 




) |(𝑎=𝑎0) = 3𝑚𝑎0
2 ………………………………………………..(6.3)[ [108] 






 ……………………………………………………………(6.4) [108] 
Practically, the value of the fracture toughness obtained by equation (6.4) is first taken as a 
candidate toughness 𝐺𝑄 . If the percentages of 𝐺𝑄 (%𝐺𝑄) that were achieved during the 
compliance loadings satisfy15 ≤ %𝐺𝑄 ≤ 35, the candidate toughness value is accepted as 
𝐺𝐼𝐼
𝐶 = 𝐺𝑄  [108].  
For the current example, the values of the parameters at the right hand side of equation 6.4 
are given below. 
𝑚 = (4E-08) (1/Nmm2) [See figure 6.5] 
𝑎0 = 35 (mm) [The crack length at which the fracture loading is carried out] 
𝑝 = 804 (N) [See figure 6.4] 
𝐵 = 20 (mm) [Width of the sample] 
Putting the above values in equation (6.4), we can first calculate a candidate toughness 
𝐺𝑄 = 2.38 (N/mm), or, 
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𝐺𝑄 = 2380 (J/m
2) ………………………………………………………………(6.5) [108] 
Validation 






]; j =1, 2…………………………………......(6.6) [108] 
Where,  
%𝐺𝑄,𝑗 ------Two values of 𝐺𝑄 associated with two compliance loadings 
𝑃𝑚𝑎𝑥 ------Peak value of the force achieved during the fracture loading (see figure 6.4) 
𝑃𝑗 -----------Peak value of the forces achieved during compliance loadings at 𝑎𝑗  (see 
figure 6.4); and  
𝑎𝑗 ----------- 𝑗th crack length used during the compliance loading. 
For the current example, the values of the parameters in the right hand side of equation 
(6.6) are given below 
𝑎0 = 35 𝑚𝑚  
𝑃𝑚𝑎𝑥 = 804 𝑁 (see figure 6.4) 
i) for the first compliance loading 
𝑎1 = 45𝑚𝑚  
𝑃1 = 313 𝑁 (see figure 6.4) 
Putting these values in equation 6.6, 
%𝐺𝑄,1 = 25% which remains in the validity range 15 ≤ %𝐺𝑄,1 ≤ 35 
ii) for the second compliance loading 
𝑎2 = 25𝑚𝑚  
𝑃1 = 452 𝑁 (see figure 6.4) 
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Putting these values in equation 6.6, 
%𝐺𝑄,2 = 16% which remains in the validity range 15 ≤ %𝐺𝑄,2 ≤ 35 
As the %𝐺𝑄 achieved during both the compliance loadings satisfy the validity 
criteria15 ≤ %𝐺𝑄 ≤ 35, the candidate toughness value 𝐺𝑄 obtained in equation (6.5) is 
accepted as  
 𝐺𝐼𝐼
𝐶 = 𝐺𝑄 = 2380 (J/m
2) ……………………………………………………(6.7) 
Thus, the procedure for determining the NPC fracture toughness of a composite sample 
using the compliance calibration method according to ASTM D7905/7905M is described above. 
At least three samples for each category of composite samples with NPC configurations were 
tested following the above procedure and the average values of  𝐺𝐼𝐼,𝑁𝑃𝐶
𝑐  are determined. 
Determination of the location of the natural crack tip 
Figure 6.6 shows the schematic of the composite sample before and after the NPC test 
showing the advancement of delamination from the pre-implanted insert and the relative location 


















Figure 6.6 Schematic of the composite sample showing the relative position of the tip of 
the a) artificial crack (pre-implanted insert) before the NPC fracture loading and b) 
natural crack after the NPC fracture loading. Dotted line represents the natural crack 































Figure 6.6 shows that the delamination has been advanced from its pre-implanted insert 
(artificial crack) after the NPC test of the composite sample. However, the exact location of the 












New mark on the 




















Instead, the location of the tip of the natural crack (𝑎𝑐𝑎𝑙𝑐) is calculated from the unloading data 






 .....…………………………………………………(6.8) [108] 
Where,  
𝑎𝑐𝑎𝑙𝑐 -----------------Distance between the locations of the tip of the natural crack and the 
left support roller in the NPC fracture test setting (mm) as shown in figure 6.6 b). 
𝐴 and 𝑚 --------------The compliance parameters as shown in figure 6.5 
𝐶𝑢 --------------------Compliance determined from the unloading line of the NPC fracture 
test (mm/N) (shown in figure 6.7 below) 
For the current example, figure 6.7 shows the plot of displacement Vs. load data obtained 



















Figure 6.7 Unloading compliance (𝑪𝒖) determined from the displacement-load data 
obtained during the unloading after the NPC fracture loading. The unloading 





















Thus, for the current example,  
𝐶𝑢= 0.0094 mm/N 
𝑚 = (4E-08) (1/Nmm2) [See figure 6.5] 
𝐴 = 0.0026 mm/N [See figure 6.5] 
Putting these values in equation (6.8), we get 
𝑎𝑐𝑎𝑙𝑐 = 55.4 mm  
As, the crack length during the fracture loading  
𝑎0 = 35 mm 
Thus, the crack advancement (see figure 6.6 b) is given by 
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(𝑎𝑐𝑎𝑙𝑐- 𝑎0) = 20.4 mm 
This location of the natural crack tip is further verified by close visual observations, 
adjusted if seems necessary and marked on the composite sample (see figure 6.6 b) for the 
subsequent PC test as recommended in the ASTM standard [108].  
In summary, NPC test consists of three loadings of a composite sample which contains a 
pre-implanted teflon insert as an artificial crack. Among the three loadings, two are compliance 
loadings where the artificial crack is not allowed to propagate and the other one is fracture 
loading where the artificial crack is allowed to propagate. Fracture loading is carried out at a 
specific crack length (𝑎0 = 35 mm) while the two compliance loadings are carried out at crack 
lengths 10 mm below (i.e. 𝑎 = 25 mm) and 10 mm above  (i.e. 𝑎 = 45 mm) the fracture 
crack length. Data for the instantaneous loads and displacements are recorded for the two 
compliance loadings, one fracture loading and final fracture unloading during the NPC test. The 
amount of crack advancement is calculated from the unloading compliance. This advancement of 
crack during the NPC test creates the precrack that is used for the PC test. The tip of this natural 
crack is marked with a vertical line on the composite sample for the subsequent PC test. The 
composite sample is allowed to heal for 24 hours at targeted environment before the PC test is 
carried out. 
 
PC (Pre-cracked) test  
Once the NPC test of the composite sample is completed, the samples are kept inside a 
zipped plastic bag to minimize mainly the moisture effect and kept at room temperature (RT) for 
24 hours to allow the self-healing reaction (between the monomer oozed out of broken 
microcapsules and the dispersed catalyst) at the crack plane to complete before the PC test. 
Regular composite samples (without healing agents), however, do not require healing time. They 
are, however, also kept inside the zipped plastic bag and kept in RT for 24 hours before the PC 
test. For cold temperature tests, the samples are kept in a dry ice chamber maintained at -40oC 
for 24 hours to allow for healing in cold temperature. The cold temperature experiment is 
described in chapter 7. After 24 hours, the samples are loaded into the three point bending fixture 
of the MTS machine. PC fracture toughness is calculated using the load and displacement data 
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Figure 6.8 Schematic of the composite sample showing the relative position of the tip of 
the natural precrack for the PC fracture loading. Dotted line represents the natural crack 
created during the NPC fracture loading [108] 















Before placing the sample on the fixture for PC test, new PC compliance calibration 
markings are put on the sample at a distance of 𝑎0 (= 35 mm), (𝑎0 + 10) mm, and (𝑎0 − 10) 
mm from the tip of the natural precrack (that were created during the NPC fracture loading) as 
shown in figure 6.8. The composite sample is then placed between the support rollers such that 
the left support roller touches the new PC marking at (𝑎0 − 10) mm on the sample. The sample 
is then loaded at this crack length (= 25 mm) with the displacement control mode at a rate of 0.5 
mm/min until a certain predetermined load (equal to 50% of the expected critical load at this 
crack length) is reached and then unloaded. This concludes the first PC compliance loading. The 
other PC compliance loading at (𝑎0 + 10) mm, and the PC fracture loading at (𝑎0 = 35 mm) is 
carried out and the value of PC fracture toughness is determined similarly as described for NPC 
test. At least three samples for each category of composite samples are tested with PC 
configurations following the above procedure and the average values of 𝐺𝐼𝐼,𝑃𝐶
𝐶  are determined.  
During the PC compliance loading, the natural precrack is not allowed to propagate while during 
the PC fracture loading it is allowed to propagate. The amount of crack advancement is, 
however, not required to calculate, in the case of PC test.  
Composite 
sample 𝑎0 
Original CC markings 
(for NPC test) 








Table 6-2. Summary of the type of tests performed at RT and CT (-40oC) with different 
types of composite samples (I-VII) indicating the designation of individual test results 
MC: Microcapsules; RT: Room Temperature; CT: Cold (-40oC) temperature 
A summary of the types of tests performed at room temperature and low temperature (-40oC) 
with different types of FRP composite samples (Type I-VII) indicating the designation of the 
individual test result are listed in table 6.2. Table 6.2 summarizes the designation of the test 
results (fracture toughness values) that would be obtained with the kind of tests performed (NPC 
and PC) at room temperature and low temperature (-40oC) on different types of composite 
samples (I-VII) containing varying average size and concentration of microcapsules. The 





Thus, the value of NPC fracture toughness of regular type I sample (containing no 
microcapsules) is termed as NPC (0%). The value of PC fracture toughness of the same type 
sample is termed as PC (0%). Similarly, the value of NPC fracture toughness of modified type 
VII sample (containing 8wt% microcapsules of average size 45 μm), for example, is termed as 
NPC (8%, 45 μm) and so on. The NPC and PC fracture toughness is generally designated as 
𝑮𝑰𝑰,𝑵𝑷𝑪
𝑪  and 𝑮𝑰𝑰,𝑷𝑪








Kind of tests performed at room temperature and low temperature (-40oC) 
on each type of sample 

















I NPC (0%) PC (0%) NPC (0%) PC (0%) 
II NPC(2%,100 µm) PC(2%,100 µm) NPC(2%,100 µm) PC(2%,100 µm) 
III NPC(5%,100 µm) PC(5%,100 µm) NPC(5%,100 µm) PC(5%,100 µm) 
IV NPC(8%,100 µm) PC(8%,100 µm) NPC(8%,100 µm) PC(8%,100 µm) 
V NPC(2%,45 µm) PC (2%,45 µm) - - 
VI NPC(5%,45 µm) PC (5%,45 µm) - - 
VII NPC(8%,45 µm) PC (8%,45 µm) NPC(8%,45 µm) PC(8%, 45 µm) 
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Figure 6.9 Representative load-displacement curves for the NPC and PC fracture 
loading of regular (Type I) composite samples  
6.4   Results and Discussions 
A representative load-displacement curves for the NPC and PC fracture loading of composite 
samples and the corresponding NPC and PC fracture toughness values as determined according 
to the procedure described above are shown and discussed in section 6.4.1. The effect of 
inclusion of microcapsules of different average size on the NPC fracture toughness and the effect 
of self-healing on the PC fracture toughness measured at room temperature are discussed in the 
subsequent sections. 
6.4.1 Elaboration of representative load-displacement curves and measured 
values of fracture toughness of regular (Type I) composite sample as 
example 
Figure 6.9 shows a representative load-displacement curve for the NPC and PC fracture 



















From the load-displacement curve in figure 6.9, it is observed that during the NPC fracture 
loading, the load increases linearly up to a displacement of about 3.8 mm and then suddenly 
drops which is also associated with a loud cracking sound implying rapid crack propagation. The 
nearly vertical drop of the load implies a high speed of crack propagation. The load-displacement 
curve during PC fracture loading of the same composite sample, on the other hand, shows also a 
linear increase of load up to a displacement of about 3.1 mm after which the load drops and the 
slope of the line changes more smoothly. This drop in load and the change in slope is also 
associated with a mild cracking sound implying an advancement of the PC crack. However, the 
speed of crack propagation is slower than NPC fracture loading as implied by the smoother 
change in the slope. When comparing the linear portions of the NPC and PC curves, it can be 
observed that both the slopes and the peak value of PC curve are substantially lower than the 
slope and the peak value, respectively, of the NPC curve. This difference is because of the fact 
that there is no real precrack in the composite sample during the NPC test. A pre-implanted 
teflon film acts as an artificial crack starter and delamination is propagated from this pre-
implanted insert during the NPC test (see figure 6.3). On the contrary, a naturally occurred sharp 
crack already exists during the PC test and delamination is propagated from this sharp natural 
crack (see figure 6.8). The existence of the naturally occurred sharp crack makes the slope and 
the peak value of the PC line substantially lower than the NPC line. The same is true for the 
speed of crack propagation. As no natural sharp precrack exists in the NPC configuration, the 
composite sample can absorb substantial strain energy before it propagates at a high speed 
(vertical drop of load). However, the existence of a naturally occurred sharp crack in the PC 
configuration allows the sample to absorb smaller strain energy before its slower extension. With 
the above comparisons of the representative load-displacement curves, it can be estimated that 
PC fracture toughness (𝐺𝐼𝐼,𝑃𝐶
𝐶 ) is smaller than the NPC fracture toughness (𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 ).  The actual 
values of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  and 𝐺𝐼𝐼,𝑃𝐶
𝐶  are, however, determined using the compliance calibration method 








Figure 6.10 NPC and PC fracture toughness of regular (Type I) composite samples 
designated as NPC (0%) and PC (0%), respectively. Error bars represent one standard 






















Figure 6.10 shows the NPC and PC fracture toughness of composite samples as a function of 
concentration of microcapsules for later comparisons. It is observed from the figure that there is 
almost 50% reduction in fracture toughness when a natural pre-crack exists in the regular (Type 
I) sample compared to the same sample (Type I) without a natural pre-crack (i.e. PC fracture 
toughness is about 50% of NPC fracture toughness). Percentage reduction of fracture toughness 
of the composite sample from NPC to PC configuration is calculated as 





𝐶  ………………………………………………(6.9)  
Thus, the drastic reduction of fracture toughness with PC configuration is, ultimately, the 
effect of having a sharp natural pre-crack (which is not healed due to the absence of healing 
agents) in the regular sample (Type I). The idea of incorporating healing agents (i.e. 
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microcapsules and catalysts) into the composite samples of different types (II, III…..VII) is to 
heal this natural pre-crack as much as possible to improve its PC fracture toughness. In doing so, 
however, the original NPC fracture toughness might have been compromised by the 
incorporation of microcapsules and catalyst particles into the samples. An optimum average size 
and concentration of microcapsules for incorporating into modified composite samples (Type II-
VII) is searched for, in this work, which would improve the PC fracture toughness as much as 
possible while would not degrade the NPC fracture toughness substantially, compared to type I 
sample. 
The effect of inclusion of varying concentration of different sizes of microcapsules into the 
composite sample is determined by comparing the NPC fracture toughness of different types of 
samples (Type II, III……VII) with the NPC fracture toughness  of type I sample. Similarly, the 
effect of self-healing is determined by comparing the PC fracture toughness of different types of 
samples (Type II, III……VII) with the PC fracture toughness of type I sample. These effects are 
discussed in the following sections. 
6.4.2. Effect of inclusion of microcapsules on the NPC fracture toughness of 
composite samples 
As a reminder, regular composite sample (Type I) contains no microcapsules and catalysts. 
Modified composite samples (Type II, III……..VII) contain microcapsules and catalysts. The 
NPC fracture toughness is the value of fracture toughness obtained with the advancement of 
delamination from the pre-implanted insert. No self-healing takes place yet during the NPC test 
even for modified samples as the natural crack is just generated during this test. Thus, when 
comparing the NPC fracture toughness of regular (Type I) and modified composite samples 
(Type II-VII), it represents the effect of incorporating those foreign healing agent particles into 
the modified composite samples since the only difference between the two types of samples is 
the presence (modified) or absence (regular) of those foreign healing agent particles.  
The effects of inclusion of microcapsules on the NPC fracture toughness of modified 







Figure 6.11 NPC fracture toughness of composite samples as a function of concentration 
of microcapsules of average size of 100 µm.  Error bars represent one standard deviation 
of measured values.             
Effect of concentration of larger microcapsules (average size 100 µm) on the 
NPC fracture toughness 
The values of the NPC fracture toughness (𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 ) of the composite samples (Type I, II, III 
and IV) as a function of concentration of microcapsules of average size 100 µm are shown in 




















Figure 6.11 shows that incorporation of varying concentration of microcapsules (average size 
100 μm) tend to reduce the NPC fracture toughness (𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 ). The values of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  of modified 
composite samples of type II, III and IV [containing certain wt% of larger microcapsules 
(average size 100 μm)] are always less than the values of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  of regular composite samples of 
type I (containing no microcapsules). NPC fracture toughness is reduced by 17% in type II 






other words, the values of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  are reduced by 17%, 14% and 31% when incorporated with 
2wt%, 5 wt% and 8 wt% of larger microcapsules (average size 100 μm), respectively, in the 
composites.  
Percentage reduction in NPC fracture toughness due to incorporation of microcapsules in the 







× 𝟏𝟎𝟎 ---------------------------------(6.10) 
where, 
(𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 )𝑹--------------- NPC fracture toughness of regular composite sample (Type I) not 
incorporated with microcapsules, and 
(𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 )𝑴---------------NPC fracture toughness of modified composite (Type II-VII) sample 
incorporated with certain wt% of microcapsules 
The observation of reduction of fracture toughness of modified (incorporated with 
microcapsules of average size 100 μm) fiber reinforced composite samples is consistent with the 
observations made by Keller and Sottos [49], Brown et al. [ [50], [51] ] and Rule et al. [52] who 
investigated the effect of microcapsule properties on the modified (incorporated with 
microcapsules) epoxy (without fibers) sample. They [ [49]- [52] ] found that poorly bonded 
particles tend to reduce the mode I fracture toughness of epoxy specimen. They observed a 
continuous reduction in strength of the epoxy specimen with increasing wt% of microcapsules 
[49]. According to [50], weak bonding of particles act as voids in composites. However, they 
concluded that microcapsules if adequately bonded to the matrix can actually improve its 
fracture toughness. The observations made by [ [49]- [52] ]  prompts to think debonding of 
microcapsules as one of the key reasons for the observed reduction in 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  of fiber reinforced 
composites in the current work. Representative fracture features of the modified composites 
(Type II-IV containing certain wt% of microcapsules of average size 100 μm) as observed under 
SEM, is shown in figure 6.12. It shows the evidence of matrix-microcapsule debonding which 







Figure 6.12 Matrix-microcapsule debonding during crack propagation leaving deep 
















As the larger microcapsules (average size 100 μm) tend to debond from the matrix, as 
revealed in figure 6.12, increasing the concentration of larger microcapsules beyond 5wt% 
reduces its NPC fracture significantly as shown in figure 6.11. 
Thus, it is concluded that larger microcapsules (average size 100 µm) tend to form weaker 
bonding with the matrix which eventually leads to debonding from the matrix during the mode II 
crack propagation within composites. This results in significant degradation of NPC fracture 
toughness above the concentration of 5wt%. Brown [50] observed that the fracture behavior of 
epoxy with poor microcapsule bonding was identical to samples containing similar concentration 
of voids showing significant reduction in fracture toughness which is consistent with the 
observations in the current work. In his analytical models, Lauke [111] concluded that size and 
size distributions of particles might have significant influence on the fracture toughness of 
polymer composites resulting from the particle debonding, voiding and yielding of the polymer. 
In addition to the average size and size distribution, the morphology and shell thicknesses of the 
larger microcapsules, as investigated in the current work and discussed in chapter 3, might also 
contribute to the weaker matrix-microcapsule bonding in the composites. More research is 
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Figure 6.13 NPC fracture toughness of composite samples as a function of concentration 
of microcapsules of average size of 45 µm.  Error bars represent one standard deviation of 
measured values.             
necessary to understand the effects of these factors on the bonding behavior of microcapsules 
with polymer matrix composites. 
Effect of concentration of small microcapsules (average size 45 µm) on the 
NPC fracture toughness 
The values of the NPC fracture toughness (𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 ) of the composite samples as a function of 

















Figure 6.13 shows that, incorporation of small microcapsules (average size 45 μm) up to 5 
wt% reduces the NPC fracture toughness (𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 ) of the samples of type V and VI compared 
with sample type I. However, incorporation of higher concentration (8wt%) of small 
microcapsules does not reduce the value of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  of sample type VI. Compared with type I 
sample, 35% reduction in NPC fracture toughness is observed in type V sample, 30% reduction 
in type VI sample and almost no reduction in type VII sample is observed. In other words, the 
values of 𝐺𝐼𝐼,𝑁𝑃𝐶






Figure 6.14 a) and b). SEM micrographs showing good bonding of smaller 
microcapsules (average size 45 µm) with the matrix on the fracture surface. 
small microcapsules (average size 45μm), respectively, in the composites. The value of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 , 
however, is not affected by incorporation of 8 wt% small microcapsules in the composites. 
SEM observations of fracture surface of the modified composites (containing microcapsules 






























Figure 6.15 SEM micrograph (2700X) showing broken shells of smaller microcapsules 
(average size 45 µm) still attached to the fracture surface. 
SEM micrograph with higher magnification (2700X) in figure 6.15 shows, more clearly, 

























As pointed out earlier, the size, size distribution, morphology and shell thicknesses of the 
microcapsules which are shown to be different for larger and smaller microcapsules as 
investigated in the current work and discussed in chapter 3, might have significant effects on the 
matrix-microcapsule bonding and requires more research works to understand the behavior. 
The good bonding between matrix and small microcapsules (average size 45 μm) does not, 
however, explain the reduction of NPC fracture toughness of modified composites of type V and 
VI as shown in figure 6.13. In order to find possible reasons for this, fracture surfaces of the 
composite samples near the NPC crack fronts were observed under SEM. Figure 6.16 shows the 
fracture surfaces of the composites of type V, VI and VII samples near their NPC crack fronts 





Figure 6.16 SEM micrographs showing features of fracture surface near NPC crack front 
of modified composite samples containing a) 2wt% (Type V) b) 5wt% (Type VI) and c) 


































Figure 6.16. SEM micrographs showing features of fracture surface near NPC crack front 
of modified composite samples containing a) 2wt% (Type V) b) 5wt% (Type VI) and c) 




















Figure 6.16 a), b) reveals that extra resin, rich in microcapsule concentration, are 
accumulated at the NPC crack front and its vicinity of the type V and type VI samples. Figure 
6.16 c), however, does not show such accumulation of microcapsule-rich extra resin at the NPC 
crack front of type VII samples. This explains the reason why significant degradation of NPC 
fracture toughness occurred in type V and type VI samples, but not with type VII samples as 
shown in figure 6.13. The accumulation of microcapsule-rich extra resin at a preferred location 
(tip of the teflon film insert) possibly causes stress concentration weakening the NPC crack front. 
It significantly reduces the NPC fracture toughness the value of which is obtained by the 
advancement of this crack front. As no such accumulation is observed in type VII samples, no 
significant reduction in NPC fracture toughness is observed. 
The accumulation of microcapsules and extra resin at the vicinity of NPC crack front (teflon 
insert) occurred during the hand lay-up. During hand lay-up, modified epoxy incorporated with 
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the microcapsules were first poured upon the mid-layer of carbon fibers and then spread and 
infused it over the layer with a hand applicator. Teflon film (with a thickness of about 15 micron) 
was located at one end of the layer across its width as shown in figure 6.17. During the lay-up, 
the epoxy poured on the layer is drawn with the applicator along the length (and width) direction 
of the layer in both way (towards the teflon film starting from the other end and starting from the 















During drawing the modified epoxy incorporated with healing agents to the left of the 
composite layer with the applicator moving towards the teflon film, modified epoxy gets 
obstructed at the teflon edge. Repeated drawing of the epoxy toward the teflon film starting from 
the other end of the layer results in accumulation of extra resin incorporated with microcapsules 
at its edge. This accumulation of microcapsules at a preferred location (tip of the teflon film 
insert) causes stress concentration which drastically reduces its NPC fracture toughness. Once 
the problem in manufacturing the laminate was identified, proper care was taken to avoid the 
accumulation of extra resin with microcapsules at a preferred location. It was done by avoiding 
the drawing of the modified epoxy to the left where teflon film was placed. Instead, the epoxy 
was drawn with the applicator repeatedly starting from the teflon end to the right towards the 
other end of the layer. This allowed smoother infusion of modified epoxy over the layer without 
Teflon film Unidirectional 
carbon fabric 
Applicator 
Accumulation of extra resin with 
microcapsules at the teflon edge 
Figure 6.17 Schematic of lay-up method showing accumulation of microcapsules at the tip 
of the teflon film insert (NPC crack front) of composite samples 
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any obstruction. As the modified epoxy was not obstructed at the edge of the teflon film in this 
amended lay-up procedure, there was no accumulation of extra resin with microcapsules at a 
preferred site (NPC crack front). Type VII composite samples (8wt%, 45 µm) were made 
according to the amended lay-up practice and the NPC crack front was found to be free from 
accumulation of extra resin with microcapsules as shown in figure 6.16 c) before.  
It is thus observed through the investigation that significant deterioration of NPC fracture 
toughness can be caused by issues related to manufacturing of modified composites even the 
matrix-small microcapsule (45 μm) bonding is good. The manufacturing issues are, however, 
controllable once identified. No degradation of NPC fracture toughness is observed in type VII 
sample even with the high concentration (8wt%) of small microcapsules (average size 45 μm) 
due to the good matrix-microcapsule bonding as evidenced in figures 6.14 and 6.15 shown 
before.  
Effect of average size of microcapsules on the NPC fracture toughness 
The effect of average size of microcapsules on the NPC fracture toughness of modified 



















Figure 6.18 Effect of size of microcapsules on the NPC fracture toughness of modified 
composite samples (Type II-VII).  Error bars represent one standard deviation of 





















Figure 6.18 shows that incorporation of larger microcapsules (average size 100 μm) reduces 
the NPC fracture toughness of modified composites (Type II-IV) compared with regular 
composites (Type I) and it worsens above the concentration of 5 wt% due to the debonding 
issues of larger microcapsules discussed before. On the other hand, compared with regular 
composite samples (Type I), significant reduction in NPC fracture toughness is observed with 
samples type V and VI incorporated with 2wt% and 5 wt% of small microcapsules (average size 
45 μm), respectively, due to some manufacturing issues (like accumulation of extra resin 
incorporated with microcapsules at the NPC crack front of the modified sample during the hand 
lay-up) discussed before. Once the manufacturing issues are detected and resolved, incorporation 
of even higher concentration (8 wt%) of small microcapsules does not reduce its NPC fracture 
toughness. Thus, considering the deterioration of the original fracture toughness (i.e. 𝑮𝑰𝑰,𝑵𝑷𝑪
𝑪 ), 
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small microcapsules are preferred for their good bonding properties with the matrix as evidenced 
earlier.  
6.4.3 Effect of self-healing on PC fracture toughness of composite samples 
Again, as a reminder, PC test is carried out after allowing the naturally occurred crack to be 
healed (for the modified composite samples) for 24 hours. The regular composite sample (Type 
I), however, does not have the self-healing ability. Thus, any difference in PC fracture toughness 
between the Type I and modified composite samples (Type II-VII) is due to the self-healing 
reaction between the monomer which oozed out from broken microcapsules and the catalyst 
particles at the natural crack plane of modified composites.  
The effects of self-healing on the PC fracture toughness of modified composite samples 
(Type II-VII) measured at room temperature are discussed below. 
Effect of concentration of larger microcapsules (average size 100 µm) on the 
PC fracture toughness 
The values of the PC fracture toughness (𝐺𝐼𝐼,𝑃𝐶
𝐶 ) of the composite samples (Type I, II, III and 


















Figure 6.19 PC fracture toughness of composite samples as a function of concentration of 
microcapsules of average size of 100 µm.  Error bars represent one standard deviation of 




















Figure 6.19 shows that the values of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of modified composite samples of type II, III and 
IV [containing certain wt% of larger microcapsules (average size 100 μm)] are always greater 
than the values of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of regular composite samples of type I (containing no microcapsules). 
This first implies that the natural precrack is healed in the modified composite samples 
incorporated with larger microcapsules. Compared with type I samples, PC fracture toughness is 
improved by 37% in type II sample, 33% in type III sample and about 35%  in type IV sample. 
In other words, the values of 𝐺𝐼𝐼,𝑃𝐶
𝐶  are improved by 37%, 33% and 35%  when the composite 
samples are incorporated with 2wt%, 5 wt% and 8 wt% of larger microcapsules (average size 
100 μm), respectively.  
Percentage improvement in PC fracture toughness of modified composites due to the self-












× 𝟏𝟎𝟎 ---------------------------------(6.11) 
where, 
(𝐺𝐼𝐼,𝑃𝐶
𝐶 )𝑹--------------- PC fracture toughness of regular composite sample (Type I) not 
incorporated with microcapsules, and 
(𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 )𝑴---------------PC fracture toughness of modified composite sample (Type II-VII) 
incorporated with certain wt% of microcapsules. 
This improvement of PC fracture toughness of modified composite samples (Type II-IV 
containing certain wt% of microcapsules of average size 100 μm) compared with regular sample 
(Type I containing no microcapsules) is the direct contribution of self-healing of the naturally 
occurred pre-crack. Comparison of SEM micrographs of the fracture surfaces of the regular and 
modified composites, as shown in figure 6.20 below, show the presence of the self-healed 
polymer layer which is believed to be formed by the reaction between the monomer oozed out 
from broken microcapsules and dispersed Gruubs catalyst in the delamination crack plane. 
Comparison of representative SEM micrographs (as shown in figure 6.20) of the fracture 
surfaces of the regular and modified composite samples shows the difference in features between 

















Figure 6.20 Comparison of representative fracture surfaces of (a) regular and b) modified 
composite samples showing the differences in morphology and appearance between 


































The differences in morphology and appearance of fracture surfaces of regular and modified 
composite samples as shown in figure 6.20 indicate clearly the presence of self-healed polymer 
layers produced by self-healing reaction between the monomers released out of broken 
microcapsules and the dispersed Grubbs catalyst. Fracture surface of regular (without 
microcapsules and catalyst) composite sample, as shown in figure 6.20 a), is featured with 
exposed bare fibers, striations, hackle markings and marks of matrix cracking which are the 
common mode of fractures for mode II delamination. These markings indicate a combination of 
adhesive- cohesive failure of regular composite sample. On the other hand, an absence (or 
limited presence) of these common fracture features is observed on the fracture surface of 
modified (with microcapsules and catalyst) composite sample. This indicates that the fracture 
features of mode II delamination (which were observed in regular samples) are mostly covered 
and hidden by a newly created polymer layer which is the product of self-healing reaction 
between monomer oozed out of broken microcapsules and Grubbs catalyst. Fracture surface of 
modified composite sample, as shown in figure 6.20 b), is featured with relatively smooth 
surface made of self-healed polymer layer with marks of broken microcapsules, abrasion marks 
and other stress marks indicating mostly cohesive failure. Some portion of the same fibers can 
also be seen exposed bare while the remaining portion is covered under the self-healed polymer 
layer. The comparative observation of fracture surfaces of regular and modified composites thus 
confirms the self-healing of the mode II fracture cracks which effectively translates into superior 
PC fracture toughness of modified composites compared to regular composites as shown before 
in figure 6.19. 
The improvement in PC fracture performance of modified composites containing larger 
microcapsules (Type II-IV), however, is not increased proportionally with increasing 
concentration of microcapsules (average size 100 μm) as can be seen in figure 6.19. Higher 
concentration of microcapsules means higher number of microcapsules available per unit 
fracture area which is expected to deliver higher amount of self-healing monomer upon their 
breaking to cover increased area of the fracture plane resulting in increased PC fracture 
toughness. However, in reality, the PC fracture toughness of the type II, III and IV samples 
containing increasing concentration of microcapsules (2wt%, 5wt% and 8 wt%, respectively) 
remains almost the same as shown in figure 6.19. Debonding of larger microcapsules (average 
size 100 μm) in modified composites (Type II-IV), as evidenced in figure 6.12 before, which 
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Figure 6.21 PC fracture toughness of composite samples as a function of concentration of 
microcapsules of average size of 45 µm.  Error bars represent one standard deviation of 
measured values.             
limits the breaking of sufficient number of microcapsules during crack propagation, again, 
explains the fact. 
Effect of concentration of small microcapsules (average size 45 µm) on the PC 
fracture toughness 
The values of the PC fracture toughness (𝐺𝐼𝐼,𝑃𝐶
𝐶 ) of the composite samples (Type I, V, VI and 
VII) as a function of concentration of microcapsules of average size 45 µm are shown in figure 




















Figure 6.21 shows that the values of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of modified composite samples (Type V-VII) tend 
to be higher than the value of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of regular composite sample (Type I). This first implies that 
the natural precrack is healed in the modified composite samples. Figure 6.21 also indicates that 
the values of 𝐺𝐼𝐼,𝑃𝐶






small microcapsules. Compared with the value of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of regular composite samples of type I, 
the values of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of modified composite samples of type V [containing 2 wt% of 
microcapsules (average size 45 μm)] does not improve significantly (containing no 
microcapsules). 𝐺𝐼𝐼,𝑃𝐶
𝐶  is, however, improved by 14% with type VI sample and by about 100% 
with type VII sample as calculated by equation.6.11. In other words, the values of 𝐺𝐼𝐼,𝑃𝐶
𝐶  are 
improved by 0%, 14% and 100%  when the composite samples are incorporated with 2wt%, 5 
wt% and 8 wt% of small microcapsules (average size 45 μm), respectively. Rule et al. [47] 
observed that the healing performance of epoxy sample (without fibers) was maximized when 
sufficient volume of monomer was present to fill the cracks completely. For the fiber reinforced 
composite samples of type V and VI, in the current work, incorporation of small microcapsules 
of average size 45 μm does not improve the 𝐺𝐼𝐼,𝑃𝐶
𝐶  significantly up to 5wt% because of 
insufficient coverage of the fracture surface with relatively less number of microcapsules, as 
shown in the SEM micrograph in figure 6.22 a). Figure 6.22 b), on the contrary, shows the SEM 
micrograph of the fracture surface of composite sample of type VII (containing 8wt% of small 
microcapsules of average size 45 μm) showing sufficient number of microcapsules covering the 
full fracture surface area resulting in 100% improvement in PC fracture toughness which is 

















Figure 6.22 SEM micrograph of the fracture surface of composite samples containing 
a) 5wt%, microcapsules (45 µm) showing insufficient number of microcapsules to cover 
the full fracture surface area and b) 8wt%, microcapsules (45 µm) showing sufficient 
number of microcapsules covering the full fracture surface area 
a) Fracture surface of sample type VI (5wt%, 45 μm) 






























Complete coverage of fracture surface with 8wt% small microcapsules (45 μm) together with 
good bonding with matrix as evidenced in figure 6.22, 6.14 and 6.15 results in excellent 
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Figure 6.23 SEM micrograph of the fracture surfaces of modified composite sample 
containing microcapsules of average size 45 μm showing healed polymer layer. 
improvement (100%) in 𝐺𝐼𝐼,𝑃𝐶
𝐶  (PC fracture toughness) of type VII sample. Figure 6.29 b) further 
shows that microcapsules are well distributed in the matrix and attached well with it even after 
their breaking. A substantial number of microcapsules distributed over the fracture surface are 
also seen broken with the lower portion of their shells still attached to the matrix (black dots in 
figure 6.22 b). The good matrix-microcapsule bonding and its well distribution over the entire 
fracture surface enable the breaking of a large number of microcapsules releasing sufficient 
amount of monomer to cover the entire fracture surface area and subsequent self-healing reaction 
with dispersed catalyst. This translates into 100% increase in PC fracture toughness of type VII 
composite samples (containing 8wt% of small microcapsules) compared with regular type I 
composite samples where no self-healing takes place due to the absence of microcapsules and 
catalyst.  
The self-healed polymer layer on the fracture surface of the modified composite samples can 





















Figure 6.24 Effect of size of microcapsules on the PC fracture toughness of modified 
composite samples (Type II-VII).  Error bars represent one standard deviation of measured 
values.             
Effect of average size of microcapsules on the PC fracture toughness 
The effect of average size of microcapsules on the PC fracture toughness of modified 
composites can be extracted by simply comparing the figures 6.19 and 6.21 which is shown in 




















From figure 6.24, it can be observed that, up to the concentration of 5wt%, modified 
composite samples containing larger microcapsules (type II and e III) have better PC fracture 
toughness compared with samples containing small microcapsules (type V and VI). However, 
the highest PC fracture toughness is achieved by the samples containing higher concentration 
(8wt%) of small microcapsules (type VII). This phenomenon can be explained by the fact that 
larger microcapsules being able to release relatively higher volume of monomer upon their 
breaking can cover larger area of the crack surface than small microcapsules in the low 
concentration range (up to 5 wt%). However, because of the debonding nature of larger 
 PC (100 μm) 









microcapsules, increased concentration of larger microcapsules beyond 5wt% does not result in 
breaking of sufficient number of microcapsules to release proportionately increased amount of 
monomer to cover the entire crack surface area. On the other hand, small microcapsules up to 
5wt% cannot deliver sufficient amount of monomer upon their breaking to cover the entire crack 
surface area. However, as they bond well with the matrix,  increased concentration up to 8wt% 
of small microcapsules results in breaking of increased number of microcapsules during crack 
propagation releasing increased amount of monomer to cover the entire crack surface area. This 
results in much better PC fracture toughness of type VII sample than type IV sample as shown in 
figure 6.24. 
In summary, it is observed through the investigation that drastic deterioration of NPC 
fracture toughness can be caused by issues related to manufacturing of modified composites. 
These are, however, more easily controllable once identified. The other key factor that mostly 
affect the NPC fracture toughness is the debonding of microcapsule during the crack 
propagation. On the other hand, PC fracture toughness is mainly dependent upon the availability 
of self-healing monomer over the entire fracture surface which, ultimately, depends on the 
distribution of microcapsules and their ability to break during crack propagation. The ability of 
breaking of microcapsules, in turn, depends on the matrix-microcapsule bonding. In addition to 
deteriorating the NPC fracture toughness, debonding of microcapsules also restricts the breaking 
of sufficient number of microcapsules during crack propagation. The microcapsules debond, in 
such case, rather than break, which in turn, limits the availability of sufficient monomer over the 
entire fracture surface area restricting self-healing.  
It is further observed from the investigation that larger microcapsules (average size 100 µm) 
tend to debond from the matrix. Debonding of larger microcapsules during the mode II crack 
propagation deteriorates both the NPC fracture toughness and limits self-healing leading to 
reduced PC fracture toughness. Due to this debonding, again, increasing the concentration of 
larger microcapsules in the composites does not supply proportionately increased amount of 
monomer over the fracture surface to achieve higher PC fracture toughness. Smaller 
microcapsules (average size 45 μm), on the contrary, can be smeared into the matrix more 
efficiently possibly due to their smaller individual surface area and are observed to have good 
bonding with the matrix which results in excellent self-healing performance at high microcapsule 
concentration (8 wt%). There was no deterioration in NPC fracture toughness and excellent 
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improvement in PC fracture toughness was achieved at this high concentration (8 wt%) of small 
microcapsules. As stated earlier, the size, size distribution, morphology and shell thicknesses of 
the microcapsules, which are shown to be different for larger and smaller microcapsules. as 
investigated in the current work and discussed in chapter 3, might have significant effects on the 
matrix-microcapsule bonding and requires more research works to understand their behavior. 
The modified composites containing lower concentration (2wt% and 5 wt%) of small 
microcapsules, however, did not possess acceptable NPC fracture toughness due to some 
manufacturing issues discussed earlier as well as show unattractive PC fracture toughness due to 
the lack of sufficient coverage of the fracture surface by lower concentration of small 
microcapsules.  
6.5 Comparison of fracture toughness and evaluation of healing 
performance of the composites 
 
In this section, NPC and PC fracture toughness of each type of composite samples (I-VII) are 
compared. The conventional healing efficiency, ηh,c and healing performance index 𝑃𝐼 as 
defined in equations 5.2-5.5 (in chapter 5) are also evaluated and compared. The comparison 
proves the rational for choosing 𝑃𝐼 instead of ηh,c as the better indicator of actual healing 
performance. Using the, values of 𝑃𝐼, the type of composite samples showing the best healing 
performance can be identified accurately. The findings from this investigation of self-healing of 
FRP composites at room temperature are utilized in investigating self-healing of FRP composites 
at low temperature which is discussed in chapter 7. 
Figure 6.25 shows the comparison of NPC and PC fracture toughness of composite samples 











Figure 6.25 Comparison of NPC and PC fracture toughness of composite samples as a 
function of concentration of microcapsules of average size of 100 µm.  Error bars 




















The percentage changes (improvement or deterioration) in fracture toughness values in 
different modified composites (Type II, III and IV) compared to regular composites (Type I) as 
calculated by equations (6.10) and (6.11) are shown in table 6.3. The corresponding values of 
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Figure 6.26 Comparison of conventional healing efficiency and healing performance index 
of modified composite samples as a function of concentration of microcapsules of average 
size of 100 µm.   
Table 6-3. Comparison of changes in fracture toughness of modified composites (Type 






Figure 6.26 compares the corresponding values of ηh,c and 𝑃𝐼 for the three types of modified 
























Type of modified composite samples Causes of 
change II 
(2wt%, 100 μm) 
III 
(5wt%, 100 μm) 
IV 
(8wt%, 100 μm) 
% 𝒓𝒆𝒅.(𝑵𝑷𝑪) 17 14 31 Debonding of 
microcapsules 
% 𝒊𝒎𝒑.(𝑷𝑪) 37 33 35 Self-healing 
reaction 
ηh,c (%) 79 74 94 - 










Figure 6.26 shows that type II samples have high value of ηh,c (about 80%) although 
incorporation of 2wt% larger microcapsules (100 μm) into the samples reduced the value of 
𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  by 17% and improved the value of 𝐺𝐼𝐼,𝑃𝐶
𝐶  by only 37% compared with regular type I 
sample as can be seen in table 6.3. 𝑃𝐼, on the contrary, takes into account both information of the 
reduction of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  and the improvement of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of type II sample to give a realistic value of 
only about 17%. Type III samples show similar values of ηh,c and 𝑃𝐼 as in the previous case. 
Interestingly, for the type IV composite sample for which the value of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  is further worsen 
by 31% while having the similar improvement in the value of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of only 35% compared to 
regular type I sample, as can be seen in table 6.3, the value of ηh,c increases oppositely up to 
about 94% (see figure 6.26). This is, indeed, a wrong indication given by the value of 
conventional healing efficiency ηh,c. Healing performance index, 𝑃𝐼, on the other hand, takes 
this reduction of the value of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  into account correctly, and correspondingly lowers its value 
near to 0% as can be seen in figure 6.26 for the type IV sample . 𝑃𝐼 thus gives realistic and 
reliable values of actual healing performance. The comparison in figure 6.26 thus proves the 
rational for choosing 𝑃𝐼 instead of ηh,c as the better indicator of actual healing performance. 
Similarly, figure 6.27 shows the comparison of NPC and PC fracture toughness of composite 
















Figure 6.27 Comparison of NPC and PC fracture toughness of composite samples as a 
function of concentration of microcapsules of average size of 45 µm.  Error bars represent 




















   The percentage changes (improvement or deterioration) in fracture toughness values in 
different modified composites (Type V, VI and VII) compared to regular composites (Type I) as 
calculated by equations (6.10) and (6.11) are shown in table 6.4. The corresponding values of 
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Table 6-4. Comparison of changes in fracture toughness of modified composites (Type 
V, VI and VII) compared with regular composites (Type I) containing no microcapsules 
 
Figure 6.28 Comparison of conventional healing efficiency and healing performance index of 









Figure 6.28 compares the corresponding values of ηh,c and 𝑃𝐼 for the three types of modified 





















Types of composite samples Causes of 
change V 
(2wt%, 45 μm) 
VI 
(5wt%, 45 μm) 
VII 
(8wt%, 45 μm) 
% 𝒓𝒆𝒅.(𝑵𝑷𝑪) 35 30 0 Manufacturing 
issues 
% 𝒊𝒎𝒑.(𝑷𝑪) 0 14 100 Self-healing 
reaction 
ηh,c (%) 74 78 95 - 
𝑃𝐼 (%) -37 -18 95 - 
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Figure 6.28 shows that type V samples have high value of ηh,c (about 73%) although 
incorporation of 2wt% smaller microcapsules (μm) reduced the values of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  by 35% and, 
even, there is no improvement in 𝐺𝐼𝐼,𝑃𝐶
𝐶  compared with regular type I sample as can be seen in 
table 6.4. 𝑃𝐼, on the contrary, takes both of this information into account and gives a negative 
value of about -37%. The negative value of 𝑃𝐼 gives a warning that there is more degradation of 
𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  due to incorporating microcapsules than any improvement of 𝐺𝐼𝐼,𝑃𝐶
𝐶  achieved due to self-
healing. A negative value of 𝑃𝐼, thus, tells us that there is no real advantage of incorporating 
microcapsules into composites in such case. ηh,c does not give such warning and always gives a 
positive value indicating a good advantage of incorporating microcapsules even for the type V 
sample. Healing performance index,𝑃𝐼, thus again proves to be a better indicator of actual 
healing performance in such case. Type VI samples show similar values of ηh,c and 𝑃𝐼 as in the 
previous case. For the type VII samples, the value of 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  is not reduced compared with type I 
samples and the value of its 𝐺𝐼𝐼,𝑃𝐶
𝐶  closely matches the value of 𝐺𝐼𝐼,𝑃𝐶
𝐶  of type I sample as can be 
seen in table 6.4 and figure 6.27.  In such case only, both ηh,c and 𝑃𝐼 give close values of about 
94% (see figure 6.28). In most other likely situations, ηh,c gives exaggerated values as shown in 
the above examples and as discussed in more detail in chapter 5. Thus, in every likely situations, 
healing performance index, 𝑃𝐼 gives a reliable and better indication of actual healing 
performance of composite samples compared to conventional healing efficiency, ηh,c.  
Among the types of composite samples tested that showed the best healing performance, 
thus, can easily be detected just by comparing the 𝑃𝐼 values of each type of modified composite 
samples. Figure 6.29 below shows the comparison of 𝑃𝐼 values (%) of all types of modified 











Figure 6.29 Comparison of healing performance index (%) of all modified composite 



















Studying figure 6.29, it can be concluded that, among the modified composite samples tested 
at room temperature, type II and type III samples containing larger microcapsules (average size 
100 μm) show better healing performance at room temperature with low concentration up to 5 
wt%. However, the best healing performance at room temperature is achieved by type VII 
samples containing small microcapsules (average size 45 μm) with higher concentration of 
8wt%. This phenomenon can be explained by the fact that larger microcapsules being able to 
release higher volume of monomer upon their breaking can cover larger area of the crack surface 
than small microcapsules. However, because of the debonding issues, increased concentration of 
larger microcapsules beyond 5wt% does not result in breaking of sufficient number of 
microcapsules to release proportionately increased amount of monomer to cover the entire crack 
surface area. Additionally, increased concentration of larger microcapsules degrades the original 
NPC fracture toughness of composites due to debonding nature reducing the healing 









5wt% of small microcapsules of average size 45 μm (Type V and VI) was drastically reduced by 
some manufacturing issues which was resolved later for samples with higher concentration 
(8wt%). Further, small microcapsules up to 5wt% cannot deliver sufficient amount of monomer 
upon their breaking to cover the crack surface area. However, as they bond well with the matrix, 
increased concentration up to 8wt% of small microcapsules does not degrade the original NPC 
fracture toughness of composites while being capable of releasing increased amount of monomer 
to cover the crack surface area. This results in excellent healing performance at relatively higher 
concentration of small microcapsules. Thus, for best healing performance, composites should be 
incorporated with relatively high concentration (8wt%) of small microcapsules of average size of 
45 μm. 
6.6 Conclusions 
Investigation of self-healing at room temperature is carried out with different types of FRP 
composite samples containing varying percentage of microcapsules with different average sizes. 
Two average sizes (100 μm and 45 μm) and three different concentrations (2wt%, 5wt% and 
8wt%) of microcapsules are selected to investigate their effect on self-healing performance of 
FRP composite. Self-healing performance is evaluated by measuring the NPC and PC fracture 
toughness of the composite samples according to ASTM D7905/D7905M. The values of NPC 
fracture toughness are obtained by propagating a delamination from the pre-implanted insert in 
the composite sample. The values of PC fracture toughness, on the other hand, are determined by 
propagating the natural precrack (allowed to heal beforehand) that is created during the NPC test. 
Larger microcapsules (average size 100 µm) are found to debond from the matrix more easily 
during the mode II fracture. This limits the self-healing performance of composites containing 
larger microcapsules. Debonding of microcapsules affects both the NPC fracture toughness and 
the PC fracture toughness of modified composites. Increasing the concentration of larger 
microcapsules up to 8 wt% did not help in achieving high PC fracture toughness post healing at 
room temperature. Rather, increased concentration of larger microcapsules degrades the base 
NPC fracture toughness significantly due to the debonding of larger microcapsules as evidenced 
in SEM micrographs. On the contrary, smaller microcapsules (average size 45µm) are shown to 
form good bonding with the matrix leading to excellent improvement of PC fracture toughness 
post healing at room temperature while not deteriorating the NPC fracture toughness at high 
concentration (8 wt%) of microcapsules. Care should, however, be taken in manufacturing 
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modified composites so that the microcapsules does not preferentially accumulate at a preferred 
site which might weaken the crack-front to reduce the original NPC fracture toughness.   
Self-healing performance is evaluated by calculating both conventional healing efficiency 
ηh,c and healing performance index 𝑃𝐼 as defined in chapter 2. ηh,c is found to give exaggerated 
values in many instances while 𝑃𝐼 is found to give reliable values better indicating the actual 
healing performance of modified composites taking into account the likely degradation and 
improvement of NPC and PC fracture toughness compared to regular composites containing no 
microcapsules. The best healing performance at room temperature is obtained with FRP 
composite sample containing 8wt% of microcapsules of average size 45 μm. 
The investigation of self-healing of FRP composites is also carried out in a low temperature 
set up to understand the effect of low temperature on self-healing performance and the results are 
















CHAPTER 7  
Investigation of Self-healing of FRP 
Composites at Low Temperature 
7.1   Introduction 
Structures and parts made of fiber reinforced polymer (FRP) composites are often subjected 
to low temperature in service. For example, external key structures and parts like the fuselage, 
wings and rotor blades of modern air planes and helicopters made of FRP composites are 
subjected to cold temperatures (-40oC to -60oC) at cruising altitudes during in-flight operations. 
These air vehicles also often stay in mild cold temperatures in runways and tarmacs for a 
considerable time in colder regions on earth where the environment temperature remains as low 
as -40oC and less, especially, during the winter seasons. Further, after the inflight operations at 
high altitude, the air vehicles land in warmer environments thus might be subjected to thermal 
cycling. Modern satellites and their components made of FRP composites are also exposed to 
extreme cold (down to -150oC) conditions and again return to extreme hot (up to +150oC) 
conditions during their orbiting in space. It is thus interesting to investigate the effect of low 
temperatures as well as effect of thermal cycling on self-healing of composites. The current work 
explores the effect of thermal cycling on self-healing of unreinforced epoxy samples and 
investigates in detail the effect of mild low temperature (-40oC) on the self-healing of FRP 
composites. 
The reason for choosing the value of the low temperature at -40oC for investigation of self-
healing of FRP composites lies in making a balance between limitations imposed by the thermal 
properties of the healing agents (i.e., the monomers and catalyst used) used and the fact that it 
nearly represents the actual conditions in earth atmosphere. The thermal shock investigation of 
epoxy (without fiber), however, is done in wider temperature range (-196oC to 120oC) 
representing space conditions as it suits the requirement of self-healing.  
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7.2   Limitations of healing agents at low temperature and choice of 
suitable catalyst 
The healing agents used for investigating self-healing at room temperature in this study are 
5E2N and Grubbs catalyst first generation. 5E2N remains functional at a much wider 
temperature range compared to DCPD. However, it has a freezing point near -80oC [93]. That 
means, around this temperature liquid 5E2N gets frozen and loses its ability to flow which is a 
key requirement for self-healing to take place. Thus, on principle, self-healing cannot take place 
with 5E2N if the working temperature remains fixed around -80oC and below. This is the 
material limitation imposed by the monomer used in this study. Another material limitation, 
observed in this study, was imposed by the other healing agent, i.e. the first generation Grubbs 
catalyst, (G1) at low temperature. A simple experiment was carried out to reveal this limitation. 
In this experiment, some liquid 5E2N monomer was first taken into a scintillation vial (vial #1) 
and kept inside a covered chamber full of dry ice (the temperature inside the box was measured 
to be around -40oC) for 2 hours. Similarly, a pinch amount of first generation Grubbs catalyst 
was taken into another scintillation vial (vial #2) and kept inside the dry ice chamber. After 2 
hours, liquid 5E2N from vial #1 was poured into vial #2, hand shaken and immediately put back 
into the dry ice chamber. The 5E2N/G1 mixture was then kept in the dry ice chamber for 24 
hours. Interestingly, the mixture was observed to be liquid even after 24 hours which implies that 
no self-healing reaction took place between 5E2N and G1 at a temperature of -40oC in 24 hours. 
When the same experiment was carried out, but with second generation Hoveyda-Grubbs 
catalyst (HG2) this time, the mixture (of 5E2N and HG2) kept at -40oC was found to be 
polymerized when observed after 24 hours. It is noteworthy to mention that when the liquid 
5E2N was mixed with G1 or HG2 in a scintillation vial at room temperature, it started reaction, 
got polymerized and became solid within few seconds. In order to understand this behavior, the 
mechanism of self-healing reaction between the monomer and the Grubbs catalyst needs to be 
understood. 
7.2.1 Understanding the mechanism of self-healing reaction between 5E2N 
and Grubbs catalyst 
The self-healing reaction that takes place between the 5E2N monomer (similarly as DCPD) 
and Grubbs catalyst, is essentially a Ring Opening Metathesis Polymerization (ROMP) reaction.  
191 
 
Figure 7.1 A generalized example of ROMP reaction [112] 
ROMP is a chain growth polymerization process where a mixture of cyclic olefins is converted 







The mechanism of the polymerization is based on olefin metathesis, a unique metal-mediated 
carbon-carbon double bond exchange process. As a result, any unsaturation associated with the 
monomer is conserved as it is converted to polymer. This is an important feature that 
distinguishes ROMP from typical olefin addition polymerization (e.g. ethylene-polyethylene). 
The reaction is driven from monomer to polymer by the release of strain associated with the 
cyclic olefin (ring strain) balanced by entropic penalties [112].  
Similarly, cyclic olefins with high ring strain, such as 5-ethylidene-2-Norbornene (5E2N), is 













The temperature, however, has significant influence on the activity of catalyst that initiates 
the ROMP reaction by opening up the cyclic ring of the olefin releasing its ring strain. A number 
of transition metal alkylidene complexes based on tungsten and molybdenum metals are capable 
of catalyzing the metathesis of olefins. However, it is the ruthenium based alkylidene complexes 
which has found widespread applications in polymer and organic chemistry as a catalyst 









5-ethylidene-2norbornene (5E2N) Poly (5E2N) 
Figure 7.2 Ring Opening Metathesis Polymerization of 5E2N 
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tolerance to most functional groups, relatively thermally stable and possess ease of handling 
characteristics due to its stability in air and moisture. [112] 
In order to understand the effect of temperature on the reactivity of Grubbs catalyst in ROMP 
of cyclic olefins, it is necessary to understand the chemical structure of the catalyst and how it 
takes part in the ROMP reaction. Grubbs catalysts are based on a ruthenium atom surrounded by 
five ligands and can generally be written as (L) (L’) X2 Ru=CHR, where L and L’ are two 
neutral electron donating entities (e.g. tryalkylphosphines), X2 are the two mono-anionic groups 
(e.g halides) and one alkylidene moiety (e.g. substituted methylidenes, =CHR) [113]. Ligands 
play a key role in stabilizing and activating the central metal atom [114]. For example, phosphine 
ligands in the first generation Grubbs catalyst has profound impact on the reaction initiation 
[112]. Besides the neutral ligands, the nature of the halide and alkylidene ligands also has an 
impact on the catalyst initiation rate [113]. 
ROMP of cyclic olefins proceeds broadly in two stages. The first stage is the initiation or 
activation of reaction. The second stage is the propagation or chain growth reaction stage. The 
















At the beginning, the metal alkylidene remains inactive until it comes into contact with a 
cyclic olefin. In the presence of a cyclic olefin (with some ring strain such as 5E2N), a 
coordination reaction activates the catalyst by forming a coordination complex. The coordination 
metal complex then undergoes a [2+2] cycloaddition reaction to form an intermediate 
metallacyclobutane. This intermediate then undergoes a cycloreversion reaction which opens up 
the ring of the olefin and a new metal alkylidene forms as shown in the initiation step in 7.4. The 
Figure 7.3 A general mechanism to a typical ROMP reaction [112] 
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reactivity of this newly formed metal alkylidenes remains similar to that of the initiator and, thus, 
the analogous steps are repeated during the propagation stage until polymerization ceases (i.e. all 
monomer is consumed, a reaction equilibrium is reached or the reaction is terminated) [112]. As 





















First generation Grubbs catalyst is a five coordinated ruthenium alkylidene which contains  
two neutral phosphine ligands, two chloride ligands and one benzylidene ligand as shown in 
figure 7.4. This five coordinated form of the Grubbs catalyst remains inactive until it comes into 
contact with a cyclic olefin. It was determined that the mechanism to the olefin metathesis 
reaction with the catalyst was dissociative in nature. Thus, one of the phosphine ligands of the 
first generation Grubbs catalyst must separate from the inactive five coordinated form of the 
catalyst before olefin coordination (and subsequent reaction) may occur [115] as shown 
previously in the general mechanism to ROMP in figure 7.3. The scheme is also shown in figure 







Figure 7.5 Scheme for ROMP with Grubbs catalyst showing phosphine dissociation and 
olefin binding steps during coordination and subsequent metathesis [116] 
Figure 7.4 Chemical structure of first generation Grubbs catalyst containing two neutral 
















Thus the first step of the ROMP reaction of olefins (e.g. 5E2N) with first generation Grubbs 
catalyst involves dissociation of the bound PCy3 in the inactive five coordinated form of the 
catalyst to form the active four coordinated intermediate. This intermediate can be trapped by 
free PCy3 to generate the starting inactive alkylidene or bind an olefin substrate during the 
coordination reaction and undergo subsequent metathesis as shown in figure 7.5 [116] 
The activity of first generation Grubbs catalyst therefore depends not only on phosphine 
dissociation but also on the ratio of the rate of phosphine reassociation ( k-1) and the rate of 
olefin binding ( k2). While phosphine dissociation occurs rapidly at room temperature in first 
generation Grubbs catalyst, it is the ratio k-1/k2 which determines whether the four coordinated 
intermediate returns to the inactive five coordinated form or binds to the olefin [116]. Phosphine 
dissociation, which is a requirement to provide active catalyst for ROMP, is slow at low 
temperatures and, therefore, first generation Grubbs catalyst (together with other phosphine 
containing catalysts) suffer from decreased reactivity at low temperatures [117]. This is the 
reason why the mixture of 5E2N and first generation Grubbs catalyst, in our experiment, 
remained liquid at -40oC even after 24 hours of healing time. Second generation Hoveyda-
Grubbs catalyst, the chemical structure of which is given in figure 7.6 [118], on the other hand, is 

























Being phosphine free, HG2 does not require prior phosphine dissociation to activate the 
catalyst and the ROMP reaction with strained cyclic olefin (such as 5E2N) initiates more readily 
at lower temperatures [118]. This explains the observation made in our experiment at -40oC. 
HG2 catalyst is thus chosen for fabricating carbon/epoxy composite samples and subsequent 
investigation of self-healing at low temperature (-40oC). 
7.3   Fabrication of composite samples 
Epoxy samples (without reinforcement) and fiber reinforced carbon/epoxy samples were 
fabricated for self-healing experiments. Two types of epoxy samples were fabricated. One type is 
regular epoxy sample that does not contain healing agents (i.e. no microcapsules or catalyst). The 
other type is modified epoxy sample which contains healing agents (i.e. both microcapsules and 
catalyst). The epoxy samples were used for thermal shock experiments. 
Similarly, two types of fiber reinforced carbon/epoxy composite samples were fabricated. 
Regular composite samples do not contain any healing agents. Modified, composite samples, on 
the other hand, contain healing agents. The fiber reinforced composite samples were used for 
mode II fracture tests. All composite samples manufactured contain a pre-implanted teflon insert 
as a crack initiator. All FRP composite samples manufactured are thus of NPC configuration.   
The formulation of regular (without healing agents) and modified (with healing agents) 
epoxy matrix and the procedure of fabricating fiber reinforced composite samples were discussed 
in chapter 6. The procedure of fabricating epoxy (without reinforcement) samples for thermal 
shock experiment is discussed in the following section. 
7.3.1 Fabrication of epoxy (without reinforcement) samples 
Epoxy (without reinforcing fibers) samples with taper doubled cantilever beam (TDCB) 
geometry (extensively used by the research group of White and Sottos [6] for self-healing 
experiments) were fabricated for the thermal shock experiment. This geometry of the samples 
already contains some discontinuities (holes, grooves, tapered regions etc.) which are expected to 
facilitate cracking of the samples due to thermal stresses induced during the thermal shock 
experiment. In order to fabricate the epoxy samples, a silicone mold containing the cavity with 
TDCB geometry was first manufactured. Aluminum blocks which were machined to form the 
TDCB geometry with specified configuration were used as the tool (positive of the cavity) to 
make the cavity. The tools were attached to a flat aluminum plate with adhesives and enclosed 
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within boundary walls built by cardboards attached together by silicone tape adhesives.  Mold 
making silicone rubber materials and hardener (V-340 mold making silicone rubber, Freeman 
Mfg. & supp. Co.) were mixed in appropriate ratio and poured inside the cardboard wall 
boundaries upon the aluminum tools attached to flat aluminum plate. The mixture was then cured 
at room temperature for few days, demolded and post cured in an oven.  
Regular epoxy samples without self-healing capability were manufactured by pouring regular 
epoxy matrix (without healing agents) into the cavities of the mold kept on a flat surface. It was 
then cured at room temperature for 2 weeks followed by post curing at 100oC for 2 hours. The 
regular epoxy samples were then demolded to be ready for thermal shock experiment. In a 
similar way, modified epoxy samples with self-healing capability were manufactured by pouring 
modified epoxy matrix (with healing agents) into the cavities of the mold kept on a flat surface. 
It was then cured, similarly, at room temperature for 2 weeks followed by post curing at 100oC 
for 2 hours. The modified epoxy samples were then demolded to be ready for thermal shock 















Unreinforced epoxy samples were subjected to thermal cycles (between -196oC and +120oC) 
which is representative of the actual thermal environment that a space shuttle can be exposed to 
a) b) 
Figure 7.7 a) Regular (without healing agents) and b) modified (with healing 
agents) epoxy samples 
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while orbiting the earth. Both regular and modified epoxy samples underwent the thermal shock 
experiment in order to investigate the effect of extreme thermal environment on the materials and 
any improvement that can be achieved through imparting self-healing capability to the materials. 
As the thermal shock experiment involves both cooling and heating cycles, the limitations 
imposed by healing agent materials are minimal. Thus, if the self-healing mechanism works at 
this extreme thermal shock environment, it will also work for other mild thermal cycling 
environment.   
Mode II fracture test, on the other hand, was carried out for the FRP composite samples, 
under three-point bending loading conditions which represent realistic scenario that a composite 
structures are often exposed to in many applications at mild cold conditions (-40oC), prevailing, 
mostly, in earth’s environment. Extreme cold conditions prevailing in space was not intended to 
imitate, in this case, because of the limitations of the healing agent materials discussed in section 
7.2. 
7.4.1 Thermal shock testing of unreinforced epoxy sample 
 
Unreinforced regular (without healing agent) and modified (with healing agent) epoxy 
samples with TDCB geometry were exposed to extreme cold temperature of liquid nitrogen 
(boiling point, -196oC) and a high set temperature of 120oC, cyclically. First, the regular epoxy 
sample was completely submerged into an open container filled with liquid nitrogen. The sample 
was kept submerged under liquid nitrogen for 2 minutes. The sample was then taken out of liquid 
nitrogen and quickly transferred to a convection oven preheated at 120oC. The sample was kept 
in the oven for 2 minutes at 120oC. The thermal cycles were continued a number of times. The 
same experiment was carried out for modified epoxy samples. The difference in appearance of 
the epoxy samples before and after the thermal shock test were observed visually and the result is 
discussed in section 7.5.  
7.4.2 Fracture test of fiber reinforced composites at low temperature 
(-40oC) 
Mode II fracture toughness of FRP composites was directly measured according to ASTM 
D7905-7905M-14 standard using a compliance calibration method [3] in a low temperature set 
up consisting of an environmental chamber with liquid nitrogen supply which is shown in section 
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7.4.3. Two values of fracture toughness at low temperature were measured from each composite 
sample. The fracture toughness obtained with the propagation of delamination from the pre-
implanted insert (acting as artificially introduced initial crack) is termed as NPC (Non-pre-
cracked) fracture toughness. The fracture toughness obtained afterwards with the propagation of 
delamination from naturally occurred initial crack is termed as PC (Pre-cracked) fracture 
toughness. The samples are allowed to heal for 24 hours at low temperature (-40oC) in-between 
the completion of the NPC test and beginning of PC test. 
The configurations of composite samples and the procedure of determining the two values of 
fracture toughness are explained, separately, in chapter 6. The only difference is that before the 
NPC test, the composite samples are kept inside a zipped plastic bag which is kept inside a dry 
ice chamber for few hours. The composite samples are then removed from the dry ice chamber 
and loaded into the three point bending fixture of the MTS machine surrounded by environment 
chamber which is already maintained at target low temperature (-40oC). The low temperature set 
up is shown later in section 7.4.3. Once the NPC test of the composite sample is completed, the 
samples are kept similarly inside a zipped plastic bag and kept inside a dry ice chamber for 24 
hours to allow for healing of the natural crack before the PC test. Regular composite samples 
(without healing agents), however, do not require healing time. They are, however, also kept 
inside the zipped plastic bag and kept inside the dry ice chamber for 24 hours before the PC test. 
After 24 hours, the samples are removed from the dry ice chamber and similarly loaded into the 
three point bending fixture of the MTS machine surrounded by environment chamber which is 
already maintained at target low temperature (-40oC). The low temperature set up is shown in 
section 7.4.3. 
7.4.3 Set up for low temperature test 
The composite samples are loaded into a three point bending fixture attached with the 
required extensions. The entire fixture with the extensions are inserted into an environmental 
chamber equipped with liquid nitrogen flow facility and temperature controller. The fixture is 
then attached to the MTS machine. Liquid nitrogen cylinder is attached to the environmental 
chamber. The test set up is shown in figure 7.8. When the temperature reaches to the desired 
level and becomes stable, loading of the composite samples starts. Instantaneous load and 




Figure 7.8 a) Environmental chamber enclosing the fixtures in the MTS machine, and 
attached to liquid nitrogen supply. b) 3-point bending fixtures holding the composite 
samples inside the environmental chamber and extensions attached to MTS machine and 
c) The controller of the environmental chamber showing that the set temperature of -40oC 




































The dry ice chamber where the composite samples are kept enclosed before and after the 










Figure 7.9 a) Composite samples are put inside the zipped plastic bag which is kept inside 
the chamber containing dry ice pellets. b) A thermocouple wire is placed inside the zipped 
plastic bag in the dry ice chamber and is connected to a digital display to monitor the 
temperature c) The digital display showing that the temperature inside the zipped plastic bag 


































7.4.4 Types of tests performed on different types of FRP samples at  
-40oC 
FRP composite panels incorporated with no microcapsules (Type I), 2wt% (Type II), 5wt% 
(type III) and 8 wt% [type IV] microcapsules of average size 100 µm were fabricated. with mid-
layer teflon insert (NPC configuration) as described in chapter 6. All modified composite panels 
are incorporated with 1wt% of HG2 catalyst also. Investigation of self-healing of composites at 
room temperature revealed that among the different types of modified composite samples 
investigated, the samples containing 8 wt% microcapsules of average size 45 µm (Type VII) 





MC: Microcapsules; CT: Cold Temperature 
Table 7-1. Summary of the type of tests performed at CT (-40oC) with different types of 
composite samples (I-VII) indicating the designation of individual test results 
microcapsules of average size 45 µm (Type VII) was also fabricated and tested at low 
temperature to compare the best results between room temperature and low temperature.  
A summary of the types of tests performed at low temperature (-40oC) with different types of 
FRP composite samples indicating the designation of the individual test result are listed in table 
7.1. At least 3 replicates are tested for each type of samples to determine the mode II fracture 




7.5 Results and Discussions 
Results of the thermal shock experiment of the unreinforced epoxy sample is shown in 
section 7.5.1. Representative load-displacement curves for the NPC and PC fracture loading of 
the fiber reinforced composite samples and the corresponding NPC and PC fracture toughness 
values as measured at cold temperature (-40oC) according to the procedure described in section 
7.4.2 are shown and discussed in section 7.5.2. 
7.5.1 Result of the thermal shock experiment of unreinforced epoxy 
samples 
The appearances of regular epoxy sample (without microcapsules and catalysts) before and 








Categories of composite 
samples manufactured with 
pre-implanted teflon insert  
(NPC configuration) 
Types of tests performed at low 
temperature  









0 - I NPC (0%) PC (0%) 
2 100 II NPC(2%,100 µm) PC(2%,100 µm) 
5 100 III NPC(5%,100 µm) PC(5%,100 µm) 
8 100 IV NPC(8%,100 µm) PC(8%,100 µm) 
8 45 VII NPC(8%,45 µm) PC(8%, 45 µm) 
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Figure 7.10 Regular epoxy sample a) before the thermal shock cycles and b) after 5 



























Regular epoxy sample (without microcapsules and catalysts) shattered rapidly during the 
initial cycles of the thermal shock experiment. A significant portion of the regular epoxy sample 
fell off (particularly at the corners and regions of holes) after only 5 thermal shock cycles 
between -196oC and 120oC. This result indicates that the regular epoxy sample without self-
healing capability is vulnerable to failure at extreme thermal shock environment.  
Similarly, the appearance of modified epoxy sample (incorporated with microcapsules 










Figure 7.11 Modified epoxy sample a) before the thermal shock cycles and b) after 15 


























Modified epoxy sample (with microcapsules and catalysts) remained intact up to 8 thermal 
shock cycles between -196oC and 120oC after which a little portion at the right corner of the 
sample fell off. The sample remained as it is even after 15 cycles of thermal shock. A fine 
network of cracks was seen on the samples which are believed to be self-healed at the crack 
surfaces restricting the shattering and subsequent falling apart  at the weaker regions of the 
samples even after 15 thermal shock cycles. This result proves that self-healing with 
microencapsulated 5E2N monomer and Hoveyda-Grubbs catalyst (HG2) system works well even 
at the extreme thermal shock environment and can improve the lifetime of composite structures. 
In the following section, the effects of inclusion of microcapsules on the NPC fracture 
toughness and the effect of self-healing reaction on the PC fracture toughness of fiber reinforced 







Figure 7.12 Low temperature NPC fracture toughness of composite samples containing 
varying concentration of microcapsules of average size 100 µm. Error bars represent 
one standard deviation of measured values. 
7.5.2 Effect of inclusion of microcapsules on the low temperature NPC 
fracture toughness of FRP composite samples  
The effect of inclusion of microcapsules on the NPC fracture toughness of modified 
composite samples (Type II, III, IV and VII) measured at -40oC temperature is discussed below. 
Effect of concentration of larger microcapsules (average size 100 µm) on the 
low temperature NPC fracture toughness 
The values of the low temperature NPC fracture toughness (𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 ) of the composite 
samples (Type I, II, III and IV) as a function of concentration of microcapsules of average size 


























Figure 7.13 Evidence of debonding of larger microcapsules (average size 100 µm) 
leaving a smooth deep impression on the matrix surface during NPC crack propagation 
at low temperature 
Figure 7.12 shows that incorporation of microcapsules of average size 100 µm into 
composites reduces the low temperature NPC fracture toughness(𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶 ) slightly up to 5 wt% 
beyond which the drop in 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  is considerable. The values of low temperature 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  is 
reduced by only 2% in type II sample, again only 2% in type III sample and about 20% in type 
IV sample compared with type I sample.  In other words, the values of low temperature 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  
are reduced by 2%, 2% and 20% when incorporated with 2wt%, 5 wt% and 8 wt% of larger 
microcapsules (average size 100 μm), respectively, in the composites. Increasing the 
concentration of larger microcapsules into composites beyond 5 wt% considerably degrades its 
low temperature  𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  which is likely due to the debonding of the microcapsules to the matrix 
[ [49]- [52] ]. The debonding of larger microcapsules is also evidenced by the observation of 
debonding impressions on the crack surface as shown in figure 7.13 which shows a typical SEM 
micrograph of the fracture surface of the modified composites (with larger microcapsules) tested 





















Figure 7.14 Low temperature NPC fracture toughness of composite samples containing 
8 wt% microcapsules of average size 45 µm (Type VII) compared with regular sample 
(Type I). Error bars represent one standard deviation of measured values. The scale 
and spacing of the graph is kept the same as previous for later comparison. 
The micrograph in figure 7.13 shows the debonding of larger microcapsules leaving a smooth 
deep impression on the crack surface. This is similar to what was observed for the modified 
composite samples (with larger microcapsules) tested at room temperature. 
Effect of concentration of small microcapsules (average size 45 µm) on the low 
temperature NPC fracture toughness 
Figure 7.14 shows the low temperature 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  of type VII sample (containing 8wt% of 
small microcapsules of average size 45 μm) compared with type I sample (containing no 



















Figure 7.14 shows that, similar as in the case of larger microcapsules, incorporation of 8wt% 
small microcapsules (average size 45 μm) also reduces the low temperature 𝐺𝐼𝐼,𝑁𝑃𝐶





18% in type VII modified samples compared with low temperature 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  of type I regular 
sample. SEM observations of the fracture surface of the composites tested at low temperature, 
however, shows that the smaller microcapsules (average size 45 µm) forms good bonding with 












 SEM micrograph in figure 7.15 demonstrates that the smaller microcapsules forms good 
bonding with the matrix showing the rough inner surface of the lower halves of the smaller 
microcapsules still attached to the matrix after the crack propagation at low temperature. The 
good bonding of small microcapsules, however, does not explain the observed reduction in low 
temperature 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  in type VII sample as seen in figure 7.14. This reduction in 𝐺𝐼𝐼,𝑁𝑃𝐶
𝐶  is 
possibly associated with some manufacturing issues related to the hand lay-up process as found 
in room temperature cases discussed in the previous chapter. 
 
Figure 7.15 Evidence of good bonding of smaller microcapsules (average size 45 µm) 
showing the rough inner surfaces of the lower halves of microcapsules still attached to 




Figure 7.16 Low temperature PC fracture toughness of composite samples containing 
varying concentration of microcapsules of average size 100 µm. Error bars represent one 
standard deviation of measured values. The scale and spacing of the graph are kept the 





7.5.3 Effect of self-healing on the low temperature PC fracture toughness of 
composite samples  
 
The effect of self-healing on the PC fracture toughness of modified composite samples (Type 
II-VII) measured at low temperature are discussed below. 
Effect of concentration of larger microcapsules (average size 100 µm) on the 
low temperature PC fracture toughness 
The values of the low temperature PC fracture toughness (𝐺𝐼𝐼,𝑃𝐶
𝐶 ) of the composite samples 
(Type I, II, III and IV) as a function of concentration of microcapsules of average size 100 µm 























Figure 7.16 shows that the values of low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶  of modified composite samples 
of type II, III and IV [containing certain wt% of larger microcapsules (average size 100 μm)] are 
always greater than the values of low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶  of regular composite samples of type I 
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(containing no microcapsules). This implies that the natural precrack is healed in the modified 
composite samples at low temperature also. Compared with type I samples, low temperature PC 
fracture toughness is improved by 27% in type II sample, 11% in type III sample and about 13%  
in type IV sample. In other words, compared with regular sample (0wt% microcapsules), the 
values of low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶  are improved by 27%, 11% and 13%  when the samples are 
incorporated with 2wt%, 5 wt% and 8 wt% of larger microcapsules (average size 100 μm), 
respectively. The improvement in low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶 , however, diminishes with increasing 
concentration of larger microcapsules beyond 2 wt%. Debonding of larger microcapsules during 
the NPC crack propagation, as evidenced in figure 7.13 before, limits the number of 
microcapsules broken which restricts the release of sufficient amount of monomer into the crack 
plane. Thus, as in the case of room temperature, increasing the concentration of larger 
microcapsules (average size 100 µm) does not translate into proportionate increase in 𝐺𝐼𝐼,𝑃𝐶
𝐶  at 
low temperature.  
Effect of concentration of small microcapsules (average size 45 µm) on the low 
temperature PC fracture toughness 
Finally, figure 7.17 shows the best results showing significantly improved low temperature 
𝐺𝐼𝐼,𝑃𝐶
𝐶  of modified composite samples of type VII [containing 8 wt% of smaller microcapsules 
(average size 45 µm)] compared to low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶  of regular composite samples of type 













Figure 7.17 Low temperature PC fracture toughness of composite samples containing 
8wt% microcapsules of average size 45 µm compared with regular sample [(PC (0%)]. 



























 About 68% improvement in low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶  is observed in type VII sample 
compared with type I sample. This, again, first implies that self-healing of the natural precrack in 
the modified composite samples takes place, even at low temperature.   
The improvement of low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶  of modified composite samples containing 
certain wt% of microcapsules (Type II-VII) compared with low temperature 𝐺𝐼𝐼,𝑃𝐶
𝐶  of regular 
composite sample containing no microcapsules (Type I), as shown in figure 7.17 and 7.16 
before, is the direct contribution of self-healing of the naturally occurred precrack at low 
temperature. Comparison of representative SEM micrographs (as shown in figure 7.18) of the 
fracture surfaces of the regular and modified composite samples, both fractured at low 
temperature, shows the difference in features between the healed (modified) and unhealed 





Figure 7.18 Comparison of fracture surfaces of (a) regular (no microcapsules) and b) 
modified (with microcapsules) composite samples both fractured at -40oC.  Broken shells of 




































The micrograph in figure 7.18 a) shows exposed bare fibers, striations, hackle markings, 
marks of stress whitening and severe matrix cracking which are the common features of low 
temperature mode II fracture of regular sample (no microcapsules). The fracture features 
indicates a combination of adhesive-cohesive failure. The micrograph in figure 7.18 b), on the 
other hand, shows the presence of relatively smooth self-healed polymer layer (more clearly seen 
at the bottom right corner of the micrograph 7.18 b) which is believed to be the product of the 
self-healing ROMP reaction (poly 5E2N) hiding the common fracture features seen in regular 
samples. The self-healed polymer layer is formed by the reaction between the monomer oozed 
out from broken microcapsules and dispersed HG2 catalyst in the delamination crack plane at 
low temperature. 
The presence of lower halves of the microcapsules together with relatively smooth self-
healed layer and some portion of the exposed bare fibers (at the top left corner of the micrograph 
7.18b) implies that the failure of the modified sample is mostly cohesive in nature. The 
micrograph also confirms the fact that the self-healing mechanism still works at low temperature 
(-40oC). 
Comparing figures 7.16 and 7.17 it can be concluded that relatively high concentration in the 
vicinity of 8 wt% of smaller microcapsules (average size 45 µm) works better for self-healing of 
the natural precrack than high concentration of larger microcapsules (average size 100 µm), even 
at low temperature. This is due to the tendency of smaller microcapsules of forming better 
bonding with the matrix (as evidenced in figure 7.15 before) allowing the breaking of greater 
number microcapsules releasing sufficient amount of liquid monomer into the crack plane for 
effective self-healing.  
7.5.4 Comparison of fracture toughness and evaluation of healing 
performance of the composites tested at low temperature 
In this section, the low temperature NPC and PC fracture toughness of each type of 
composite samples (Type I-IV and VII) are compared. As the healing performance index, 𝑃𝐼, as 
defined in equations 5.2-5.4 (in chapter 5) is found to be the reliable indicator of actual healing 
performance, the values of 𝑃𝐼 are evaluated for each type of samples tested at low temperature 
and compared. Using the, values of 𝑃𝐼, the composite sample showing the best healing 
performance at low temperature can be correctly identified.  
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Figure 7.19 Comparison of low temperature NPC and PC fracture toughness of composite 
samples as a function of concentration of microcapsules of average size of 100 µm.  Error 
bars represent one standard deviation of measured values.             
Figure 7.19 shows the comparison of low temperature NPC and PC fracture toughness of 
composite samples of type I-IV as a function of concentration of larger microcapsules of average 


























Similarly, figure 7.20 below shows the comparison of low temperature NPC and PC fracture 
toughness of composite samples of type I containing no microcapsules and type VII containing 






 NPC (100 μm, -40oC) 







Figure 7.20 Comparison of low temperature NPC and PC fracture toughness of 
composite samples of type I containing no microcapsules and type VII containing 8wt% 
of microcapsules of average size of 45 μm.  Error bars represent one standard deviation 



























The percentage changes (improvement or deterioration) in low temperature fracture 
toughness values in the modified composites (Type II, III, IV and VII) compared with regular 









 NPC (45 μm, -40oC) 




Table 7-2. Comparison of changes in low temperature fracture toughness of modified 







Figure 7.21 compares the corresponding values of 𝑃𝐼 (%) for the three types of modified 
composite samples (Type II-IV) containing larger microcapsules of average size of 100 μm and 





















Types of composite samples tested at low 
temperature (-40oC) 













% 𝒓𝒆𝒅.(𝑵𝑷𝑪) 2 2 20 18 Debonding of larger 
microcapsules and 
manufacturing issues 
% 𝒊𝒎𝒑.(𝑷𝑪) 27 11 13 68 Self-healing reaction 
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Figure 7.21 Comparison of healing performance index, PI (%) of modified composite 

























𝑃𝐼 values of about 45%, 30%, 12% and 73% are achieved in type II, III, IV and VII samples, 
respectively, tested at low temperature. A continuous reduction of 𝑃𝐼 values with increasing 
concentration of larger microcapsules (average size 100 μm) in the composite samples (Type II, 
III and IV) is also indicated in figure 7.21. The best PI value at low temperature is obtained with 
the modified composite samples of type VII containing 8wt% of small microcapsules of average 
size of 45 μm. The values of PI (%) corresponds appropriately with the percentage reduction in 
NPC fracture toughness due to the effect of inclusion of microcapsules into the composites and 
percentage improvement in PC fracture toughness due to the effect of self-healing as indicated in 
table 7.2.  Thus, from the above investigation, it is concluded that for best healing performance at 
low temperature, composites should be incorporated with relatively high concentration (8wt%) 







Figure 7.22 Comparison of NPC fracture toughness of composite samples (Type I-IV) 
measured at room temperature and low temperature.  
7.5.5 Effect of low temperature on the self-healing performance of the 
composites  
The effect of low temperature (-40oC) on the self-healing performance of the composites can 
be extracted by comparing the fracture toughness and 𝑃𝐼 values measured both at room 
temperature and low temperature. 
As such, figure 7.22 shows the effect of low temperature on the NPC fracture toughness, of 
the composite samples of type II-IV containing larger microcapsules (average size 100 μm) 





















The comparison in figure 7.22 indicates that the low temperature NPC fracture toughness is 
greater than room temperature fracture toughness in all composite samples (I-IV). This implies 
that exposure of the composite samples to low temperature tends to increase their NPC fracture 
toughness. Kichhannagari [119] studied the effect of low temperature on the FRP composites and 
observed a continuous increase in apparent interlaminar shear strength, as measured by short 
beam shear test, with decrease in temperature from room temperature down to -100oC. 
According to Isacc and Ishai [120], interlaminar shear strength is a measure of the in situ shear 
 NPC (100 μm, -40oC) 






strength of the matrix layer between plies. She [119] observed about 29%, 57% and 110% 
increase in shear strength of carbon/epoxy composites at -5oC, -50oC and -100oC compared with 
shear strength at room temperature. This can explain the observed increase in NPC fracture 
toughness of composites at low temperature compared with room temperature as shown in figure 
7.22. A comparison of the fracture surfaces of regular (Type I) composites fractured at room 



















Figure 7.23 Comparison of fracture surfaces of regular composite samples (Type I) 


































Figure 7.24 Comparison of PC fracture toughness of composite samples (Type I-IV) 
measured at room temperature and low temperature.  
Both fracture surfaces in figure 7.23 are associated with common features of mode II fracture 
which include striations, exposed bare fibers, hackle markings and matrix cracking. However, 
severe matrix cracks along with distinct marks of stress whitening observed in the composite 
samples fractured at low temperature differentiates it from the sample fractured at room 
temperature. The presence of severe matrix cracks and marks of stress whitening indicates that 
the composite samples at low temperature undergoes more severe shear stress before the 
propagation of cracks further indicating higher fracture toughness than composite samples 
fractured at room temperature. 
Figure 7.24 below, on the other hand, indicates the effect of low temperature on self-
healing of natural precracks translated into PC fracture toughness of composite samples of type 






















The values of low temperature PC fracture toughness of the composite samples of each type 
(II-IV) matches closely with the PC fracture toughness measured at room temperature. This 
indicates that, low temperature (-40oC) does not have significant effect on self-healing of 
composites.  
 PC (100 μm, -40oC) 







Similarly, figure 7.25 a) and b) below show the effect of low temperature on the NPC and PC 
fracture toughness of the composite samples of type VII containing 8wt% of small microcapsules 































Figure 7.25 Comparison of a) NPC and b) PC fracture toughness of composite 
samples of type VII measured at room temperature and low temperature in relation to 
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Figure 7.25 a) shows some reduction of low temperature NPC fracture toughness of 
composite sample of type VII compared with room temperature NPC fracture toughness of the 
same type of sample. This reduction of low temperature NPC fracture toughness is possibly due 
to the variations in human control in the manufacturing of composites using the hand lay-up 
methods. The values of PC fracture toughness of the type VII sample (containing 8wt% of small 
microcapsules) measured at room temperature and low temperature, however, matches closely 
indicating, again, a little influence of low temperature (-40oC) on the self-healing of composites. 
7.6 Conclusions 
In order to extract the effect of low temperature, investigation of self-healing at low 
temperature (-40oC) is carried out with the same type of FRP composite samples (Type I-IV) 
containing larger microcapsules (average size 100 μm) which are tested at room temperature. 
Additionally, composite samples containing 8wt% of small microcapsules (average size 45 μm) 
(Type VII) which showed the best healing performance at room temperature are also tested at 
low temperature to verify the effectiveness of self-healing at low temperature. However, the 
modified composite samples, in this case, contained HG2 catalyst (instead of Grubbs 1st 
generation catalyst) suitable for self-healing ROMP reaction at low temperature. Self-healing 
performance is evaluated by measuring the NPC and PC fracture toughness of the composite 
samples at -40oC according to ASTM D7905/D7905M. The values of NPC fracture toughness 
are obtained by propagating a delamination at low temperature from the pre-implanted insert in 
the composite sample. The values of PC fracture toughness, on the other hand, are determined by 
propagating the natural precrack (allowed to heal beforehand at low temperature) that is created 
during the NPC test at low temperature. 
Generally, NPC fracture toughness of the composites are found to be increased at lower 
temperature. The PC fracture toughness, on the other hand, remained almost the same as of the 
room temperature. It is thus first concluded from the above investigation that self-healing of FRP 
composites takes place at low temperature (-40oC). NPC fracture toughness of composites is 
increased at low temperature. However, low temperature (-40oC) has no significant effect on the 
self-healing of FRP composites. The type of composite samples (Type VII) that shows the best 





CHAPTER 8  
Conclusions, Contributions and 
Recommendations for Future Work 
8.1   Conclusions 
The investigation is this work offers a complete package of procedures of manufacturing 
FRPC with optimal healing capability starting from the raw materials (fiber, matrix, monomer, 
catalyst, encapsulating reagents etc.) using 5E2N and Grubbs catalyst as healing agents.  
Microcapsules containing liquid 5E2N in the core with PMUF shells have been synthesized 
using the established procedure in literature. The effect of agitation speed and SLS concentration 
is investigated and an optimum combination of speed-SLS concentration is established through 
numerous synthesis trials. The quality of produced microcapsules in terms of average size, size 
distribution, surface morphology and shell thickness are compared. Microcapsules produced with 
optimum process parameters (agitation speed and SLS concentration) meets the desired quality 
standard of microcapsules with good thermal stability and core monomer content. The procedure 
established can be utilized to produce microcapsules of required average size with desired 
quality characteristics.  
In the preliminary investigations, feasibility of self-healing with the microencapsulated 5E2N 
and Grubbs catalyst system is demonstrated by visual observation of the self-healed cracks 
which are created on the resin sample (without fibers) with realistic loading (by high velocity 
projectile impacts). The self-healing of crack in the resin sample is demonstrated to be achieved 
without any requirement for assisting healing by manual intervention. 
Strength based approach of evaluating self-healing performance of FRP composites based on 
the established testing standard (ASTM D7264) was found to be inadequate as the effect of self-
healing on residual flexural properties of the composites cannot be extracted independently. It is 
due to the possible dependence of residual flexural properties of the FRP composites on the 
sample geometry and uncontrolled crack lengths.  
Fracture based approach of evaluating self-healing performance of FRP composites based on 
recently approved ASTM standard (ASTM D7905.7905M-14) for measuring the mode II 
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interlaminar fracture, or delamination, toughness is found to be the better choice. The method is 
based on calibration of compliance of the composite sample with crack lengths under three point 
bending set up and provides values of mode II fracture toughness (𝐺𝐼𝐼
𝐶 ) which is independent of 
geometry of the samples. This method of determining 𝐺𝐼𝐼
𝐶  of the FRP composites, thus, matches 
well within the framework of the current work one of the global objectives of which is to 
propose a protocol of evaluating the healing performance of composites under realistic loading 
conditions and without any requirement for assisting healing by manual interventions. 
The proposed protocol involves the measurement and comparison of mode II fracture 
toughness determined from NPC (non-pre-cracked) and PC (pre-cracked) configurations of both 
regular (without healing capability) and modified (with healing capability) FRP composite 
samples. Healing Performance Index (𝑃𝐼) is defined taking into account the possible 
improvement in PC fracture toughness due to healed crack in modified composites compared 
with PC fracture toughness with unhealed crack in regular composites. It also takes into account 
the possible effect of incorporating microcapsules into the NPC fracture toughness. Healing 
Performance Index (𝑃𝐼) is found to give reliable and much better indication of healing 
compared with conventional healing efficiency in every likely situations as found in different 
scenario analysis and in the real evaluations.  
Investigation of self-healing at room temperature is first carried out with different types of 
FRP composite samples containing varying percentage of microcapsules with different average 
sizes. Two average sizes (100 μm and 45 μm) and three different concentrations (2wt%, 5wt% 
and 8wt%) of microcapsules are selected to investigate their effect on self-healing performance 
of FRP composite. 
Larger microcapsules (average size 100 µm) are found to debond from the matrix more 
easily during the mode II fracture. This limits the self-healing performance of composites 
containing larger microcapsules. Debonding of microcapsules affects both the NPC fracture 
toughness and the PC fracture toughness of modified composites. Increasing the concentration of 
larger microcapsule up to 8 wt% did not help in achieving high PC fracture toughness post 
healing at room temperature. Rather, increased concentration of larger microcapsules degrades 
the base NPC fracture toughness significantly due to the debonding of larger microcapsules as 
evidenced in SEM micrographs. On the contrary, smaller microcapsules (average size 45µm) are 
shown to form good bonding with the matrix leading to excellent improvement of PC fracture 
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toughness post healing at room temperature while not deteriorating the NPC fracture toughness 
at relatively high concentration (8 wt%) of microcapsules. The best healing performance at room 
temperature is obtained with FRP composite samples containing 8wt% of microcapsules of 
average size 45 μm. 
In order to extract the effect of low temperature, investigation of self-healing at low 
temperature (-40oC) is carried out with the same type of FRP composite samples containing 
larger microcapsules (average size 100 μm) which are tested at room temperature. Additionally, 
composite samples containing 8wt% of small microcapsules (average size 45 μm) which showed 
the best healing performance at room temperature are also tested at low temperature to verify the 
effectiveness of self-healing at low temperature. However, the modified composite samples, 
tested at low temperature, contained HG2 catalyst (instead of Grubbs 1st generation catalyst) 
suitable for self-healing ROMP reaction at low temperature. 
Generally, NPC fracture toughness of the composites are found to be increased at lower 
temperature. The PC fracture toughness post healing, on the other hand, remained almost the 
same as of the room temperature. It is thus concluded that low temperature (-40oC) has no 
significant effect on the self-healing of FRP composites. 
8.2   Contributions 
The main contributions from this work are given below. 
1)  A complete package of procedures of producing FRPC with optimal healing capability 
(both at room temperature and low temperature) is offered in this work starting from the 
raw materials (i.e. fiber, resin, monomer, catalyst, encapsulating reagents etc.) 
2)  Self-healing of cracks in the resin sample created with realistic loading (impact of 
projectile) is demonstrated directly by visual observation.  
3)  A suitable protocol for evaluating self-healing performance of FRPC under realistic 
loading conditions and without any requirement for assisting healing by manual 
interventions is proposed and verified to provide reliable indication of realistic healing 
performance.  
4) Effects of agitation speed and SLS concentration on the quality characteristics of 
microcapsules (containing 5E2N monomer) are investigated. The results of the 
investigation can be utilized to produce microcapsules of required average size with 
desired quality characteristics.  
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5)   Effects of average size and concentration of microcapsules on the self-healing 
performance of FRP composites are investigated at room temperature with the current 
healing agent system (i.e. 5E2N/Grubbs catalyst system) 
6)  Effect of low temperature on the self-healing performance of FRP composites are also 
investigated in this work. 
8.3   Recommendations for future work 
Many technical challenges and issues were encountered during the investigations in this 
work. Recommendations for related future work based on the practical experience gained and the 
thorough literature studies are given below 
1)  Physical or chemical functionalization of microcapsule surfaces can improve their 
bonding with the matrix resulting in superior healing performance. 
2) Self-healing of other forms of damages than the delamination in composites can be 
investigated   
3)   Self-healable composites can be made from prepregs incorporated with microcapsules 
and catalyst.  
4)  Efforts can be made to produce line-shaped microcapsules instead of current spherical 
microcapsules to have more encounter events with a propagating cracks. 
5)  Investigations can be made to find alternative catalyst systems which is less expensive or 
find a more efficient ways of utilizing current catalysts to reduce the cost of the 
components.  
6)  Investigations can be made to determine the effects of space conditions (e.g. thermal 
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